Difference between revisions of "LncRNAWiki:Featured"
Line 1: | Line 1: | ||
− | {|class="wikitable sortable" style="width:90%;text-align:center" | + | {|class="wikitable sortable" style="width:90%;text-align:center" |
|- | |- | ||
!Name | !Name | ||
Line 5: | Line 5: | ||
!Alias | !Alias | ||
!Description | !Description | ||
+ | |- | ||
+ | |''FAM3D-AS1'' | ||
+ | |[[FAM3D-AS1]] | ||
+ | |lnc-KCTD6-3 | ||
+ | |FAM3D antisense RNA 1 | ||
+ | |- | ||
+ | |''SHANK2-AS3'' | ||
+ | |[[SHANK2-AS3]] | ||
+ | |N/A | ||
+ | |SHANK2 antisense RNA 3 | ||
|- | |- | ||
|''21A'' | |''21A'' | ||
Line 20: | Line 30: | ||
|7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486 | |7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486 | ||
|RNA, 7SL, cytoplasmic 1 | |RNA, 7SL, cytoplasmic 1 | ||
+ | |- | ||
+ | |''AATBC'' | ||
+ | |[[AATBC]] | ||
+ | |N/A | ||
+ | |apoptosis associated transcript in bladder cancer | ||
|- | |- | ||
|''ABALON'' | |''ABALON'' | ||
Line 25: | Line 40: | ||
|INXS | |INXS | ||
|apoptotic BCL2L1-antisense long non-coding RNA | |apoptotic BCL2L1-antisense long non-coding RNA | ||
+ | |- | ||
+ | |''ABHD11-AS1'' | ||
+ | |[[ABHD11-AS1]] | ||
+ | |NCRNA00035 | ||
+ | |ABHD11 antisense RNA 1 (tail to tail) | ||
+ | |- | ||
+ | |''ABHD15-AS1'' | ||
+ | |[[ABHD15-AS1]] | ||
+ | |linc-TP53I13, lnc-TP53I13 | ||
+ | |ABHD15 antisense RNA 1 | ||
+ | |- | ||
+ | |''ACTA2-AS1'' | ||
+ | |[[ACTA2-AS1]] | ||
+ | |uc001kfo.1, ZXF1 | ||
+ | |ACTA2 antisense RNA 1 | ||
+ | |- | ||
+ | |''ADAMTS9-AS2'' | ||
+ | |[[ADAMTS9-AS2]] | ||
+ | |N/A | ||
+ | |ADAMTS9 antisense RNA 2 | ||
+ | |- | ||
+ | |''ADORA2A-AS1'' | ||
+ | |[[ADORA2A-AS1]] | ||
+ | |FLJ34651 | ||
+ | |ADORA2A antisense RNA 1 | ||
+ | |- | ||
+ | |''AFAP1-AS1'' | ||
+ | |[[AFAP1-AS1]] | ||
+ | |MGC10981 | ||
+ | |AFAP1 antisense RNA 1 | ||
+ | |- | ||
+ | |''AGAP2-AS1'' | ||
+ | |[[AGAP2-AS1]] | ||
+ | |LOC100130776, PUNISHER | ||
+ | |AGAP2 antisense RNA 1 | ||
|- | |- | ||
|''AIRN'' | |''AIRN'' | ||
Line 31: | Line 81: | ||
|Antisense of IGF2R non-protein coding RNA | |Antisense of IGF2R non-protein coding RNA | ||
|- | |- | ||
− | |'' | + | |''Alpha 250/Alpha 280'' |
− | |[[ | + | |[[NONHSAT104559,lnc-NDST1-1:2]] |
− | | | + | |N/A |
− | | | + | |N/A |
+ | |- | ||
+ | |''ANP32A-IT1'' | ||
+ | |[[ANP32A-IT1]] | ||
+ | |FLJ11722, HsT18971 | ||
+ | |ANP32A intronic transcript 1 | ||
+ | |- | ||
+ | |''APOA1-AS'' | ||
+ | |[[APOA1-AS]] | ||
+ | |APOA1 antisense RNA | ||
+ | |N/A | ||
+ | |- | ||
+ | |''APTR'' | ||
+ | |[[APTR]] | ||
+ | |Alu-mediated CDKN1A/p21 | ||
+ | |N/A | ||
+ | |- | ||
+ | |''ARRDC1-AS1'' | ||
+ | |[[ARRDC1-AS1]] | ||
+ | |N/A | ||
+ | |ARRDC1 antisense RNA 1 | ||
+ | |- | ||
+ | |''ASAP1-IT1'' | ||
+ | |[[ASAP1-IT1]] | ||
+ | |HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT | ||
+ | |ASAP1 intronic transcript 1 | ||
+ | |- | ||
+ | |''ASMTL-AS1'' | ||
+ | |[[ASMTL-AS1]] | ||
+ | |FLJ13330 | ||
+ | |ASMTL antisense RNA 1 | ||
+ | |- | ||
+ | |''ATP1A1-AS1'' | ||
+ | |[[ATP1A1-AS1]] | ||
+ | |MGC16179 | ||
+ | |ATP1A1 antisense RNA 1 | ||
+ | |- | ||
+ | |''ATXN8OS'' | ||
+ | |[[NONHSAT034251]] | ||
+ | |NCRNA00003, non-protein coding RNA 3, ATXN8OS, KLHL1AS, SCA8, ENSG00000230223 | ||
+ | |Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand | ||
+ | |- | ||
+ | |''B3GALT5-AS1'' | ||
+ | |[[B3GALT5-AS1]] | ||
+ | |N/A | ||
+ | |B3GALT5 antisense RNA 1 | ||
+ | |- | ||
+ | |''B4GALT1-AS1'' | ||
+ | |[[B4GALT1-AS1]] | ||
+ | |N/A | ||
+ | |B4GALT1 antisense RNA 1 | ||
+ | |- | ||
+ | |''BAALC-AS2'' | ||
+ | |[[BAALC-AS2]] | ||
+ | |MGC39526 | ||
+ | |BAALC antisense RNA 2 | ||
+ | |- | ||
+ | |''BACE1-AS'' | ||
+ | |[[NONHSAT024403,lnc-RNF214-1:2]] | ||
+ | |BACE1AS,NCRNA00177; FJ573250 | ||
+ | |BACE1 antisense RNA | ||
+ | |- | ||
+ | |''BANCR'' | ||
+ | |[[BANCR]] | ||
+ | |LINC00586 | ||
+ | |BRAF-activated non-protein coding RNA | ||
+ | |- | ||
+ | |''BCAR4'' | ||
+ | |[[BCAR4]] | ||
+ | |N/A | ||
+ | |breast cancer anti-estrogen resistance 4 (non-protein coding) | ||
|- | |- | ||
|''BCYRN1'' | |''BCYRN1'' | ||
Line 40: | Line 160: | ||
|BC200,BC200a, NCRNA00004, LINC00004 | |BC200,BC200a, NCRNA00004, LINC00004 | ||
|BCYRN1, brain cytoplasmic RNA 1 | |BCYRN1, brain cytoplasmic RNA 1 | ||
+ | |- | ||
+ | |''BDNF-AS'' | ||
+ | |[[BDNF-AS]] | ||
+ | |BDNF antisense RNA | ||
+ | |BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049 | ||
+ | |- | ||
+ | |''Beta-globin transcripts'' | ||
+ | |[[NONHSAT017676,NONHSAT017675,NONHSAT017674]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |''BFSP2-AS1'' | ||
+ | |[[BFSP2-AS1]] | ||
+ | |MGC2848 | ||
+ | |BFSP2 antisense RNA 1 | ||
+ | |- | ||
+ | |''BGLT3'' | ||
+ | |[[BGLT3]] | ||
+ | |LINC01083, BGL3, lncRNA-BGL3 | ||
+ | |beta globin locus transcript 3 (non-protein coding) | ||
+ | |- | ||
+ | |''BIN3-IT1'' | ||
+ | |[[BIN3-IT1]] | ||
+ | |FLJ14107 | ||
+ | |BIN3 intronic transcript 1 | ||
+ | |- | ||
+ | |''BIRC6-AS1'' | ||
+ | |[[BIRC6-AS1]] | ||
+ | |N/A | ||
+ | |BIRC6 antisense RNA 1 | ||
+ | |- | ||
+ | |''BIRC6-AS2'' | ||
+ | |[[BIRC6-AS2]] | ||
+ | |megamind | ||
+ | |BIRC6 antisense RNA 2 | ||
+ | |- | ||
+ | |''BISPR'' | ||
+ | |[[BISPR]] | ||
+ | |N/A | ||
+ | |BST2 interferon stimulated positive regulator (non-protein coding) | ||
+ | |- | ||
+ | |''BLACAT1'' | ||
+ | |[[BLACAT1]] | ||
+ | |linc-UBC1,LINC00912, onco-lncRNA-30 | ||
+ | |bladder cancer associated transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''BOK-AS1'' | ||
+ | |[[BOK-AS1]] | ||
+ | |NCRNA00151, NAToB | ||
+ | |BOK antisense RNA 1 | ||
+ | |- | ||
+ | |''BPESC1'' | ||
+ | |[[BPESC1]] | ||
+ | |NCRNA00187 | ||
+ | |blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding) | ||
+ | |- | ||
+ | |''BRWD1-AS2'' | ||
+ | |[[BRWD1-AS2]] | ||
+ | |N/A | ||
+ | |BRWD1 antisense RNA 2 | ||
+ | |- | ||
+ | |''C1QTNF9B-AS1'' | ||
+ | |[[C1QTNF9B-AS1]] | ||
+ | |PCOTH | ||
+ | |C1QTNF9B antisense RNA 1 | ||
+ | |- | ||
+ | |''C21orf91-OT1'' | ||
+ | |[[C21orf91-OT1]] | ||
+ | |D21S2089E | ||
+ | |C21orf91 overlapping transcript 1 | ||
+ | |- | ||
+ | |''C5orf66-AS1'' | ||
+ | |[[C5orf66-AS1]] | ||
+ | |CTC-276P9.1, Epist | ||
+ | |C5orf66 antisense RNA 1 | ||
+ | |- | ||
+ | |''C5orf66-AS2'' | ||
+ | |[[C5orf66-AS2]] | ||
+ | |N/A | ||
+ | |C5orf66 antisense RNA 2 | ||
+ | |- | ||
+ | |''C8orf34-AS1'' | ||
+ | |[[C8orf34-AS1]] | ||
+ | |N/A | ||
+ | |C8orf34 antisense RNA 1 | ||
+ | |- | ||
+ | |''CACNA1G-AS1'' | ||
+ | |[[CACNA1G-AS1]] | ||
+ | |N/A | ||
+ | |CACNA1G antisense RNA 1 | ||
+ | |- | ||
+ | |''CAHM'' | ||
+ | |[[CAHM]] | ||
+ | |LINC00468 | ||
+ | |colon adenocarcinoma hypermethylated (non-protein coding) | ||
+ | |- | ||
+ | |''CAPN10-AS1'' | ||
+ | |[[CAPN10-AS1]] | ||
+ | |locus959 | ||
+ | |CAPN10 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''CAR Intergenic 10'' | ||
+ | |[[NONHSAT016928,lnc-FANK1-3:1]] | ||
+ | |Intergenic10, CR611911, AK055628 | ||
+ | |Chromatin Associated RNA 10 | ||
+ | |- | ||
+ | |''CARD8-AS1'' | ||
+ | |[[CARD8-AS1]] | ||
+ | |LOC100505812 | ||
+ | |CARD8 antisense RNA 1 | ||
+ | |- | ||
+ | |''CARMN'' | ||
+ | |[[CARMN]] | ||
+ | |CARMEN | ||
+ | |cardiac mesoderm enhancer-associated non-coding RNA | ||
+ | |- | ||
+ | |''CASC11'' | ||
+ | |[[CASC11]] | ||
+ | |TCONSN/A00014535, LINC00990, CARLo-7 | ||
+ | |cancer susceptibility candidate 11 (non-protein coding) | ||
+ | |- | ||
+ | |''CASC15'' | ||
+ | |[[CASC15]] | ||
+ | |N/A | ||
+ | |cancer susceptibility candidate 15 (non-protein coding) | ||
+ | |- | ||
+ | |''CASC19'' | ||
+ | |[[CASC19]] | ||
+ | |CARLo-6 | ||
+ | |cancer susceptibility candidate 19 (non-protein coding) | ||
+ | |- | ||
+ | |''CASC2'' | ||
+ | |[[CASC2]] | ||
+ | |N/A | ||
+ | |cancer susceptibility candidate 2 (non-protein coding) | ||
+ | |- | ||
+ | |''CASC21'' | ||
+ | |[[CASC21]] | ||
+ | |CARLo-2 | ||
+ | |cancer susceptibility candidate 21 (non-protein coding) | ||
+ | |- | ||
+ | |''CASC22'' | ||
+ | |[[CASC22]] | ||
+ | |TCONSN/A00024290, LincRNA-ENST00000515084 | ||
+ | |cancer susceptibility candidate 22 (non-protein coding) | ||
+ | |- | ||
+ | |''CASC8'' | ||
+ | |[[CASC8]] | ||
+ | |LINC00860,CARLo-1 | ||
+ | |cancer susceptibility candidate 8 (non-protein coding) | ||
+ | |- | ||
+ | |''CASC9'' | ||
+ | |[[CASC9]] | ||
+ | |LINC00981, ESCCAL-1 | ||
+ | |cancer susceptibility candidate 9 (non-protein coding) | ||
+ | |- | ||
+ | |''CBR3-AS1'' | ||
+ | |[[CBR3-AS1]] | ||
+ | |PlncRNA-1 | ||
+ | |CBR3 antisense RNA 1 | ||
+ | |- | ||
+ | |''CCAT1'' | ||
+ | |[[CCAT1]] | ||
+ | |CARLo-5, onco-lncRNA-40 | ||
+ | |colon cancer associated transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''CCAT2'' | ||
+ | |[[CCAT2]] | ||
+ | |NCCP1, LINC00873 | ||
+ | |colon cancer associated transcript 2 (non-protein coding) | ||
+ | |- | ||
+ | |''CCDC18-AS1'' | ||
+ | |[[CCDC18-AS1]] | ||
+ | |ENST00000440778.1 | ||
+ | |CCDC18 antisense RNA 1 | ||
+ | |- | ||
+ | |''CCDC26'' | ||
+ | |[[CCDC26]] | ||
+ | |MGC27434, RAM | ||
+ | |CCDC26 long non-coding RNA | ||
+ | |- | ||
+ | |''CCEPR'' | ||
+ | |[[CCEPR]] | ||
+ | |CCHE1 | ||
+ | |cervical carcinoma expressed PCNA regulatory lncRNA | ||
+ | |- | ||
+ | |''CDKN1A-AS1'' | ||
+ | |[[CDKN1A-AS1]] | ||
+ | |p21NAT | ||
+ | |CDKN1A antisense RNA 1 | ||
+ | |- | ||
+ | |''CDKN2B-AS1'' | ||
+ | |[[NONHSAT130421,lnc-C9orf53-2:1]] | ||
+ | |ANRIL, p15AS, ENSG00000240498 | ||
+ | |CDKN2B antisense RNA 1 | ||
+ | |- | ||
+ | |''CDR1-AS'' | ||
+ | |[[CDR1-AS]] | ||
+ | |CDR1NAT, ciRS-7, CDR1as | ||
+ | |CDR1 antisense RNA | ||
+ | |- | ||
+ | |''CDRT7'' | ||
+ | |[[CDRT7]] | ||
+ | |NCRNA00025, LINC00025 | ||
+ | |CMT1A duplicated region transcript 7 (non-protein coding) | ||
+ | |- | ||
+ | |''CDRT8'' | ||
+ | |[[CDRT8]] | ||
+ | |N/A | ||
+ | |CMT1A duplicated region transcript 8 | ||
+ | |- | ||
+ | |''CECR3'' | ||
+ | |[[CECR3]] | ||
+ | |N/A | ||
+ | |cat eye syndrome chromosome region, candidate 3 (non-protein coding) | ||
+ | |- | ||
+ | |''CECR5-AS1'' | ||
+ | |[[CECR5-AS1]] | ||
+ | |NCRNA00017 | ||
+ | |CECR5 antisense RNA 1 | ||
+ | |- | ||
+ | |''CECR7'' | ||
+ | |[[CECR7]] | ||
+ | |SAHL1 | ||
+ | |cat eye syndrome chromosome region, candidate 7 (non-protein coding) | ||
+ | |- | ||
+ | |''CECR9'' | ||
+ | |[[CECR9]] | ||
+ | |N/A | ||
+ | |cat eye syndrome chromosome region, candidate 9 (non-protein coding) | ||
+ | |- | ||
+ | |''CEP83-AS1'' | ||
+ | |[[CEP83-AS1]] | ||
+ | |N/A | ||
+ | |CEP83 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''CIRBP-AS1'' | ||
+ | |[[CIRBP-AS1]] | ||
+ | |MGC39338 | ||
+ | |CIRBP antisense RNA 1 | ||
+ | |- | ||
+ | |''CISTR'' | ||
+ | |[[CISTR]] | ||
+ | |CISTR-ACT, CISTRACT, re52431 | ||
+ | |chondrogenesis-associated transcript | ||
+ | |- | ||
+ | |''CLRN1-AS1'' | ||
+ | |[[CLRN1-AS1]] | ||
+ | |UCRP | ||
+ | |CLRN1 antisense RNA 1 | ||
+ | |- | ||
+ | |''COPG2IT1'' | ||
+ | |[[COPG2IT1]] | ||
+ | |CIT1, NCRNA00170, COPG2AS | ||
+ | |COPG2 imprinted transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''CPS1-IT1'' | ||
+ | |[[CPS1-IT1]] | ||
+ | |PRO0132, CPS1-IT | ||
+ | |CPS1 intronic transcript 1 | ||
+ | |- | ||
+ | |''CRNDE'' | ||
+ | |[[CRNDE]] | ||
+ | |LOC643911, LINC00180, CRNDEP | ||
+ | |colorectal neoplasia differentially expressed (non-protein coding) | ||
+ | |- | ||
+ | |''CSNK1G2-AS1'' | ||
+ | |[[CSNK1G2-AS1]] | ||
+ | |MGC39696 | ||
+ | |CSNK1G2 antisense RNA 1 | ||
+ | |- | ||
+ | |''CSTF3-AS1'' | ||
+ | |[[CSTF3-AS1]] | ||
+ | |N/A | ||
+ | |CSTF3 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''CTBP1-AS'' | ||
+ | |[[CTBP1-AS]] | ||
+ | |PCAT10 | ||
+ | |CTBP1 antisense RNA | ||
+ | |- | ||
+ | |''CTBP1-AS2'' | ||
+ | |[[CTBP1-AS2]] | ||
+ | |MGC21675 | ||
+ | |CTBP1 antisense RNA 2 (head to head) | ||
+ | |- | ||
+ | |''CYP1B1-AS1'' | ||
+ | |[[CYP1B1-AS1]] | ||
+ | |MGC34824 | ||
+ | |CYP1B1 antisense RNA 1 | ||
|- | |- | ||
|''CYP4A22-AS1'' | |''CYP4A22-AS1'' | ||
Line 46: | Line 456: | ||
|CYP4A22 antisense RNA 1 | |CYP4A22 antisense RNA 1 | ||
|- | |- | ||
− | |'' | + | |''CYP51A1-AS1'' |
− | |[[ | + | |[[CYP51A1-AS1]] |
− | | | + | |ENST00000453068, LRRD1-AS1 |
− | | | + | |CYP51A1 antisense RNA 1 |
+ | |- | ||
+ | |''CYYR1-AS1'' | ||
+ | |[[CYYR1-AS1]] | ||
+ | |cysteine and tyrosine rich 1 antisense RNA 1 | ||
+ | |N/A | ||
+ | |- | ||
+ | |''DACOR1'' | ||
+ | |[[DACOR1]] | ||
+ | |TCONSN/A00023265 | ||
+ | |DNMT1-associated colon cancer repressed lncRNA 1 | ||
+ | |- | ||
+ | |''DALIR'' | ||
+ | |[[DALIR]] | ||
+ | |DALI | ||
+ | |DNMT1-associated long intergenic non-coding RNA | ||
+ | |- | ||
+ | |''DANCR'' | ||
+ | |[[DANCR]] | ||
+ | |differentiation antagonizing non-protein coding RNA | ||
+ | |ANCR, AGU2, lncRNA-ANCR | ||
+ | |- | ||
+ | |''DANT1'' | ||
+ | |[[DANT1]] | ||
+ | |N/A | ||
+ | |DXZ4 associated non-coding transcript 1, proximal | ||
+ | |- | ||
+ | |''DANT2'' | ||
+ | |[[DANT2]] | ||
+ | |N/A | ||
+ | |DXZ4 associated non-coding transcript 2, distal | ||
+ | |- | ||
+ | |''DAOA-AS1'' | ||
+ | |[[DAOA-AS1]] | ||
+ | |G30 | ||
+ | |DAOA antisense RNA 1 | ||
+ | |- | ||
+ | |''DAPK1-IT1'' | ||
+ | |[[DAPK1-IT1]] | ||
+ | |N/A | ||
+ | |DAPK1 intronic transcript 1 | ||
+ | |- | ||
+ | |''DBET'' | ||
+ | |[[DBET]] | ||
+ | |DBE-T, DUX4L30 | ||
+ | |D4Z4 binding element transcript (non-protein coding) | ||
+ | |- | ||
+ | |''DBH-AS1'' | ||
+ | |[[DBH-AS1]] | ||
+ | |BPR | ||
+ | |DBH antisense RNA 1 | ||
+ | |- | ||
+ | |''DGCR10'' | ||
+ | |[[DGCR10]] | ||
+ | |DGS-B | ||
+ | |DiGeorge syndrome critical region gene 10 (non-protein coding) | ||
+ | |- | ||
+ | |''DGCR11'' | ||
+ | |[[DGCR11]] | ||
+ | |DGS-D | ||
+ | |DiGeorge syndrome critical region gene 11 (non-protein coding) | ||
+ | |- | ||
+ | |''DGCR12'' | ||
+ | |[[DGCR12]] | ||
+ | |DGS-E | ||
+ | |DiGeorge syndrome critical region gene 12 (non-protein coding) | ||
+ | |- | ||
+ | |''DGCR5'' | ||
+ | |[[DGCR5]] | ||
+ | |NCRNA00037, LINC00037 | ||
+ | |DiGeorge syndrome critical region gene 5 (non-protein coding) | ||
+ | |- | ||
+ | |''DGCR9'' | ||
+ | |[[DGCR9]] | ||
+ | |DGS-A, POM121L5P | ||
+ | |DiGeorge syndrome critical region gene 9 (non-protein coding) | ||
|- | |- | ||
|''DHFR upstream transcripts'' | |''DHFR upstream transcripts'' | ||
|[[NONHSAT102417]] | |[[NONHSAT102417]] | ||
− | | DHFR minor transcript 5'-UTR, ENSG00000228716 | + | |DHFR minor transcript 5'-UTR, ENSG00000228716 |
− | | | + | |N/A |
+ | |- | ||
+ | |''DHRS4-AS1'' | ||
+ | |[[DHRS4-AS1]] | ||
+ | |DHRS4 antisense RNA 1 | ||
+ | |PRO1488,AS1DHRS4 | ||
+ | |- | ||
+ | |''DIAPH2-AS1'' | ||
+ | |[[DIAPH2-AS1]] | ||
+ | |N/A | ||
+ | |DIAPH2 antisense RNA 1 | ||
+ | |- | ||
+ | |''DIO3OS'' | ||
+ | |[[NONHSAT040032,NONHSAT040039]] | ||
+ | |DIO3-AS1, NCRNA00041, non-protein coding RNA 41, ENSG00000258498 | ||
+ | |DIO3 opposite strand/antisense RNA (head to head) | ||
+ | |- | ||
+ | |''DISC1FP1'' | ||
+ | |[[DISC1FP1]] | ||
+ | |N/A | ||
+ | |DISC1 fusion partner 1 (non-protein coding) | ||
|- | |- | ||
|''DISC2'' | |''DISC2'' | ||
Line 60: | Line 565: | ||
|DISC1-AS1, DISC1OS, NCRNA00015 | |DISC1-AS1, DISC1OS, NCRNA00015 | ||
|disrupted in schizophrenia 2 (non-protein coding) | |disrupted in schizophrenia 2 (non-protein coding) | ||
+ | |- | ||
+ | |''DLEU1'' | ||
+ | |[[DLEU1]] | ||
+ | |deleted in lymphocytic leukemia 1 (non-protein coding) | ||
+ | |LEU1, XTP6, NCRNA00021, LINC00021, BCMS1 | ||
+ | |- | ||
+ | |''DLEU2'' | ||
+ | |[[DLEU2]] | ||
+ | |deleted in lymphocytic leukemia 2 (non-protein coding) | ||
+ | |LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG | ||
+ | |- | ||
+ | |''DLG2-AS1'' | ||
+ | |[[DLG2-AS1]] | ||
+ | |PSZA11q14, SZ-1 | ||
+ | |DLG2 antisense RNA 1 | ||
+ | |- | ||
+ | |''DLGAP1-AS3'' | ||
+ | |[[DLGAP1-AS3]] | ||
+ | |N/A | ||
+ | |DLGAP1 antisense RNA 3 | ||
+ | |- | ||
+ | |''DLX6-AS1'' | ||
+ | |[[DLX6-AS1]] | ||
+ | |FLJ34048, Evf-2 | ||
+ | |DLX6 antisense RNA 1 | ||
+ | |- | ||
+ | |''DNM3OS'' | ||
+ | |[[DNM3OS]] | ||
+ | |MIR199A2HG, DNM3-AS1 | ||
+ | |DNM3 opposite strand/antisense RNA | ||
+ | |- | ||
+ | |''DRAIC'' | ||
+ | |[[DRAIC]] | ||
+ | |N/A | ||
+ | |downregulated RNA in cancer, inhibitor of cell invasion and migration | ||
+ | |- | ||
+ | |''DSCR10'' | ||
+ | |[[DSCR10]] | ||
+ | |N/A | ||
+ | |Down syndrome critical region 10 (non-protein coding) | ||
+ | |- | ||
+ | |''DSCR9'' | ||
+ | |[[DSCR9]] | ||
+ | |NCRNA00038 | ||
+ | |Down syndrome critical region 9 (non-protein coding) | ||
+ | |- | ||
+ | |''DUBR'' | ||
+ | |[[DUBR]] | ||
+ | |N/A | ||
+ | |DPPA2 upstream binding RNA | ||
+ | |- | ||
+ | |''EGFR-AS1'' | ||
+ | |[[EGFR-AS1]] | ||
+ | |N/A | ||
+ | |EGFR antisense RNA 1 | ||
|- | |- | ||
|''EGOT'' | |''EGOT'' | ||
|[[NONHSAT087635]] | |[[NONHSAT087635]] | ||
− | |EGO, | + | |EGO, eosinophil granule ontogeny, NCRNA00190, non-protein coding RNA 190, ENSG00000235947 |
|Eosinophil granule ontogeny (EGO) RNA | |Eosinophil granule ontogeny (EGO) RNA | ||
+ | |- | ||
+ | |''ELFN1-AS1'' | ||
+ | |[[ELFN1-AS1]] | ||
+ | |N/A | ||
+ | |ELFN1 antisense RNA 1 | ||
|- | |- | ||
|''EMX2OS'' | |''EMX2OS'' | ||
|[[lnc-PDZD8-3:1]] | |[[lnc-PDZD8-3:1]] | ||
− | |EMX2-AS1, NCRNA00045, | + | |EMX2-AS1, NCRNA00045, non-protein coding RNA 45,ENSG00000229847 |
|Emx2 opposite strand transcript. | |Emx2 opposite strand transcript. | ||
+ | |- | ||
+ | |''ENTPD3-AS1'' | ||
+ | |[[ENTPD3-AS1]] | ||
+ | |FLJ36665 | ||
+ | |ENTPD3 antisense RNA 1 | ||
+ | |- | ||
+ | |''EPB41L4A-AS1'' | ||
+ | |[[EPB41L4A-AS1]] | ||
+ | |TIGA1 | ||
+ | |EPB41L4A antisense RNA 1 | ||
+ | |- | ||
+ | |''EPB41L4A-AS2'' | ||
+ | |[[EPB41L4A-AS2]] | ||
+ | |FLJ11235 | ||
+ | |EPB41L4A antisense RNA 2 (head to head) | ||
+ | |- | ||
+ | |''ERC2-IT1'' | ||
+ | |[[ERC2-IT1]] | ||
+ | |Po42 | ||
+ | |ERC2 intronic transcript 1 | ||
+ | |- | ||
+ | |''ERICD'' | ||
+ | |[[ERICD]] | ||
+ | |TCONS_00014875, ERIC | ||
+ | |E2F1-regulated inhibitor of cell death (non-protein coding) | ||
+ | |- | ||
+ | |''ERICH1-AS1'' | ||
+ | |[[ERICH1-AS1]] | ||
+ | |N/A | ||
+ | |ERICH1 antisense RNA 1 | ||
+ | |- | ||
+ | |''ESRG'' | ||
+ | |[[ESRG]] | ||
+ | |HESRG | ||
+ | |embryonic stem cell related (non-protein coding) | ||
|- | |- | ||
|''Evf2'' | |''Evf2'' | ||
|[[lnc-DLX5-3:1]] | |[[lnc-DLX5-3:1]] | ||
|Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764 | |Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764 | ||
− | | | + | |N/A |
+ | |- | ||
+ | |''EWSAT1'' | ||
+ | |[[EWSAT1]] | ||
+ | |FLJ33768 | ||
+ | |Ewing sarcoma associated transcript 1 | ||
+ | |- | ||
+ | |''EXOC3-AS1'' | ||
+ | |[[EXOC3-AS1]] | ||
+ | |N/A | ||
+ | |EXOC3 antisense RNA 1 | ||
+ | |- | ||
+ | |''EXTL3-AS1'' | ||
+ | |[[EXTL3-AS1]] | ||
+ | |N/A | ||
+ | |EXTL3 antisense RNA 1 | ||
+ | |- | ||
+ | |''F11-AS1'' | ||
+ | |[[F11-AS1]] | ||
+ | |N/A | ||
+ | |F11 antisense RNA 1 | ||
+ | |- | ||
+ | |''FALEC'' | ||
+ | |[[ENST00000416894.1]] | ||
+ | |LINC00568, long intergenic non-protein coding RNA 568, ENSG00000228126.1 | ||
+ | |focally amplified long non-coding RNA in epithelial cancer | ||
+ | |- | ||
+ | |''FAM138A'' | ||
+ | |[[FAM138A]] | ||
+ | |F379 | ||
+ | |family with sequence similarity 138 member A | ||
+ | |- | ||
+ | |''FAM138B'' | ||
+ | |[[FAM138B]] | ||
+ | |F379 | ||
+ | |family with sequence similarity 138 member B | ||
+ | |- | ||
+ | |''FAM138C'' | ||
+ | |[[FAM138C]] | ||
+ | |F379 | ||
+ | |family with sequence similarity 138 member C | ||
+ | |- | ||
+ | |''FAM138D'' | ||
+ | |[[FAM138D]] | ||
+ | |F379 | ||
+ | |family with sequence similarity 138 member D | ||
+ | |- | ||
+ | |''FAM138E'' | ||
+ | |[[FAM138E]] | ||
+ | |F379 | ||
+ | |family with sequence similarity 138 member E | ||
+ | |- | ||
+ | |''FAM138F'' | ||
+ | |[[FAM138F]] | ||
+ | |F379 | ||
+ | |family with sequence similarity 138 member F | ||
+ | |- | ||
+ | |''FAM13A-AS1'' | ||
+ | |[[FAM13A-AS1]] | ||
+ | |NCRNA00039 | ||
+ | |FAM13A antisense RNA 1 | ||
+ | |- | ||
+ | |''FAM201A'' | ||
+ | |[[FAM201A]] | ||
+ | |N/A | ||
+ | |family with sequence similarity 201 member A | ||
+ | |- | ||
+ | |''FAM215A'' | ||
+ | |[[FAM215A]] | ||
+ | |APR-2, LINC00530 | ||
+ | |family with sequence similarity 215 member A (non-protein coding) | ||
+ | |- | ||
+ | |''FAM222A-AS1'' | ||
+ | |[[FAM222A-AS1]] | ||
+ | |N/A | ||
+ | |FAM222A antisense RNA 1 | ||
+ | |- | ||
+ | |''FAM226A'' | ||
+ | |[[FAM226A]] | ||
+ | |MGC34827 | ||
+ | |family with sequence similarity 226 member A (non-protein coding) | ||
+ | |- | ||
+ | |''FAM226B'' | ||
+ | |[[FAM226B]] | ||
+ | |N/A | ||
+ | |family with sequence similarity 226 member B (non-protein coding) | ||
+ | |- | ||
+ | |''FAM27E3'' | ||
+ | |[[FAM27E3]] | ||
+ | |MGC42630 | ||
+ | |family with sequence similarity 27 member E3 | ||
+ | |- | ||
+ | |''FAM41AY1'' | ||
+ | |[[FAM41AY1]] | ||
+ | |N/A | ||
+ | |family with sequence similarity 41 member A, Y-linked 1 | ||
+ | |- | ||
+ | |''FAM41C'' | ||
+ | |[[FAM41C]] | ||
+ | |N/A | ||
+ | |family with sequence similarity 41 member C | ||
+ | |- | ||
+ | |''FAM66C'' | ||
+ | |[[FAM66C]] | ||
+ | |N/A | ||
+ | |family with sequence similarity 66 member C | ||
+ | |- | ||
+ | |''FAM74A3'' | ||
+ | |[[FAM74A3]] | ||
+ | |OTTHUMG00000067149 | ||
+ | |family with sequence similarity 74 member A3 | ||
+ | |- | ||
+ | |''FAM83H-AS1'' | ||
+ | |[[FAM83H-AS1]] | ||
+ | |onco-lncRNA-3 | ||
+ | |FAM83H antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''FAM87A'' | ||
+ | |[[FAM87A]] | ||
+ | |N/A | ||
+ | |family with sequence similarity 87 member A | ||
+ | |- | ||
+ | |''FAS-AS'' | ||
+ | |[[NONHSAT015489]] | ||
+ | |SAF, ENSG00000026103 | ||
+ | |FAS antisense RNA 1 | ||
+ | |- | ||
+ | |''FAS-AS1'' | ||
+ | |[[FAS-AS1]] | ||
+ | |SAF | ||
+ | |FAS antisense RNA 1 | ||
+ | |- | ||
+ | |''FENDRR'' | ||
+ | |[[FENDRR]] | ||
+ | |FOXF1 adjacent non-coding developmental regulatory RNA | ||
+ | |lincFOXF1, onco-lncRNA-21 | ||
+ | |- | ||
+ | |''FGF10-AS1'' | ||
+ | |[[FGF10-AS1]] | ||
+ | |RP11-473L15.2 | ||
+ | |FGF10 antisense RNA 1 | ||
+ | |- | ||
+ | |''FIRRE'' | ||
+ | |[[FIRRE]] | ||
+ | |firre intergenic repeating RNA element | ||
+ | |LINC01200 | ||
+ | |- | ||
+ | |''FLG-AS1'' | ||
+ | |[[FLG-AS1]] | ||
+ | |N/A | ||
+ | |FLG antisense RNA 1 | ||
+ | |- | ||
+ | |''FLVCR1-AS1'' | ||
+ | |[[FLVCR1-AS1]] | ||
+ | |LQK1 | ||
+ | |FLVCR1 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''FMR1-AS1'' | ||
+ | |[[FMR1-AS1]] | ||
+ | |ASFMR1, FMR4 | ||
+ | |FMR1 antisense RNA 1 | ||
+ | |- | ||
+ | |''FOXC2-AS1'' | ||
+ | |[[FOXC2-AS1]] | ||
+ | |ODRUL | ||
+ | |FOXC2 antisense RNA 1 | ||
+ | |- | ||
+ | |''FOXCUT'' | ||
+ | |[[FOXCUT]] | ||
+ | |TCONS_00011636 | ||
+ | |FOXC1 upstream transcript (non-protein coding) | ||
+ | |- | ||
+ | |''FOXG1-AS1'' | ||
+ | |[[FOXG1-AS1]] | ||
+ | |FOXG1-AS | ||
+ | |FOXG1 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''FRGCA'' | ||
+ | |[[FRGCA]] | ||
+ | |LncRNA-AP001631.9 | ||
+ | |FOXM1-regulated, gastric cancer associated | ||
+ | |- | ||
+ | |''FTX'' | ||
+ | |[[FTX]] | ||
+ | |LINC00182,FLJ33139 | ||
+ | |FTX transcript, XIST regulator (non-protein coding) | ||
+ | |- | ||
+ | |''GABPB1-AS1'' | ||
+ | |[[GABPB1-AS1]] | ||
+ | |N/A | ||
+ | |GABPB1 antisense RNA 1 | ||
+ | |- | ||
+ | |''GACAT1'' | ||
+ | |[[GACAT1]] | ||
+ | |LINC00876, AC096655.1-002 | ||
+ | |gastric cancer associated transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''GACAT2'' | ||
+ | |[[GACAT2]] | ||
+ | |HMlincRNA717 | ||
+ | |gastric cancer associated transcript 2 (non-protein coding) | ||
+ | |- | ||
+ | |''GACAT3'' | ||
+ | |[[GACAT3]] | ||
+ | |lncRNA-AC130710 | ||
+ | |gastric cancer associated transcript 3 (non-protein coding) | ||
+ | |- | ||
+ | |''GAPLINC'' | ||
+ | |[[GAPLINC]] | ||
+ | |TCONSN/A00026238 | ||
+ | |gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA | ||
+ | |- | ||
+ | |''GAS1RR'' | ||
+ | |[[GAS1RR]] | ||
+ | |LncRNA-Hh | ||
+ | |GAS1 adjacent regulatory RNA | ||
|- | |- | ||
|''GAS5'' | |''GAS5'' | ||
|[[NONHSAT007663]] | |[[NONHSAT007663]] | ||
− | |SNHG2, ENSG00000234741 | + | |SNHG2, ENSG00000234741 |
− | | | + | |N/A |
+ | |- | ||
+ | |''GAS6-AS1'' | ||
+ | |[[GAS6-AS1]] | ||
+ | |N/A | ||
+ | |GAS6 antisense RNA 1 | ||
+ | |- | ||
+ | |''GAS8-AS1'' | ||
+ | |[[GAS8-AS1]] | ||
+ | |N/A | ||
+ | |GAS8 antisense RNA 1 | ||
+ | |- | ||
+ | |''GATA3-AS1'' | ||
+ | |[[GATA3-AS1]] | ||
+ | |N/A | ||
+ | |GATA3 antisense RNA 1 | ||
+ | |- | ||
+ | |''GATA6-AS1'' | ||
+ | |[[GATA6-AS1]] | ||
+ | |locus5689 | ||
+ | |GATA6 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''GDNF-AS1'' | ||
+ | |[[GDNF-AS1]] | ||
+ | |GDNFOS | ||
+ | |GDNF antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''GHET1'' | ||
+ | |[[GHET1]] | ||
+ | |lncRNA-GHET1 | ||
+ | |gastric carcinoma proliferation enhancing transcript 1 | ||
+ | |- | ||
+ | |''GHRLOS'' | ||
+ | |[[GHRLOS]] | ||
+ | |NCRNA00068,GHRL-AS1 | ||
+ | |ghrelin opposite strand/antisense RNA | ||
+ | |- | ||
+ | |''GLIDR'' | ||
+ | |[[GLIDR]] | ||
+ | |MGC21881, TCONSN/A00015562 | ||
+ | |glioblastoma down-regulated RNA | ||
+ | |- | ||
+ | |''GLIS3-AS1'' | ||
+ | |[[GLIS3-AS1]] | ||
+ | |MGC16153 | ||
+ | |GLIS3 antisense RNA 1 | ||
|- | |- | ||
− | |'' | + | |''GNAS-AS1'' |
− | |[[lnc- | + | |[[lnc-CTSZ-5:1]] |
− | | | + | |GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, non-protein coding RNA 75, SANG, ENSG00000235590 |
− | | | + | |neuroendocrine secretory protein (Nesp) antisense. |
+ | |- | ||
+ | |''GNG12-AS1'' | ||
+ | |[[GNG12-AS1]] | ||
+ | |N/A | ||
+ | |GNG12 antisense RNA 1 | ||
+ | |- | ||
+ | |''GPR1-AS'' | ||
+ | |[[GPR1-AS]] | ||
+ | |GPR1AS | ||
+ | |GPR1 antisense RNA | ||
+ | |- | ||
+ | |''GTSCR1'' | ||
+ | |[[GTSCR1]] | ||
+ | |N/A | ||
+ | |Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding) | ||
|- | |- | ||
|''H19'' | |''H19'' | ||
Line 90: | Line 965: | ||
|Q96MK8,ENSG00000130600 | |Q96MK8,ENSG00000130600 | ||
|H19, imprinted maternally expressed transcript (non-protein coding) | |H19, imprinted maternally expressed transcript (non-protein coding) | ||
+ | |- | ||
+ | |''H1FX-AS1'' | ||
+ | |[[H1FX-AS1]] | ||
+ | |FLJ34151 | ||
+ | |H1FX antisense RNA 1 | ||
+ | |- | ||
+ | |''HAGLR'' | ||
+ | |[[HAGLR]] | ||
+ | |Mdgt | ||
+ | |HOXD antisense growth-associated long non-coding RNA | ||
+ | |- | ||
+ | |''HAND2-AS1'' | ||
+ | |[[HAND2-AS1]] | ||
+ | |DEIN, NBLA00301, FLJ11539 | ||
+ | |HAND2 antisense RNA 1 (head to head) | ||
|- | |- | ||
|''HAR1A'' | |''HAR1A'' | ||
Line 100: | Line 990: | ||
|HAR1R, ENSG00000231133 | |HAR1R, ENSG00000231133 | ||
|highly accelerated region 1B | |highly accelerated region 1B | ||
+ | |- | ||
+ | |''HAS2-AS1'' | ||
+ | |[[HAS2-AS1]] | ||
+ | |HASNT, NCRNA00077 | ||
+ | |HAS2 antisense RNA 1 | ||
+ | |- | ||
+ | |''HCCAT5'' | ||
+ | |[[HCCAT5]] | ||
+ | |HTA, FJ222407 | ||
+ | |hepatocellular carcinoma associated transcript 5 (non-protein coding) | ||
+ | |- | ||
+ | |''HCG27'' | ||
+ | |[[HCG27]] | ||
+ | |bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123 | ||
+ | |HLA complex group 27 (non-protein coding) | ||
+ | |- | ||
+ | |''HCG4'' | ||
+ | |[[HCG4]] | ||
+ | |HCGIV-10, HCGIV.9 | ||
+ | |HLA complex group 4 (non-protein coding) | ||
+ | |- | ||
+ | |''HCG4B'' | ||
+ | |[[HCG4B]] | ||
+ | |HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3 | ||
+ | |HLA complex group 4B (non-protein coding) | ||
+ | |- | ||
+ | |''HCG9'' | ||
+ | |[[HCG9]] | ||
+ | |PERB11, HCGIX, HCGIX4, HCGIX-4 | ||
+ | |HLA complex group 9 (non-protein coding) | ||
+ | |- | ||
+ | |''HCP5'' | ||
+ | |[[HCP5]] | ||
+ | |D6S2650E, P5-1 | ||
+ | |HLA complex P5 (non-protein coding) | ||
+ | |- | ||
+ | |''HEIH'' | ||
+ | |[[HEIH]] | ||
+ | |LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2 | ||
+ | |hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA | ||
+ | |- | ||
+ | |''HELLPAR'' | ||
+ | |[[HELLPAR]] | ||
+ | |LINC-HELLP | ||
+ | |HELLP associated long non-coding RNA | ||
+ | |- | ||
+ | |''HEXA-AS1'' | ||
+ | |[[HEXA-AS1]] | ||
+ | |FLJ13315 | ||
+ | |HEXA antisense RNA 1 | ||
+ | |- | ||
+ | |''HIF1A-AS1'' | ||
+ | |[[HIF1A-AS1]] | ||
+ | |5'aHIF-1A | ||
+ | |HIF1A antisense RNA 1 | ||
+ | |- | ||
+ | |''HIF1A-AS2'' | ||
+ | |[[HIF1A-AS2]] | ||
+ | |3'aHIF-1A, aHIF | ||
+ | |HIF1A antisense RNA 2 | ||
+ | |- | ||
+ | |''HNF1A-AS1'' | ||
+ | |[[HNF1A-AS1]] | ||
+ | |FLJ38690 | ||
+ | |HNF1A antisense RNA 1 | ||
+ | |- | ||
+ | |''HNF4A-AS1'' | ||
+ | |[[HNF4A-AS1]] | ||
+ | |uc002xlx | ||
+ | |HNF4A antisense RNA 1 | ||
+ | |- | ||
+ | |''HORMAD2-AS1'' | ||
+ | |[[HORMAD2-AS1]] | ||
+ | |MTMR3-AS1, NONHSAG033653 | ||
+ | |HORMAD2 antisense RNA 1 | ||
|- | |- | ||
|''HOTAIR'' | |''HOTAIR'' | ||
|[[NONHSAT028508]] | |[[NONHSAT028508]] | ||
− | |Gm16258, Hox antisense intergenic RNA, ENSG00000228630 | + | |Gm16258, Hox antisense intergenic RNA, ENSG00000228630 |
|Hox antisense intergenic RNA | |Hox antisense intergenic RNA | ||
|- | |- | ||
Line 118: | Line 1,083: | ||
|''HOXA11-AS'' | |''HOXA11-AS'' | ||
|[[NONHSAT119704]] | |[[NONHSAT119704]] | ||
− | | | + | |HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, HOXA11 antisense RNA 1 (non-protein coding), HOXA11-AS1, HOXA11S, NCRNA00076, non-protein coding RNA 76, ENSG00000240990 |
|HOXA11 antisense RNA | |HOXA11 antisense RNA | ||
|- | |- | ||
Line 128: | Line 1,093: | ||
|''HOXA-AS3'' | |''HOXA-AS3'' | ||
|[[lnc-EVX1-9:1]] | |[[lnc-EVX1-9:1]] | ||
− | |HOXA6as | + | |HOXA6as |
|HOXA cluster antisense RNA 3 | |HOXA cluster antisense RNA 3 | ||
+ | |- | ||
+ | |''HPVC1'' | ||
+ | |[[HPVC1]] | ||
+ | |PE5L, HPV18E5L | ||
+ | |human papillomavirus (type 18) E5 central sequence-like 1 | ||
+ | |- | ||
+ | |''HTT-AS'' | ||
+ | |[[HTT-AS]] | ||
+ | |HTTAS | ||
+ | |HTT antisense RNA (head to head) | ||
|- | |- | ||
|''HULC'' | |''HULC'' | ||
Line 135: | Line 1,110: | ||
|ENSG00000251164 | |ENSG00000251164 | ||
|hepatocellular carcinoma up-regulated long non-coding RNA | |hepatocellular carcinoma up-regulated long non-coding RNA | ||
+ | |- | ||
+ | |''HYMAI'' | ||
+ | |[[HYMAI]] | ||
+ | |NCRNA00020 | ||
+ | |hydatidiform mole associated and imprinted (non-protein coding) | ||
+ | |- | ||
+ | |''IDI2-AS1'' | ||
+ | |[[IDI2-AS1]] | ||
+ | |HT009, Em:AC022536.4 | ||
+ | |IDI2 antisense RNA 1 | ||
+ | |- | ||
+ | |''IFNG-AS1'' | ||
+ | |[[ENST00000538665.1]] | ||
+ | |LincR-Ifng-3'AS, NEST, Theiler's murine encephalomyelitis virus persistence candidate gene 1, Tmevpg1, ENSG00000255733 | ||
+ | |IFNG antisense RNA 1 | ||
+ | |- | ||
+ | |''IGF2-AS'' | ||
+ | |[[IGF2-AS]] | ||
+ | |PEG8, IGF2-AS1 | ||
+ | |IGF2 antisense RNA | ||
+ | |- | ||
+ | |''ILF3-AS1'' | ||
+ | |[[ILF3-AS1]] | ||
+ | |N/A | ||
+ | |ILF3 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''INE1'' | ||
+ | |[[INE1]] | ||
+ | |NCRNA00010 | ||
+ | |inactivation escape 1 (non-protein coding) | ||
+ | |- | ||
+ | |''INE2'' | ||
+ | |[[INE2]] | ||
+ | |NCRNA00011 | ||
+ | |inactivation escape 2 (non-protein coding) | ||
|- | |- | ||
|''IPW'' | |''IPW'' | ||
Line 140: | Line 1,150: | ||
|NCRNA00002 | |NCRNA00002 | ||
|imprinted in Prader-Willi syndrome | |imprinted in Prader-Willi syndrome | ||
+ | |- | ||
+ | |''IRAIN'' | ||
+ | |[[IRAIN]] | ||
+ | |IGF1R-AS | ||
+ | |IGF1R antisense imprinted non-protein coding RNA | ||
+ | |- | ||
+ | |''JADRR'' | ||
+ | |[[JADRR]] | ||
+ | |lncRNA-JADE | ||
+ | |JADE1 adjacent regulatory RNA | ||
+ | |- | ||
+ | |''JMJD1C-AS1'' | ||
+ | |[[JMJD1C-AS1]] | ||
+ | |N/A | ||
+ | |JMJD1C antisense RNA 1 | ||
|- | |- | ||
|''JPX'' | |''JPX'' | ||
|[[lnc-ZCCHC13-1:1]] | |[[lnc-ZCCHC13-1:1]] | ||
− | |DCBALD06, ENOX, | + | |DCBALD06, ENOX, expressed neighbor of XIST, just proximal to XIST, LINC00183 |
|JPX transcript, XIST activator (non-protein coding) | |JPX transcript, XIST activator (non-protein coding) | ||
+ | |- | ||
+ | |''KANTR'' | ||
+ | |[[KANTR]] | ||
+ | |KDM5C adjacent non-coding transcript | ||
+ | |Spasm | ||
+ | |- | ||
+ | |''KCNIP4-IT1'' | ||
+ | |[[NONHSAT095745]] | ||
+ | |non coding transcript UM9(5), UM9-5 | ||
+ | |KCNIP4 intronic transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''KCNK15-AS1'' | ||
+ | |[[KCNK15-AS1]] | ||
+ | |RP11-445H22.4 | ||
+ | |KCNK15 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''KCNMB2-AS1'' | ||
+ | |[[KCNMB2-AS1]] | ||
+ | |RP11-385J1.2 | ||
+ | |KCNMB2 antisense RNA 1 | ||
+ | |- | ||
+ | |''KCNQ1DN'' | ||
+ | |[[KCNQ1DN]] | ||
+ | |BWRT, HSA404617 | ||
+ | |KCNQ1 downstream neighbor (non-protein coding) | ||
|- | |- | ||
|''KCNQ1OT1'' | |''KCNQ1OT1'' | ||
|[[NONHSAT017524]] | |[[NONHSAT017524]] | ||
− | | | + | |KCNQ1 antisense RNA 2 (non-protein coding), KCNQ1 overlapping transcript 1 (non-protein coding), KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, non-protein coding RNA 12 |
|KCNQ1 opposite strand/antisense transcript 1 (non-protein coding) | |KCNQ1 opposite strand/antisense transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''KIAA1614-AS1'' | ||
+ | |[[KIAA1614-AS1]] | ||
+ | |RP11-46A10.4 | ||
+ | |KIAA1614 antisense RNA 1 | ||
+ | |- | ||
+ | |''KIF25-AS1'' | ||
+ | |[[KIF25-AS1]] | ||
+ | |HGC6.1.1 | ||
+ | |KIF25 antisense RNA 1 | ||
|- | |- | ||
|''KRASP1'' | |''KRASP1'' | ||
|[[NONHSAT113225]] | |[[NONHSAT113225]] | ||
− | |ENSG00000220635 | + | |ENSG00000220635 |
|KRAS Pseudogene 1 | |KRAS Pseudogene 1 | ||
|- | |- | ||
− | |'' | + | |''LAMP5-AS1'' |
− | |[[ | + | |[[LAMP5-AS1]] |
− | | | + | |N/A |
− | | | + | |LAMP5 antisense RNA 1 |
+ | |- | ||
+ | |''LBX2-AS1'' | ||
+ | |[[LBX2-AS1]] | ||
+ | |N/A | ||
+ | |LBX2 antisense RNA 1 | ||
+ | |- | ||
+ | |''LCAL1'' | ||
+ | |[[LCAL1]] | ||
+ | |onco-lncRNA-27 | ||
+ | |lung cancer associated lncRNA 1 | ||
+ | |- | ||
+ | |''LHX5-AS1'' | ||
+ | |[[LHX5-AS1]] | ||
+ | |locus4010 | ||
+ | |LHX5 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''LIFR-AS1'' | ||
+ | |[[LIFR-AS1]] | ||
+ | |N/A | ||
+ | |LIFR antisense RNA 1 | ||
+ | |- | ||
+ | |''LINC00029'' | ||
+ | |[[LINC00029]] | ||
+ | |bA305P22.4 | ||
+ | |long intergenic non-protein coding RNA 29 | ||
+ | |- | ||
+ | |''LINC00052'' | ||
+ | |[[LINC00052]] | ||
+ | |FLJ31461 | ||
+ | |long intergenic non-protein coding RNA 52 | ||
+ | |- | ||
+ | |''LINC00094'' | ||
+ | |[[LINC00094]] | ||
+ | |FLJ35348, bA374P20.3 | ||
+ | |long intergenic non-protein coding RNA 94 | ||
+ | |- | ||
+ | |''LINC00114'' | ||
+ | |[[LINC00114]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 114 | ||
+ | |- | ||
+ | |''LINC00115'' | ||
+ | |[[LINC00115]] | ||
+ | |FLJ22639 | ||
+ | |long intergenic non-protein coding RNA 115 | ||
+ | |- | ||
+ | |''LINC00152'' | ||
+ | |[[LINC00152]] | ||
+ | |MGC4677 | ||
+ | |long intergenic non-protein coding RNA 152 | ||
+ | |- | ||
+ | |''LINC00160'' | ||
+ | |[[LINC00160]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 160 | ||
+ | |- | ||
+ | |''LINC00161'' | ||
+ | |[[LINC00161]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 161 | ||
+ | |- | ||
+ | |''LINC00163'' | ||
+ | |[[LINC00163]] | ||
+ | |NLC1-A, NLC1A | ||
+ | |long intergenic non-protein coding RNA 163 | ||
+ | |- | ||
+ | |''LINC00165'' | ||
+ | |[[LINC00165]] | ||
+ | |NLC1-B | ||
+ | |long intergenic non-protein coding RNA 165 | ||
+ | |- | ||
+ | |''LINC00189'' | ||
+ | |[[LINC00189]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 189 | ||
+ | |- | ||
+ | |''LINC00205'' | ||
+ | |[[LINC00205]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 205 | ||
+ | |- | ||
+ | |''LINC00235'' | ||
+ | |[[LINC00235]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 235 | ||
+ | |- | ||
+ | |''LINC00237'' | ||
+ | |[[LINC00237]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 237 | ||
+ | |- | ||
+ | |''LINC00244'' | ||
+ | |[[LINC00244]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 244 | ||
+ | |- | ||
+ | |''LINC00261'' | ||
+ | |[[LINC00261]] | ||
+ | |bA216C10.1, HCCDR1, TCONSN/A00027846, ALIEN, DEANR1, onco-lncRNA-17 | ||
+ | |long intergenic non-protein coding RNA 261 | ||
+ | |- | ||
+ | |''LINC00265'' | ||
+ | |[[LINC00265]] | ||
+ | |NCRNA00265-1 | ||
+ | |long intergenic non-protein coding RNA 265 | ||
+ | |- | ||
+ | |''LINC00272'' | ||
+ | |[[LINC00272]] | ||
+ | |RP1-223H12.3 | ||
+ | |long intergenic non-protein coding RNA 272 | ||
+ | |- | ||
+ | |''LINC00293'' | ||
+ | |[[LINC00293]] | ||
+ | |BEYLA | ||
+ | |long intergenic non-protein coding RNA 293 | ||
+ | |- | ||
+ | |''LINC00294'' | ||
+ | |[[LINC00294]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 294 | ||
+ | |- | ||
+ | |''LINC00299'' | ||
+ | |[[LINC00299]] | ||
+ | |FLJ45673 | ||
+ | |long intergenic non-protein coding RNA 299 | ||
+ | |- | ||
+ | |''LINC00301'' | ||
+ | |[[LINC00301]] | ||
+ | |MGC39681 | ||
+ | |long intergenic non-protein coding RNA 301 | ||
+ | |- | ||
+ | |''LINC00302'' | ||
+ | |[[LINC00302]] | ||
+ | |XP33 | ||
+ | |long intergenic non-protein coding RNA 302 | ||
+ | |- | ||
+ | |''LINC00305'' | ||
+ | |[[LINC00305]] | ||
+ | |MGC39571, HsT1235 | ||
+ | |long intergenic non-protein coding RNA 305 | ||
+ | |- | ||
+ | |''LINC00307'' | ||
+ | |[[LINC00307]] | ||
+ | |D21S2091E | ||
+ | |long intergenic non-protein coding RNA 307 | ||
+ | |- | ||
+ | |''LINC00308'' | ||
+ | |[[LINC00308]] | ||
+ | |PRED16 | ||
+ | |long intergenic non-protein coding RNA 308 | ||
+ | |- | ||
+ | |''LINC00310'' | ||
+ | |[[LINC00310]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 310 | ||
+ | |- | ||
+ | |''LINC00311'' | ||
+ | |[[LINC00311]] | ||
+ | |MGC22001 | ||
+ | |long intergenic non-protein coding RNA 311 | ||
+ | |- | ||
+ | |''LINC00312'' | ||
+ | |[[LINC00312]] | ||
+ | |NAG7, NAG-7, ERR10, LMCD1DN, ERR-10 | ||
+ | |long intergenic non-protein coding RNA 312 | ||
+ | |- | ||
+ | |''LINC00313'' | ||
+ | |[[LINC00313]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 313 | ||
+ | |- | ||
+ | |''LINC00314'' | ||
+ | |[[LINC00314]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 314 | ||
+ | |- | ||
+ | |''LINC00315'' | ||
+ | |[[LINC00315]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 315 | ||
+ | |- | ||
+ | |''LINC00320'' | ||
+ | |[[LINC00320]] | ||
+ | |PRED14, FLJ37539 | ||
+ | |long intergenic non-protein coding RNA 320 | ||
+ | |- | ||
+ | |''LINC00322'' | ||
+ | |[[LINC00322]] | ||
+ | |FLJ16545 | ||
+ | |long intergenic non-protein coding RNA 322 | ||
+ | |- | ||
+ | |''LINC00323'' | ||
+ | |[[LINC00323]] | ||
+ | |PRED42, FLJ37173 | ||
+ | |long intergenic non-protein coding RNA 323 | ||
+ | |- | ||
+ | |''LINC00324'' | ||
+ | |[[LINC00324]] | ||
+ | |FLJ34790, MGC104931 | ||
+ | |long intergenic non-protein coding RNA 324 | ||
+ | |- | ||
+ | |''LINC00334'' | ||
+ | |[[LINC00334]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 334 | ||
+ | |- | ||
+ | |''LINC00337'' | ||
+ | |[[LINC00337]] | ||
+ | |MGC40168 | ||
+ | |long intergenic non-protein coding RNA 337 | ||
+ | |- | ||
+ | |''LINC00339'' | ||
+ | |[[LINC00339]] | ||
+ | |HSPC157 | ||
+ | |long intergenic non-protein coding RNA 339 | ||
+ | |- | ||
+ | |''LINC00342'' | ||
+ | |[[LINC00342]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 342 | ||
+ | |- | ||
+ | |''LINC00346'' | ||
+ | |[[LINC00346]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 346 | ||
+ | |- | ||
+ | |''LINC00347'' | ||
+ | |[[LINC00347]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 347 | ||
+ | |- | ||
+ | |''LINC00426'' | ||
+ | |[[LINC00426]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 426 | ||
+ | |- | ||
+ | |''LINC00441'' | ||
+ | |[[LINC00441]] | ||
+ | |ncRNA-RB1 | ||
+ | |long intergenic non-protein coding RNA 441 | ||
+ | |- | ||
+ | |''LINC00461'' | ||
+ | |[[LINC00461]] | ||
+ | |EyeLinc1, Visc-1a, Visc-1b, Visc-2, LOC645323 | ||
+ | |long intergenic non-protein coding RNA 461 | ||
+ | |- | ||
+ | |''LINC00466'' | ||
+ | |[[LINC00466]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 466 | ||
+ | |- | ||
+ | |''LINC00467'' | ||
+ | |[[LINC00467]] | ||
+ | |MGC14801 | ||
+ | |long intergenic non-protein coding RNA 467 | ||
+ | |- | ||
+ | |''LINC00470'' | ||
+ | |[[LINC00470]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 470 | ||
+ | |- | ||
+ | |''LINC00471'' | ||
+ | |[[LINC00471]] | ||
+ | |MGC43122 | ||
+ | |long intergenic non-protein coding RNA 471 | ||
+ | |- | ||
+ | |''LINC00472'' | ||
+ | |[[LINC00472]] | ||
+ | |dJ288M22.3, FLJ13189 | ||
+ | |long intergenic non-protein coding RNA 472 | ||
+ | |- | ||
+ | |''LINC00473'' | ||
+ | |[[LINC00473]] | ||
+ | |bA142J11.1 | ||
+ | |long intergenic non-protein coding RNA 473 | ||
+ | |- | ||
+ | |''LINC00477'' | ||
+ | |[[LINC00477]] | ||
+ | |FLJ32894, FAM191B | ||
+ | |long intergenic non-protein coding RNA 477 | ||
+ | |- | ||
+ | |''LINC00491'' | ||
+ | |[[LINC00491]] | ||
+ | |BC008363 | ||
+ | |long intergenic non-protein coding RNA 491 | ||
+ | |- | ||
+ | |''LINC00493'' | ||
+ | |[[LINC00493]] | ||
+ | |LOC388789 | ||
+ | |long intergenic non-protein coding RNA 493 | ||
+ | |- | ||
+ | |''LINC00494'' | ||
+ | |[[LINC00494]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 494 | ||
+ | |- | ||
+ | |''LINC00507'' | ||
+ | |[[LINC00507]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 507 | ||
+ | |- | ||
+ | |''LINC00511'' | ||
+ | |[[LINC00511]] | ||
+ | |onco-lncRNA-12 | ||
+ | |long intergenic non-protein coding RNA 511 | ||
+ | |- | ||
+ | |''LINC00518'' | ||
+ | |[[LINC00518]] | ||
+ | |MGC40222 | ||
+ | |long intergenic non-protein coding RNA 518 | ||
+ | |- | ||
+ | |''LINC00526'' | ||
+ | |[[LINC00526]] | ||
+ | |MGC17515, HsT959 | ||
+ | |long intergenic non-protein coding RNA 526 | ||
+ | |- | ||
+ | |''LINC00528'' | ||
+ | |[[LINC00528]] | ||
+ | |FLJ40542 | ||
+ | |long intergenic non-protein coding RNA 528 | ||
+ | |- | ||
+ | |''LINC00529'' | ||
+ | |[[LINC00529]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 529 | ||
+ | |- | ||
+ | |''LINC00536'' | ||
+ | |[[LINC00536]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 536 | ||
+ | |- | ||
+ | |''LINC00538'' | ||
+ | |[[LINC00538]] | ||
+ | |Yiya, PROX1UT | ||
+ | |long intergenic non-protein coding RNA 538 | ||
+ | |- | ||
+ | |''LINC00570'' | ||
+ | |[[ENST00000437795.1,ENST00000432665.1,ENST00000453100.1,ENST00000417473.2]] | ||
+ | |KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, prostate cancer-associated noncoding RNA 1,ENSG00000224177, | ||
+ | |prostate cancer associated transcript 6 (non-protein coding) | ||
+ | |- | ||
+ | |''LINC00575'' | ||
+ | |[[LINC00575]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 575 | ||
+ | |- | ||
+ | |''LINC00581'' | ||
+ | |[[lnc-PRL-6:2,lnc-PRL-6:1]] | ||
+ | |BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678 | ||
+ | |long intergenic non-protein coding RNA 581 | ||
+ | |- | ||
+ | |''LINC00588'' | ||
+ | |[[LINC00588]] | ||
+ | |DKFZP434F122 | ||
+ | |long intergenic non-protein coding RNA 588 | ||
+ | |- | ||
+ | |''LINC00593'' | ||
+ | |[[LINC00593]] | ||
+ | |MGC42951 | ||
+ | |long intergenic non-protein coding RNA 593 | ||
+ | |- | ||
+ | |''LINC00598'' | ||
+ | |[[LINC00598]] | ||
+ | |TTL | ||
+ | |long intergenic non-protein coding RNA 598 | ||
+ | |- | ||
+ | |''LINC00599'' | ||
+ | |[[lnc-TNKS-1:1]] | ||
+ | |retinal non-coding RNA 3, Rncr3, ENSG00000253230 | ||
+ | |Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599 | ||
+ | |- | ||
+ | |''LINC00608'' | ||
+ | |[[LINC00608]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 608 | ||
+ | |- | ||
+ | |''LINC00612'' | ||
+ | |[[LINC00612]] | ||
+ | |MGC40170, FLJ41814 | ||
+ | |long intergenic non-protein coding RNA 612 | ||
+ | |- | ||
+ | |''LINC00620'' | ||
+ | |[[LINC00620]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 620 | ||
+ | |- | ||
+ | |''LINC00623'' | ||
+ | |[[LINC00623]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 623 | ||
+ | |- | ||
+ | |''LINC00628'' | ||
+ | |[[LINC00628]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 628 | ||
+ | |- | ||
+ | |''LINC00632'' | ||
+ | |[[LINC00632]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 632 | ||
+ | |- | ||
+ | |''LINC00634'' | ||
+ | |[[LINC00634]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 634 | ||
+ | |- | ||
+ | |''LINC00635'' | ||
+ | |[[LINC00635]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 635 | ||
+ | |- | ||
+ | |''LINC00636'' | ||
+ | |[[LINC00636]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 636 | ||
+ | |- | ||
+ | |''LINC00638'' | ||
+ | |[[LINC00638]] | ||
+ | |MGC23270 | ||
+ | |long intergenic non-protein coding RNA 638 | ||
+ | |- | ||
+ | |''LINC00649'' | ||
+ | |[[LINC00649]] | ||
+ | |TCONSN/A00028768 | ||
+ | |long intergenic non-protein coding RNA 649 | ||
+ | |- | ||
+ | |''LINC00652'' | ||
+ | |[[LINC00652]] | ||
+ | |HSPC072 | ||
+ | |long intergenic non-protein coding RNA 652 | ||
+ | |- | ||
+ | |''LINC00661'' | ||
+ | |[[LINC00661]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 661 | ||
+ | |- | ||
+ | |''LINC00662'' | ||
+ | |[[LINC00662]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 662 | ||
+ | |- | ||
+ | |''LINC00663'' | ||
+ | |[[LINC00663]] | ||
+ | |MGC39821 | ||
+ | |long intergenic non-protein coding RNA 663 | ||
+ | |- | ||
+ | |''LINC00667'' | ||
+ | |[[LINC00667]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 667 | ||
+ | |- | ||
+ | |''LINC00668'' | ||
+ | |[[LINC00668]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 668 | ||
+ | |- | ||
+ | |''LINC00673'' | ||
+ | |[[LINC00673]] | ||
+ | |HI-LNC75 | ||
+ | |long intergenic non-protein coding RNA 673 | ||
+ | |- | ||
+ | |''LINC00675'' | ||
+ | |[[LINC00675]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 675 | ||
+ | |- | ||
+ | |''LINC00682'' | ||
+ | |[[LINC00682]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 682 | ||
+ | |- | ||
+ | |''LINC00685'' | ||
+ | |[[LINC00685]] | ||
+ | |OTTHUMT00000055574 | ||
+ | |long intergenic non-protein coding RNA 685 | ||
+ | |- | ||
+ | |''LINC00689'' | ||
+ | |[[LINC00689]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 689 | ||
+ | |- | ||
+ | |''LINC00692'' | ||
+ | |[[LINC00692]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 692 | ||
+ | |- | ||
+ | |''LINC00704'' | ||
+ | |[[LINC00704]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 704 | ||
+ | |- | ||
+ | |''LINC00705'' | ||
+ | |[[LINC00705]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 705 | ||
+ | |- | ||
+ | |''LINC00839'' | ||
+ | |[[LINC00839]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 839 | ||
+ | |- | ||
+ | |''LINC00850'' | ||
+ | |[[LINC00850]] | ||
+ | |KUCG1 | ||
+ | |long intergenic non-protein coding RNA 850 | ||
+ | |- | ||
+ | |''LINC00852'' | ||
+ | |[[LINC00852]] | ||
+ | |NAG73, GHRL-AS2 | ||
+ | |long intergenic non-protein coding RNA 852 | ||
+ | |- | ||
+ | |''LINC00853'' | ||
+ | |[[ENST00000429328.2]] | ||
+ | |PDZK1IP1 antisense RNA 1 (non-protein coding), PDZK1IP1 antisense RNA 1 (tail to tail), PDZK1IP1-AS1 ,ENSG00000224805 | ||
+ | |long intergenic non-protein coding RNA 853 | ||
+ | |- | ||
+ | |''LINC00854'' | ||
+ | |[[LINC00854]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 854 | ||
+ | |- | ||
+ | |''LINC00857'' | ||
+ | |[[LINC00857]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 857 | ||
+ | |- | ||
+ | |''LINC00868'' | ||
+ | |[[LINC00868]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 868 | ||
+ | |- | ||
+ | |''LINC00869'' | ||
+ | |[[LINC00869]] | ||
+ | |KIAA0493 | ||
+ | |long intergenic non-protein coding RNA 869 | ||
+ | |- | ||
+ | |''LINC00880'' | ||
+ | |[[LINC00880]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 880 | ||
+ | |- | ||
+ | |''LINC00882'' | ||
+ | |[[LINC00882]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 882 | ||
+ | |- | ||
+ | |''LINC00887'' | ||
+ | |[[LINC00887]] | ||
+ | |linc-ATP13A4-8 | ||
+ | |long intergenic non-protein coding RNA 887 | ||
+ | |- | ||
+ | |''LINC00893'' | ||
+ | |[[LINC00893]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 893 | ||
+ | |- | ||
+ | |''LINC00901'' | ||
+ | |[[LINC00901]] | ||
+ | |TCONSN/A00005428, BC040587 | ||
+ | |long intergenic non-protein coding RNA 901 | ||
+ | |- | ||
+ | |''LINC00917'' | ||
+ | |[[LINC00917]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 917 | ||
+ | |- | ||
+ | |''LINC00936'' | ||
+ | |[[LINC00936]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 936 | ||
+ | |- | ||
+ | |''LINC00942'' | ||
+ | |[[LINC00942]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 942 | ||
+ | |- | ||
+ | |''LINC00950'' | ||
+ | |[[LINC00950]] | ||
+ | |FP588 | ||
+ | |long intergenic non-protein coding RNA 950 | ||
+ | |- | ||
+ | |''LINC00951'' | ||
+ | |[[LINC00951]] | ||
+ | |lincRNA-uc003opf.1, FLJ41649 | ||
+ | |long intergenic non-protein coding RNA 951 | ||
+ | |- | ||
+ | |''LINC00961'' | ||
+ | |[[LINC00961]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 961 | ||
+ | |- | ||
+ | |''LINC00963'' | ||
+ | |[[LINC00963]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 963 | ||
+ | |- | ||
+ | |''LINC00964'' | ||
+ | |[[LINC00964]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 964 | ||
+ | |- | ||
+ | |''LINC00970'' | ||
+ | |[[LINC00970]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 970 | ||
+ | |- | ||
+ | |''LINC00974'' | ||
+ | |[[LINC00974]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 974 | ||
+ | |- | ||
+ | |''LINC00977'' | ||
+ | |[[LINC00977]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 977 | ||
+ | |- | ||
+ | |''LINC00982'' | ||
+ | |[[LINC00982]] | ||
+ | |FLJ42875 | ||
+ | |long intergenic non-protein coding RNA 982 | ||
+ | |- | ||
+ | |''LINC00993'' | ||
+ | |[[LINC00993]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 993 | ||
+ | |- | ||
+ | |''LINC00994'' | ||
+ | |[[LINC00994]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 994 | ||
+ | |- | ||
+ | |''LINC00996'' | ||
+ | |[[LINC00996]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 996 | ||
+ | |- | ||
+ | |''LINC01016'' | ||
+ | |[[LINC01016]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1016 | ||
+ | |- | ||
+ | |''LINC01018'' | ||
+ | |[[LINC01018]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1018 | ||
+ | |- | ||
+ | |''LINC01019'' | ||
+ | |[[LINC01019]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1019 | ||
+ | |- | ||
+ | |''LINC01020'' | ||
+ | |[[LINC01020]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1020 | ||
+ | |- | ||
+ | |''LINC01021'' | ||
+ | |[[LINC01021]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1021 | ||
+ | |- | ||
+ | |''LINC01024'' | ||
+ | |[[LINC01024]] | ||
+ | |MA-linc1 | ||
+ | |long intergenic non-protein coding RNA 1024 | ||
+ | |- | ||
+ | |''LINC01029'' | ||
+ | |[[LINC01029]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1029 | ||
+ | |- | ||
+ | |''LINC01080'' | ||
+ | |[[LINC01080]] | ||
+ | |TCONSN/A00021856 | ||
+ | |long intergenic non-protein coding RNA 1080 | ||
+ | |- | ||
+ | |''LINC01081'' | ||
+ | |[[LINC01081]] | ||
+ | |TCONSN/A00024764 | ||
+ | |long intergenic non-protein coding RNA 1081 | ||
+ | |- | ||
+ | |''LINC01082'' | ||
+ | |[[LINC01082]] | ||
+ | |TCONSN/A00024492 | ||
+ | |long intergenic non-protein coding RNA 1082 | ||
+ | |- | ||
+ | |''LINC01089'' | ||
+ | |[[LINC01089]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1089 | ||
+ | |- | ||
+ | |''LINC01090'' | ||
+ | |[[LINC01090]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1090 | ||
+ | |- | ||
+ | |''LINC01091'' | ||
+ | |[[LINC01091]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1091 | ||
+ | |- | ||
+ | |''LINC01096'' | ||
+ | |[[LINC01096]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1096 | ||
+ | |- | ||
+ | |''LINC01105'' | ||
+ | |[[LINC01105]] | ||
+ | |FLJ30594, LOC150622 | ||
+ | |long intergenic non-protein coding RNA 1105 | ||
+ | |- | ||
+ | |''LINC01108'' | ||
+ | |[[LINC01108]] | ||
+ | |LncRNA-ES1 | ||
+ | |long intergenic non-protein coding RNA 1108 | ||
+ | |- | ||
+ | |''LINC01122'' | ||
+ | |[[LINC01122]] | ||
+ | |FLJ30838 | ||
+ | |long intergenic non-protein coding RNA 1122 | ||
+ | |- | ||
+ | |''LINC01133'' | ||
+ | |[[LINC01133]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1133 | ||
+ | |- | ||
+ | |''LINC01139'' | ||
+ | |[[LINC01139]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1139 | ||
+ | |- | ||
+ | |''LINC01140'' | ||
+ | |[[LINC01140]] | ||
+ | |FLJ41676 | ||
+ | |long intergenic non-protein coding RNA 1140 | ||
+ | |- | ||
+ | |''LINC01150'' | ||
+ | |[[LINC01150]] | ||
+ | |2G7, TCONSN/A00019134 | ||
+ | |long intergenic non-protein coding RNA 1150 | ||
+ | |- | ||
+ | |''LINC01152'' | ||
+ | |[[LINC01152]] | ||
+ | |TCONSN/A00025128, CMPD | ||
+ | |long intergenic non-protein coding RNA 1152 | ||
+ | |- | ||
+ | |''LINC01154'' | ||
+ | |[[LINC01154]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1154 | ||
+ | |- | ||
+ | |''LINC01157'' | ||
+ | |[[LINC01157]] | ||
+ | |TCONSN/A00010378, linc-Enc1 | ||
+ | |long intergenic non-protein coding RNA 1157 | ||
+ | |- | ||
+ | |''LINC01158'' | ||
+ | |[[LINC01158]] | ||
+ | |linc-Brn1a | ||
+ | |long intergenic non-protein coding RNA 1158 | ||
+ | |- | ||
+ | |''LINC01159'' | ||
+ | |[[LINC01159]] | ||
+ | |linc-Brn1b | ||
+ | |long intergenic non-protein coding RNA 1159 | ||
+ | |- | ||
+ | |''LINC01184'' | ||
+ | |[[LINC01184]] | ||
+ | |FLJ33630 | ||
+ | |long intergenic non-protein coding RNA 1184 | ||
+ | |- | ||
+ | |''LINC01185'' | ||
+ | |[[LINC01185]] | ||
+ | |FLJ16341 | ||
+ | |long intergenic non-protein coding RNA 1185 | ||
+ | |- | ||
+ | |''LINC01191'' | ||
+ | |[[LINC01191]] | ||
+ | |VIN, lnc-ACTR3 | ||
+ | |long intergenic non-protein coding RNA 1191 | ||
+ | |- | ||
+ | |''LINC01192'' | ||
+ | |[[LINC01192]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1192 | ||
+ | |- | ||
+ | |''LINC01193'' | ||
+ | |[[LINC01193]] | ||
+ | |LOC348120 | ||
+ | |long intergenic non-protein coding RNA 1193 | ||
+ | |- | ||
+ | |''LINC01194'' | ||
+ | |[[LINC01194]] | ||
+ | |TAG | ||
+ | |long intergenic non-protein coding RNA 1194 | ||
+ | |- | ||
+ | |''LINC01202'' | ||
+ | |[[LINC01202]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1202 | ||
+ | |- | ||
+ | |''LINC01207'' | ||
+ | |[[LINC01207]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1207 | ||
+ | |- | ||
+ | |''LINC01225'' | ||
+ | |[[LINC01225]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1225 | ||
+ | |- | ||
+ | |''LINC01228'' | ||
+ | |[[LINC01228]] | ||
+ | |lincRNA-DYNLRB2-2 | ||
+ | |long intergenic non-protein coding RNA 1228 | ||
+ | |- | ||
+ | |''LINC01230'' | ||
+ | |[[LINC01230]] | ||
+ | |linc-DMRT2, lnc-DRMT2, TCONSN/A00015639 | ||
+ | |long intergenic non-protein coding RNA 1230 | ||
+ | |- | ||
+ | |''LINC01232'' | ||
+ | |[[LINC01232]] | ||
+ | |FLJ41590, TCONSN/A00021520 | ||
+ | |long intergenic non-protein coding RNA 1232 | ||
+ | |- | ||
+ | |''LINC01233'' | ||
+ | |[[LINC01233]] | ||
+ | |XLOCN/A013014 | ||
+ | |long intergenic non-protein coding RNA 1233 | ||
+ | |- | ||
+ | |''LINC01234'' | ||
+ | |[[LINC01234]] | ||
+ | |onco-lncRNA-32 | ||
+ | |long intergenic non-protein coding RNA 1234 | ||
+ | |- | ||
+ | |''LINC01252'' | ||
+ | |[[LINC01252]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1252 | ||
+ | |- | ||
+ | |''LINC01262'' | ||
+ | |[[LINC01262]] | ||
+ | |TCONSN/Al2N/A00021807, RP11-462G22.1 | ||
+ | |long intergenic non-protein coding RNA 1262 | ||
+ | |- | ||
+ | |''LINC01264'' | ||
+ | |[[LINC01264]] | ||
+ | |RP11-124O11.2 | ||
+ | |long intergenic non-protein coding RNA 1264 | ||
+ | |- | ||
+ | |''LINC01268'' | ||
+ | |[[LINC01268]] | ||
+ | |LOC285758 | ||
+ | |long intergenic non-protein coding RNA 1268 | ||
+ | |- | ||
+ | |''LINC01296'' | ||
+ | |[[LINC01296]] | ||
+ | |FLJ39632 | ||
+ | |long intergenic non-protein coding RNA 1296 | ||
+ | |- | ||
+ | |''LINC01312'' | ||
+ | |[[LINC01312]] | ||
+ | |MGC34034 | ||
+ | |long intergenic non-protein coding RNA 1312 | ||
+ | |- | ||
+ | |''LINC01317'' | ||
+ | |[[LINC01317]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1317 | ||
+ | |- | ||
+ | |''LINC01370'' | ||
+ | |[[LINC01370]] | ||
+ | |HI-LNC25 | ||
+ | |long intergenic non-protein coding RNA 1370 | ||
+ | |- | ||
+ | |''LINC01374'' | ||
+ | |[[LINC01374]] | ||
+ | |TCONSN/A00018278 | ||
+ | |long intergenic non-protein coding RNA 1374 | ||
+ | |- | ||
+ | |''LINC01405'' | ||
+ | |[[LINC01405]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1405 | ||
+ | |- | ||
+ | |''LINC01411'' | ||
+ | |[[LINC01411]] | ||
+ | |RP11-267A15.1 | ||
+ | |long intergenic non-protein coding RNA 1411 | ||
+ | |- | ||
+ | |''LINC01420'' | ||
+ | |[[LINC01420]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1420 | ||
+ | |- | ||
+ | |''LINC01433'' | ||
+ | |[[LINC01433]] | ||
+ | |LOC728228 | ||
+ | |long intergenic non-protein coding RNA 1433 | ||
+ | |- | ||
+ | |''LINC01435'' | ||
+ | |[[LINC01435]] | ||
+ | |RP11-215N21.1, TCONSN/A00018040 | ||
+ | |long intergenic non-protein coding RNA 1435 | ||
+ | |- | ||
+ | |''LINC01436'' | ||
+ | |[[LINC01436]] | ||
+ | |AP000688.8 | ||
+ | |long intergenic non-protein coding RNA 1436 | ||
+ | |- | ||
+ | |''LINC01468'' | ||
+ | |[[LINC01468]] | ||
+ | |lnc-MBL2-4 | ||
+ | |long intergenic non-protein coding RNA 1468 | ||
+ | |- | ||
+ | |''LINC01478'' | ||
+ | |[[LINC01478]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1478 | ||
+ | |- | ||
+ | |''LINC01501'' | ||
+ | |[[LINC01501]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1501 | ||
+ | |- | ||
+ | |''LINC01503'' | ||
+ | |[[LINC01503]] | ||
+ | |lnc-PPP2R4-5 | ||
+ | |long intergenic non-protein coding RNA 1503 | ||
+ | |- | ||
+ | |''LINC01507'' | ||
+ | |[[LINC01507]] | ||
+ | |XLOCN/A000303 | ||
+ | |long intergenic non-protein coding RNA 1507 | ||
+ | |- | ||
+ | |''LINC01511'' | ||
+ | |[[LINC01511]] | ||
+ | |RP11-325I22.2 | ||
+ | |long intergenic non-protein coding RNA 1511 | ||
+ | |- | ||
+ | |''LINC01512'' | ||
+ | |[[LINC01512]] | ||
+ | |LOC100132354, TCONSN/A00011120, HI-LNC77 | ||
+ | |long intergenic non-protein coding RNA 1512 | ||
+ | |- | ||
+ | |''LINC01513'' | ||
+ | |[[LINC01513]] | ||
+ | |RP11-1C1.7, TCONSN/A00009352 | ||
+ | |long intergenic non-protein coding RNA 1513 | ||
+ | |- | ||
+ | |''LINC01525'' | ||
+ | |[[LINC01525]] | ||
+ | |lnc-MAN1A2-1 | ||
+ | |long intergenic non-protein coding RNA 1525 | ||
+ | |- | ||
+ | |''LINC01526'' | ||
+ | |[[LINC01526]] | ||
+ | |Lnc-FAM46A-1 | ||
+ | |long intergenic non-protein coding RNA 1526 | ||
+ | |- | ||
+ | |''LINC01527'' | ||
+ | |[[LINC01527]] | ||
+ | |lnc-SPRR2D-1 | ||
+ | |long intergenic non-protein coding RNA 1527 | ||
+ | |- | ||
+ | |''LINC01537'' | ||
+ | |[[LINC01537]] | ||
+ | |RP11-169D4.1-001 | ||
+ | |long intergenic non-protein coding RNA 1537 | ||
+ | |- | ||
+ | |''LINC01547'' | ||
+ | |[[LINC01547]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1547 | ||
+ | |- | ||
+ | |''LINC01553'' | ||
+ | |[[LINC01553]] | ||
+ | |AC023904.2 | ||
+ | |long intergenic non-protein coding RNA 1553 | ||
+ | |- | ||
+ | |''LINC01558'' | ||
+ | |[[LINC01558]] | ||
+ | |HGC6.2, dJ431P23.4 | ||
+ | |long intergenic non-protein coding RNA 1558 | ||
+ | |- | ||
+ | |''LINC01559'' | ||
+ | |[[LINC01559]] | ||
+ | |FLJ33810 | ||
+ | |long intergenic non-protein coding RNA 1559 | ||
+ | |- | ||
+ | |''LINC01560'' | ||
+ | |[[LINC01560]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1560 | ||
+ | |- | ||
+ | |''LINC01562'' | ||
+ | |[[LINC01562]] | ||
+ | |RP11-296A18.3 | ||
+ | |long intergenic non-protein coding RNA 1562 | ||
+ | |- | ||
+ | |''LINC01564'' | ||
+ | |[[LINC01564]] | ||
+ | |TCONSN/A00011314 | ||
+ | |long intergenic non-protein coding RNA 1564 | ||
+ | |- | ||
+ | |''LINC01565'' | ||
+ | |[[LINC01565]] | ||
+ | |GR6 | ||
+ | |long intergenic non-protein coding RNA 1565 | ||
+ | |- | ||
+ | |''LINC01574'' | ||
+ | |[[LINC01574]] | ||
+ | |HI-LNC12, TCONSN/A00009551 | ||
+ | |long intergenic non-protein coding RNA 1574 | ||
+ | |- | ||
+ | |''LINC01587'' | ||
+ | |[[LINC01587]] | ||
+ | |aC1 | ||
+ | |long intergenic non-protein coding RNA 1587 | ||
+ | |- | ||
+ | |''LINC01589'' | ||
+ | |[[LINC01589]] | ||
+ | |CTA-941F9.9, TCONSN/A00029353 | ||
+ | |long intergenic non-protein coding RNA 1589 | ||
+ | |- | ||
+ | |''LINC01591'' | ||
+ | |[[LINC01591]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA 1591 | ||
+ | |- | ||
+ | |''LINC01602'' | ||
+ | |[[LINC01602]] | ||
+ | |T1560 | ||
+ | |long intergenic non-protein coding RNA 1602 | ||
+ | |- | ||
+ | |''LINC01611'' | ||
+ | |[[LINC01611]] | ||
+ | |RP1-90L14.1, TCONSN/Al2N/A00025430 | ||
+ | |long intergenic non-protein coding RNA 1611 | ||
+ | |- | ||
+ | |''LINC01612'' | ||
+ | |[[LINC01612]] | ||
+ | |RP11-789C1.1, TCONSN/A00008319 | ||
+ | |long intergenic non-protein coding RNA 1612 | ||
+ | |- | ||
+ | |''LINC01613'' | ||
+ | |[[LINC01613]] | ||
+ | |n341773 | ||
+ | |long intergenic non-protein coding RNA 1613 | ||
+ | |- | ||
+ | |''LINC01614'' | ||
+ | |[[LINC01614]] | ||
+ | |LCAL4, TCONSN/A00003105 | ||
+ | |long intergenic non-protein coding RNA 1614 | ||
+ | |- | ||
+ | |''LINC01616'' | ||
+ | |[[LINC01616]] | ||
+ | |n341006 | ||
+ | |long intergenic non-protein coding RNA 1616 | ||
+ | |- | ||
+ | |''LINC01617'' | ||
+ | |[[LINC01617]] | ||
+ | |XLOCN/A006844 | ||
+ | |long intergenic non-protein coding RNA 1617 | ||
+ | |- | ||
+ | |''LINC01618'' | ||
+ | |[[LINC01618]] | ||
+ | |LOC152578 | ||
+ | |long intergenic non-protein coding RNA 1618 | ||
+ | |- | ||
+ | |''LINC01622'' | ||
+ | |[[LINC01622]] | ||
+ | |TCONSN/A00011202 | ||
+ | |long intergenic non-protein coding RNA 1622 | ||
+ | |- | ||
+ | |''LINC01627'' | ||
+ | |[[LINC01627]] | ||
+ | |RP11-397D12.4 | ||
+ | |long intergenic non-protein coding RNA 1627 | ||
+ | |- | ||
+ | |''LINC01628'' | ||
+ | |[[LINC01628]] | ||
+ | |AC007403.1 | ||
+ | |long intergenic non-protein coding RNA 1628 | ||
+ | |- | ||
+ | |''LINC01629'' | ||
+ | |[[LINC01629]] | ||
+ | |linc-KIAA1737-2 | ||
+ | |long intergenic non-protein coding RNA 1629 | ||
+ | |- | ||
+ | |''LINCMD1'' | ||
+ | |[[LINCMD1]] | ||
+ | |N/A | ||
+ | |long intergenic non-protein coding RNA, muscle differentiation 1 | ||
+ | |- | ||
+ | |''LINC-PINT'' | ||
+ | |[[LINC-PINT]] | ||
+ | |FLJ43663, PINT, LincRNA-Pint | ||
+ | |long intergenic non-protein coding RNA, p53 induced transcript | ||
|- | |- | ||
|''lincRNA-ROR'' | |''lincRNA-ROR'' | ||
Line 165: | Line 2,325: | ||
|ROR, lincRNA-ST8SIA3, ENSG00000258609 | |ROR, lincRNA-ST8SIA3, ENSG00000258609 | ||
|long intergenic non-protein coding RNA, regulator of reprogramming | |long intergenic non-protein coding RNA, regulator of reprogramming | ||
+ | |- | ||
+ | |''LINGO1-AS1'' | ||
+ | |[[LINGO1-AS1]] | ||
+ | |N/A | ||
+ | |LINGO1 antisense RNA 1 | ||
+ | |- | ||
+ | |''LMCD1-AS1'' | ||
+ | |[[LMCD1-AS1]] | ||
+ | |N/A | ||
+ | |LMCD1 antisense RNA 1 (head to head) | ||
|- | |- | ||
|''LOC100887755'' | |''LOC100887755'' | ||
Line 171: | Line 2,341: | ||
|translation regulatory long non-coding RNA 1 | |translation regulatory long non-coding RNA 1 | ||
|- | |- | ||
− | |'' | + | |''LOH12CR2'' |
− | |[[ | + | |[[LOH12CR2]] |
− | | | + | |LOH2CR12 |
− | | | + | |loss of heterozygosity, 12, chromosomal region 2 (non-protein coding) |
+ | |- | ||
+ | |''LOXL1-AS1'' | ||
+ | |[[LOXL1-AS1]] | ||
+ | |N/A | ||
+ | |LOXL1 antisense RNA 1 | ||
+ | |- | ||
+ | |''LPP-AS2'' | ||
+ | |[[LPP-AS2]] | ||
+ | |N/A | ||
+ | |LPP antisense RNA 2 | ||
+ | |- | ||
+ | |''LRP1-AS'' | ||
+ | |[[LRP1-AS]] | ||
+ | |N/A | ||
+ | |LRP1 antisense RNA | ||
+ | |- | ||
+ | |''LRRC75A-AS1'' | ||
+ | |[[LRRC75A-AS1]] | ||
+ | |MGC40157 | ||
+ | |LRRC75A antisense RNA 1 | ||
+ | |- | ||
+ | |''LSINCT5'' | ||
+ | |[[LSINCT5]] | ||
+ | |N/A | ||
+ | |long stress-induced non-coding transcript 5 | ||
+ | |- | ||
+ | |''LUADT1'' | ||
+ | |[[LUADT1]] | ||
+ | |N/A | ||
+ | |lung adenocarcinoma associated transcript 1 | ||
+ | |- | ||
+ | |''LUCAT1'' | ||
+ | |[[LUCAT1]] | ||
+ | |SCAL1 | ||
+ | |lung cancer associated transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''LUNAR1'' | ||
+ | |[[LUNAR1]] | ||
+ | |N/A | ||
+ | |leukemia-associated non-coding IGF1R activator RNA 1 | ||
+ | |- | ||
+ | |''MAFA-AS1'' | ||
+ | |[[MAFA-AS1]] | ||
+ | |RP11-909N17.3, TCONSN/A00014882 | ||
+ | |MAFA antisense RNA 1 | ||
+ | |- | ||
+ | |''MAFG-AS1'' | ||
+ | |[[MAFG-AS1]] | ||
+ | |N/A | ||
+ | |MAFG antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''MAFTRR'' | ||
+ | |[[MAFTRR]] | ||
+ | |linc-MAF-4 | ||
+ | |MAF transcriptional regulator RNA | ||
|- | |- | ||
− | |'' | + | |''MAGEA8-AS1'' |
− | |[[ | + | |[[MAGEA8-AS1]] |
− | | | + | |RP5-869M20.2 |
− | | | + | |MAGEA8 antisense RNA 1 (head to head) |
|- | |- | ||
|''MALAT1'' | |''MALAT1'' | ||
|[[ENST00000534336.1]] | |[[ENST00000534336.1]] | ||
− | |HCN, | + | |HCN, hepcarcin, LINC00047, long intergenic non-protein coding RNA 47, MALAT-1, mascRNA, metastasis associated in lung adenocarcinoma transcript 1, NCRNA00047, NEAT2, non-protein coding RNA 47, nuclear enriched abundant transcript 2, nuclear paraspeckle assembly transcript 2 (non-protein coding), PRO1073, ENSG00000251562 |
|metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | |metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''MAPKAPK5-AS1'' | ||
+ | |[[MAPKAPK5-AS1]] | ||
+ | |FLJ39616 | ||
+ | |MAPKAPK5 antisense RNA 1 | ||
|- | |- | ||
|''mascRNA'' | |''mascRNA'' | ||
Line 190: | Line 2,420: | ||
|Malat1 | |Malat1 | ||
|mascRNA (MALAT1-associated small cytoplasmic RNA) | |mascRNA (MALAT1-associated small cytoplasmic RNA) | ||
+ | |- | ||
+ | |''MCM3AP-AS1'' | ||
+ | |[[MCM3AP-AS1]] | ||
+ | |FLJ10508, NCRNA00031 | ||
+ | |MCM3AP antisense RNA 1 | ||
+ | |- | ||
+ | |''MDC1-AS1'' | ||
+ | |[[MDC1-AS1]] | ||
+ | |MDC1-AS | ||
+ | |MDC1 antisense RNA 1 | ||
+ | |- | ||
+ | |''MEF2C-AS1'' | ||
+ | |[[MEF2C-AS1]] | ||
+ | |N/A | ||
+ | |MEF2C antisense RNA 1 | ||
|- | |- | ||
|''MEG3'' | |''MEG3'' | ||
Line 195: | Line 2,440: | ||
|Gtl2, ENSG00000214548 | |Gtl2, ENSG00000214548 | ||
|maternally expressed 3 (non-protein coding) | |maternally expressed 3 (non-protein coding) | ||
+ | |- | ||
+ | |''MEG8'' | ||
+ | |[[ENST00000553584.1]] | ||
+ | |Bsr, Imprinted RNA near Meg3/Gtl2, Irm, LINC00024, long intergenic non-protein coding RNA 24, NCRNA00024, non-protein coding RNA 24, Rian, RNA Imprinted and Accumulated in Nucleus, ENSG00000258399 | ||
+ | |Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8 | ||
+ | |- | ||
+ | |''MEG9'' | ||
+ | |[[MEG9]] | ||
+ | |LINC00584 | ||
+ | |maternally expressed 9 (non-protein coding) | ||
+ | |- | ||
+ | |''MESTIT1'' | ||
+ | |[[MESTIT1]] | ||
+ | |NCRNA00040, MEST-AS1 | ||
+ | |MEST intronic transcript 1, antisense RNA | ||
+ | |- | ||
+ | |''MGAT3-AS1'' | ||
+ | |[[MGAT3-AS1]] | ||
+ | |TapSAKI | ||
+ | |MGAT3 antisense RNA 1 | ||
+ | |- | ||
+ | |''MHRT'' | ||
+ | |[[MHRT]] | ||
+ | |Myheart | ||
+ | |myosin heavy chain-associated RNA transcript | ||
+ | |- | ||
+ | |''MIAT'' | ||
+ | |[[lnc-CRYBA4-2:1]] | ||
+ | |FLJ25967, gomafu, LINC00066, lncRNA-MIAT, long intergenic non-protein coding RNA 66, NCRNA00066, non-protein coding RNA 66, Rncr2 | ||
+ | |myocardial infarction associated transcript (non-protein coding) | ||
+ | |- | ||
+ | |''MIF-AS1'' | ||
+ | |[[MIF-AS1]] | ||
+ | |LOC284889 | ||
+ | |MIF antisense RNA 1 | ||
+ | |- | ||
+ | |''MIMT1'' | ||
+ | |[[MIMT1]] | ||
+ | |MIM1, NCRNA00067, LINC00067 | ||
+ | |MER1 repeat containing imprinted transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''MINCR'' | ||
+ | |[[MINCR]] | ||
+ | |TCONSN/A00015189 | ||
+ | |MYC-induced long noncoding RNA | ||
+ | |- | ||
+ | |''MIR100HG'' | ||
+ | |[[MIR100HG]] | ||
+ | |AGD1, lncRNA-N2 | ||
+ | |mir-100-let-7a-2 cluster host gene | ||
+ | |- | ||
+ | |''MIR137HG'' | ||
+ | |[[MIR137HG]] | ||
+ | |N/A | ||
+ | |MIR137 host gene | ||
+ | |- | ||
+ | |''MIR155HG'' | ||
+ | |[[MIR155HG]] | ||
+ | |BIC, NCRNA00172 | ||
+ | |MIR155 host gene | ||
+ | |- | ||
+ | |''MIR17HG'' | ||
+ | |[[MIR17HG]] | ||
+ | |FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048 | ||
+ | |miR-17-92a-1 cluster host gene | ||
+ | |- | ||
+ | |''MIR181A2HG'' | ||
+ | |[[MIR181A2HG]] | ||
+ | |N/A | ||
+ | |MIR181A2 host gene | ||
+ | |- | ||
+ | |''MIR210HG'' | ||
+ | |[[MIR210HG]] | ||
+ | |N/A | ||
+ | |MIR210 host gene | ||
+ | |- | ||
+ | |''MIR222HG'' | ||
+ | |[[MIR222HG]] | ||
+ | |Lnc-Ang362 | ||
+ | |MIR222 host gene | ||
+ | |- | ||
+ | |''MIR22HG'' | ||
+ | |[[MIR22HG]] | ||
+ | |MGC14376, DKFZp686O06159, LOC554202 | ||
+ | |MIR22 host gene | ||
+ | |- | ||
+ | |''MIR34AHG'' | ||
+ | |[[MIR34AHG]] | ||
+ | |N/A | ||
+ | |MIR34A host gene | ||
+ | |- | ||
+ | |''MIR4435-2HG'' | ||
+ | |[[MIR4435-2HG]] | ||
+ | |LINC00978, AGD2, AK001796 | ||
+ | |MIR4435-2 host gene | ||
+ | |- | ||
+ | |''MIR503HG'' | ||
+ | |[[MIR503HG]] | ||
+ | |MGC16121, H19X | ||
+ | |MIR503 host gene | ||
+ | |- | ||
+ | |''MIR600HG'' | ||
+ | |[[MIR600HG]] | ||
+ | |GL012, FLJ22161 | ||
+ | |MIR600 host gene | ||
+ | |- | ||
+ | |''MIR663AHG'' | ||
+ | |[[MIR663AHG]] | ||
+ | |RP3-410C9.1 | ||
+ | |MIR663A host gene | ||
+ | |- | ||
+ | |''MIR7-3HG'' | ||
+ | |[[MIR7-3HG]] | ||
+ | |PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2 | ||
+ | |MIR7-3 host gene | ||
+ | |- | ||
+ | |''MIR99AHG'' | ||
+ | |[[MIR99AHG]] | ||
+ | |MONC | ||
+ | |mir-99a-let-7c cluster host gene | ||
+ | |- | ||
+ | |''MIRLET7BHG'' | ||
+ | |[[MIRLET7BHG]] | ||
+ | |linc-Ppara | ||
+ | |MIRLET7B host gene | ||
+ | |- | ||
+ | |''MIRLET7DHG'' | ||
+ | |[[MIRLET7DHG]] | ||
+ | |N/A | ||
+ | |MIRLET7D host gene | ||
+ | |- | ||
+ | |''MKRN3-AS1'' | ||
+ | |[[MKRN3-AS1]] | ||
+ | |FNZ127, NCRNA00009, ZNF127-AS | ||
+ | |MKRN3 antisense RNA 1 | ||
+ | |- | ||
+ | |''MLK7-AS1'' | ||
+ | |[[MLK7-AS1]] | ||
+ | |N/A | ||
+ | |MLK7 antisense RNA 1 | ||
+ | |- | ||
+ | |''MLLT4-AS1'' | ||
+ | |[[MLLT4-AS1]] | ||
+ | |HGC6.4, dJ431P23.3 | ||
+ | |MLLT4 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''MORF4L2-AS1'' | ||
+ | |[[MORF4L2-AS1]] | ||
+ | |N/A | ||
+ | |MORF4L2 antisense RNA 1 | ||
+ | |- | ||
+ | |''MT-LIPCAR'' | ||
+ | |[[MT-LIPCAR]] | ||
+ | |uc022bqs.1, LIPCAR | ||
+ | |mitochondrially encoded long non-coding cardiac associated RNA | ||
+ | |- | ||
+ | |''MYCNOS'' | ||
+ | |[[MYCNOS]] | ||
+ | |NCYM, N-CYM, MYCN-AS1 | ||
+ | |MYCN opposite strand | ||
+ | |- | ||
+ | |''MYCNUT'' | ||
+ | |[[MYCNUT]] | ||
+ | |lncUSMycN | ||
+ | |MYCN upstream transcript (non-protein coding) | ||
+ | |- | ||
+ | |''N4BP2L2-IT2'' | ||
+ | |[[N4BP2L2-IT2]] | ||
+ | |CG030 | ||
+ | |N4BPL2 intronic transcript 2 | ||
+ | |- | ||
+ | |''NALT1'' | ||
+ | |[[NALT1]] | ||
+ | |TCONSN/Al2N/A00029132 | ||
+ | |NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1 | ||
+ | |- | ||
+ | |''NAMA'' | ||
+ | |[[NAMA]] | ||
+ | |N/A | ||
+ | |non-protein coding RNA, associated with MAP kinase pathway and growth arrest | ||
+ | |- | ||
+ | |''NBAT1'' | ||
+ | |[[NBAT1]] | ||
+ | |NBAT-1 | ||
+ | |neuroblastoma associated transcript 1 | ||
+ | |- | ||
+ | |''NBR2'' | ||
+ | |[[NBR2]] | ||
+ | |NCRNA00192 | ||
+ | |neighbor of BRCA1 gene 2 (non-protein coding) | ||
+ | |- | ||
+ | |''NCBP2-AS2'' | ||
+ | |[[NCBP2-AS2]] | ||
+ | |N/A | ||
+ | |NCBP2 antisense RNA 2 (head to head) | ||
+ | |- | ||
+ | |''NCOA7-AS1'' | ||
+ | |[[NCOA7-AS1]] | ||
+ | |N/A | ||
+ | |NCOA7 antisense RNA 1 | ||
|- | |- | ||
|''ncR-PAR'' | |''ncR-PAR'' | ||
|[[NONHSAT102247]] | |[[NONHSAT102247]] | ||
|NCRUPAR, ENSG00000225407 | |NCRUPAR, ENSG00000225407 | ||
+ | |non-protein coding RNA, upstream of F2R/PAR1 | ||
+ | |- | ||
+ | |''NCRUPAR'' | ||
+ | |[[NCRUPAR]] | ||
+ | |ncR-uPAR, ncRuPAR, NCRNA00193 | ||
|non-protein coding RNA, upstream of F2R/PAR1 | |non-protein coding RNA, upstream of F2R/PAR1 | ||
|- | |- | ||
Line 204: | Line 2,654: | ||
|[[lnc-C11orf16-1:1]] | |[[lnc-C11orf16-1:1]] | ||
|29A | |29A | ||
− | |neuroblastoma differentiation marker 29 ([ | + | |neuroblastoma differentiation marker 29 (Castelnuovo (2010),?Pagano (2007)). |
+ | |- | ||
+ | |''NEAT1'' | ||
+ | |[[ENST00000501122.2,NONHSAT022111]] | ||
+ | |MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532 | ||
+ | |Nuclear enriched abundant transcript 1. | ||
+ | |- | ||
+ | |''NFIA-AS1'' | ||
+ | |[[NFIA-AS1]] | ||
+ | |RP5-833A20.1 | ||
+ | |NFIA antisense RNA 1 | ||
+ | |- | ||
+ | |''NIPBL-AS1'' | ||
+ | |[[NIPBL-AS1]] | ||
+ | |NIPBL-AS | ||
+ | |NIPBL antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''NKILA'' | ||
+ | |[[NKILA]] | ||
+ | |N/A | ||
+ | |NF-kappaB interacting long non-coding RNA | ||
+ | |- | ||
+ | |''NKX2-2-AS1'' | ||
+ | |[[NKX2-2-AS1]] | ||
+ | |NKX2-2AS | ||
+ | |NKX2-2 antisense RNA 1 | ||
+ | |- | ||
+ | |''NOP14-AS1'' | ||
+ | |[[NOP14-AS1]] | ||
+ | |RES4-24 | ||
+ | |NOP14 antisense RNA 1 | ||
+ | |- | ||
+ | |''NORAD'' | ||
+ | |[[NORAD]] | ||
+ | |N/A | ||
+ | |non-coding RNA activated by DNA damage | ||
+ | |- | ||
+ | |''NPHP3-AS1'' | ||
+ | |[[NPHP3-AS1]] | ||
+ | |N/A | ||
+ | |NPHP3 antisense RNA 1 | ||
+ | |- | ||
+ | |''NPPA-AS1'' | ||
+ | |[[NPPA-AS1]] | ||
+ | |N/A | ||
+ | |NPPA antisense RNA 1 | ||
+ | |- | ||
+ | |''NPSR1-AS1'' | ||
+ | |[[NPSR1-AS1]] | ||
+ | |AAA1, IMAGE:4827585 | ||
+ | |NPSR1 antisense RNA 1 | ||
+ | |- | ||
+ | |''NPTN-IT1'' | ||
+ | |[[NPTN-IT1]] | ||
+ | |lncRNA-LET | ||
+ | |NPTN intronic transcript 1 | ||
+ | |- | ||
+ | |''NR2F1-AS1'' | ||
+ | |[[NR2F1-AS1]] | ||
+ | |FLJ42709 | ||
+ | |NR2F1 antisense RNA 1 | ||
+ | |- | ||
+ | |''NRAV'' | ||
+ | |[[NRAV]] | ||
+ | |N/A | ||
+ | |negative regulator of antiviral response (non-protein coding) | ||
|- | |- | ||
− | |'' | + | |''NRIR'' |
− | |[[ | + | |[[NRIR]] |
− | | | + | |lncRNA-CMPK2 |
− | + | |negative regulator of interferon response (non-protein coding) | |
|- | |- | ||
|''NRON'' | |''NRON'' | ||
|[[NONHSAT134764]] | |[[NONHSAT134764]] | ||
− | |ENSG00000253079 | + | |ENSG00000253079 |
|non-protein coding RNA, repressor of NFAT | |non-protein coding RNA, repressor of NFAT | ||
|- | |- | ||
|''NTT'' | |''NTT'' | ||
|[[NONHSAT115106]] | |[[NONHSAT115106]] | ||
− | | | + | |N/A |
|noncoding transcript in T cells. | |noncoding transcript in T cells. | ||
+ | |- | ||
+ | |''OIP5-AS1'' | ||
+ | |[[ENST00000500949.2]] | ||
+ | |cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1 | ||
+ | |OIP5 antisense RNA 1 | ||
+ | |- | ||
+ | |''OLMALINC'' | ||
+ | |[[OLMALINC]] | ||
+ | |bA34D15.5, FLJ12974, HI-LNC80 | ||
+ | |oligodendrocyte maturation-associated long intergenic non-coding RNA | ||
|- | |- | ||
|''OTX2-AS1'' | |''OTX2-AS1'' | ||
Line 225: | Line 2,750: | ||
|OTX2OS1, ENSG00000248550 | |OTX2OS1, ENSG00000248550 | ||
|OTX2 antisense RNA 1 (head to head) | |OTX2 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''OVAAL'' | ||
+ | |[[OVAAL]] | ||
+ | |LINC01131,OVAL | ||
+ | |ovarian adenocarcinoma amplified long non-coding RNA | ||
+ | |- | ||
+ | |''PACERR'' | ||
+ | |[[PACERR]] | ||
+ | |PACER, PTGS2-AS1 | ||
+ | |PTGS2 antisense NFKB1 complex-mediated expression regulator RNA | ||
+ | |- | ||
+ | |''PANCR'' | ||
+ | |[[PANCR]] | ||
+ | |N/A | ||
+ | |PITX2 adjacent non-coding RNA | ||
|- | |- | ||
|''PANDAR'' | |''PANDAR'' | ||
Line 230: | Line 2,770: | ||
|P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR | |P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR | ||
|promoter of CDKN1A antisense DNA damage activated RNA | |promoter of CDKN1A antisense DNA damage activated RNA | ||
+ | |- | ||
+ | |''PAPPA-AS1'' | ||
+ | |[[PAPPA-AS1]] | ||
+ | |PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156 | ||
+ | |PAPPA antisense RNA 1 | ||
+ | |- | ||
+ | |''PAPPA-AS2'' | ||
+ | |[[PAPPA-AS2]] | ||
+ | |AGU1 | ||
+ | |PAPPA antisense RNA 2 | ||
+ | |- | ||
+ | |''PART1'' | ||
+ | |[[PART1]] | ||
+ | |DKFZP586D0823, NCRNA00206 | ||
+ | |prostate androgen-regulated transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''PARTICL'' | ||
+ | |[[PARTICL]] | ||
+ | |PARTICLE | ||
+ | |promoter of MAT2A antisense radiation-induced circulating long non-coding RNA | ||
+ | |- | ||
+ | |''PAUPAR'' | ||
+ | |[[PAUPAR]] | ||
+ | |N/A | ||
+ | |PAX6 upstream antisense RNA | ||
+ | |- | ||
+ | |''PAXIP1-AS1'' | ||
+ | |[[PAXIP1-AS1]] | ||
+ | |N/A | ||
+ | |PAXIP1 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''PCA3'' | ||
+ | |[[PCA3]] | ||
+ | |DD3, NCRNA00019, PCAT3 | ||
+ | |prostate cancer associated 3 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT1'' | ||
+ | |[[PCAT1]] | ||
+ | |PCAT-1, PCA1 | ||
+ | |prostate cancer associated transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT14'' | ||
+ | |[[PCAT14]] | ||
+ | |N/A | ||
+ | |prostate cancer associated transcript 14 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT18'' | ||
+ | |[[PCAT18]] | ||
+ | |LINC01092 | ||
+ | |prostate cancer associated transcript 18 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT19'' | ||
+ | |[[PCAT19]] | ||
+ | |LINC01190 | ||
+ | |prostate cancer associated transcript 19 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT29'' | ||
+ | |[[PCAT29]] | ||
+ | |N/A | ||
+ | |prostate cancer associated transcript 29 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT4'' | ||
+ | |[[PCAT4]] | ||
+ | |GDEP, PCAN1, PCA4 | ||
+ | |prostate cancer associated transcript 4 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT5'' | ||
+ | |[[PCAT5]] | ||
+ | |TPCAT-10-36067 | ||
+ | |prostate cancer associated transcript 5 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT6'' | ||
+ | |[[ENST00000425295.1,ENST00000553157.1,ENST00000417262.1]] | ||
+ | |N/A | ||
+ | |Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288 | ||
+ | |- | ||
+ | |''PCAT7'' | ||
+ | |[[PCAT7]] | ||
+ | |PCAN-R2 | ||
+ | |prostate cancer associated transcript 7 (non-protein coding) | ||
+ | |- | ||
+ | |''PCBP2-OT1'' | ||
+ | |[[PCBP2-OT1]] | ||
+ | |TUC338 | ||
+ | |PCBP2 overlapping transcript 1 | ||
+ | |- | ||
+ | |''PCBP3-OT1'' | ||
+ | |[[PCBP3-OT1]] | ||
+ | |FLJ44028 | ||
+ | |PCBP3 overlapping transcript 1 | ||
+ | |- | ||
+ | |''PCF11-AS1'' | ||
+ | |[[PCF11-AS1]] | ||
+ | |ENST00000602322.1 | ||
+ | |PCF11 anstisense RNA 1 | ||
|- | |- | ||
|''PCGEM1'' | |''PCGEM1'' | ||
|[[NONHSAT076153]] | |[[NONHSAT076153]] | ||
− | |ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA | + | |ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA |
|Prostate-specific transcript 1 | |Prostate-specific transcript 1 | ||
|- | |- | ||
− | |'' | + | |''PCNA-AS1'' |
− | |[[ | + | |[[PCNA-AS1]] |
− | | | + | |N/A |
− | | | + | |PCNA antisense RNA 1 |
+ | |- | ||
+ | |''PEG13'' | ||
+ | |[[PEG13]] | ||
+ | |N/A | ||
+ | |paternally expressed 13 | ||
+ | |- | ||
+ | |''PEG3-AS1'' | ||
+ | |[[PEG3-AS1]] | ||
+ | |APEG3, NCRNA00155 | ||
+ | |PEG3 antisense RNA 1 | ||
+ | |- | ||
+ | |''PICSAR'' | ||
+ | |[[PICSAR]] | ||
+ | |PRED74, NLC1-C | ||
+ | |P38 inhibited cutaneous squamous cell carcinoma associated lincRNA | ||
+ | |- | ||
+ | |''PINK1-AS'' | ||
+ | |[[PINK1-AS]] | ||
+ | |FLJ00387, PINK1AS, naPINK1 | ||
+ | |PINK1 antisense RNA | ||
+ | |- | ||
+ | |''PISRT1'' | ||
+ | |[[PISRT1]] | ||
+ | |NCRNA00195 | ||
+ | |polled intersex syndrome regulated transcript 1 (non-protein coding RNA) | ||
+ | |- | ||
+ | |''PR antisense transcripts'' | ||
+ | |[[NONHSAT023851]] | ||
+ | |N/A | ||
+ | |N/A | ||
|- | |- | ||
|''PRINS'' | |''PRINS'' | ||
Line 245: | Line 2,910: | ||
|ENSG00000238115 | |ENSG00000238115 | ||
|Psoriasis susceptibility-related RNA Gene Induced by Stress | |Psoriasis susceptibility-related RNA Gene Induced by Stress | ||
+ | |- | ||
+ | |''PRKCQ-AS1'' | ||
+ | |[[PRKCQ-AS1]] | ||
+ | |ENST00000414894.1 | ||
+ | |PRKCQ antisense RNA 1 | ||
+ | |- | ||
+ | |''PRNCR1'' | ||
+ | |[[PRNCR1]] | ||
+ | |N/A | ||
+ | |prostate cancer associated non-coding RNA 1 | ||
+ | |- | ||
+ | |''PRR7-AS1'' | ||
+ | |[[PRR7-AS1]] | ||
+ | |N/A | ||
+ | |PRR7 antisense RNA 1 | ||
+ | |- | ||
+ | |''PSMA3-AS1'' | ||
+ | |[[PSMA3-AS1]] | ||
+ | |FLJ31306 | ||
+ | |PSMA3 antisense RNA 1 | ||
+ | |- | ||
+ | |''PSMD5-AS1'' | ||
+ | |[[PSMD5-AS1]] | ||
+ | |N/A | ||
+ | |PSMD5 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''PTCSC1'' | ||
+ | |[[NONHSAT129210]] | ||
+ | |AK023948, NCRNA00197 | ||
+ | |papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding) | ||
+ | |- | ||
+ | |''PTCSC2'' | ||
+ | |[[PTCSC2]] | ||
+ | |N/A | ||
+ | |papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding) | ||
+ | |- | ||
+ | |''PTCSC3'' | ||
+ | |[[PTCSC3]] | ||
+ | |N/A | ||
+ | |papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) | ||
|- | |- | ||
|''PTENP1'' | |''PTENP1'' | ||
Line 251: | Line 2,956: | ||
|PTEN Pseudogene 1 | |PTEN Pseudogene 1 | ||
|- | |- | ||
− | |'' | + | |''PTENP1-AS'' |
− | |[[ | + | |[[PTENP1-AS]] |
− | | | + | |PTENpg1-asRNA |
− | | | + | |PTENP1 antisense RNA |
+ | |- | ||
+ | |''PTPRJ-AS1'' | ||
+ | |[[PTPRJ-AS1]] | ||
+ | |N/A | ||
+ | |PTPRJ antisense RNA 1 | ||
+ | |- | ||
+ | |''PVT1'' | ||
+ | |[[PVT1]] | ||
+ | |NCRNA00079, LINC00079, onco-lncRNA-100 | ||
+ | |Pvt1 oncogene (non-protein coding) | ||
+ | |- | ||
+ | |''PWAR1'' | ||
+ | |[[PWAR1]] | ||
+ | |PAR1, PAR-1 | ||
+ | |Prader Willi/Angelman region RNA 1 | ||
+ | |- | ||
+ | |''PWAR4'' | ||
+ | |[[PWAR4]] | ||
+ | |PAR4, PAR-4 | ||
+ | |Prader Willi/Angelman region RNA 4 | ||
+ | |- | ||
+ | |''PWAR5'' | ||
+ | |[[PWAR5]] | ||
+ | |PAR5, PAR-5 | ||
+ | |Prader Willi/Angelman region RNA 5 | ||
+ | |- | ||
+ | |''PWARSN'' | ||
+ | |[[PWARSN]] | ||
+ | |PAR-SN, PARSN | ||
+ | |Prader Willi/Angelman region RNA, SNRPN neighbor | ||
+ | |- | ||
+ | |''PWRN1'' | ||
+ | |[[PWRN1]] | ||
+ | |NCRNA00198 | ||
+ | |Prader-Willi region non-protein coding RNA 1 | ||
+ | |- | ||
+ | |''PWRN2'' | ||
+ | |[[PWRN2]] | ||
+ | |NCRNA00199 | ||
+ | |Prader-Willi region non-protein coding RNA 2 | ||
+ | |- | ||
+ | |''RAD51-AS1'' | ||
+ | |[[RAD51-AS1]] | ||
+ | |TODRA | ||
+ | |RAD51 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''RASSF1-AS1'' | ||
+ | |[[RASSF1-AS1]] | ||
+ | |RASSF1 antisense RNA 1 | ||
+ | |ANRASSF1 | ||
+ | |- | ||
+ | |''RBM5-AS1'' | ||
+ | |[[NONHSAT089783]] | ||
+ | |LUCA-15-specific transcript, LUST, ENSG00000003756 | ||
+ | |RBM5 antisense RNA 1 | ||
+ | |- | ||
+ | |''RFPL1S'' | ||
+ | |[[RFPL1S]] | ||
+ | |RFPL1-AS, NCRNA00006 | ||
+ | |RFPL1 antisense RNA 1 | ||
+ | |- | ||
+ | |''RGMB-AS1'' | ||
+ | |[[RGMB-AS1]] | ||
+ | |N/A | ||
+ | |RGMB antisense RNA 1 | ||
+ | |- | ||
+ | |''RHPN1-AS1'' | ||
+ | |[[RHPN1-AS1]] | ||
+ | |MGC3113 | ||
+ | |RHPN1 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''RMST'' | ||
+ | |[[RMST]] | ||
+ | |NCRMS, NCRNA00054, LINC00054 | ||
+ | |rhabdomyosarcoma 2 associated transcript (non-protein coding) | ||
+ | |- | ||
+ | |''RNF217-AS1'' | ||
+ | |[[RNF217-AS1]] | ||
+ | |STL | ||
+ | |RNF217 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''RNF219-AS1'' | ||
+ | |[[RNF219-AS1]] | ||
+ | |N/A | ||
+ | |RNF219 antisense RNA 1 | ||
+ | |- | ||
+ | |''RPL34-AS1'' | ||
+ | |[[RPL34-AS1]] | ||
+ | |FLJ37673, RP11-462C24.1 | ||
+ | |RPL34 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''RPS6KA2-AS1'' | ||
+ | |[[RPS6KA2-AS1]] | ||
+ | |N/A | ||
+ | |RPS6KA2 antisense RNA 1 | ||
+ | |- | ||
+ | |''RUSC1-AS1'' | ||
+ | |[[RUSC1-AS1]] | ||
+ | |FLJ35976 | ||
+ | |RUSC1 antisense RNA 1 | ||
+ | |- | ||
+ | |''SALRNA1'' | ||
+ | |[[SALRNA1]] | ||
+ | |SAL-RNA1, XLOCN/A023166 | ||
+ | |senescence associated long non-coding RNA 1 | ||
+ | |- | ||
+ | |''SALRNA2'' | ||
+ | |[[SALRNA2]] | ||
+ | |SAL-RNA2, XLOCN/A025931 | ||
+ | |senescence associated long non-coding RNA 2 | ||
+ | |- | ||
+ | |''SALRNA3'' | ||
+ | |[[SALRNA3]] | ||
+ | |SAL-RNA3, XLOCN/A025918 | ||
+ | |senescence associated long non-coding RNA 3 | ||
+ | |- | ||
+ | |''SAMD12-AS1'' | ||
+ | |[[SAMD12-AS1]] | ||
+ | |N/A | ||
+ | |SAMD12 antisense RNA 1 | ||
+ | |- | ||
+ | |''SAMMSON'' | ||
+ | |[[SAMMSON]] | ||
+ | |N/A | ||
+ | |survival associated mitochondrial melanoma specific oncogenic non-coding RNA | ||
+ | |- | ||
+ | |''SAP30L-AS1'' | ||
+ | |[[SAP30L-AS1]] | ||
+ | |FLJ38109, GALNT10-AS1 | ||
+ | |SAP30L antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''SCAANT1'' | ||
+ | |[[SCAANT1]] | ||
+ | |SCA7/ATXN7 antisense RNA 1 | ||
+ | |ATXN7-AS1 | ||
+ | |- | ||
+ | |''SCHLAP1'' | ||
+ | |[[SCHLAP1]] | ||
+ | |SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding) | ||
+ | |SChLAP1,PCAT11 | ||
+ | |- | ||
+ | |''SEC24B-AS1'' | ||
+ | |[[SEC24B-AS1]] | ||
+ | |1/2-SBSRNA4 | ||
+ | |SEC24B antisense RNA 1 | ||
+ | |- | ||
+ | |''SENCR'' | ||
+ | |[[SENCR]] | ||
+ | |smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA | ||
+ | |N/A | ||
+ | |- | ||
+ | |''SGMS1-AS1'' | ||
+ | |[[SGMS1-AS1]] | ||
+ | |N/A | ||
+ | |SGMS1 antisense RNA 1 | ||
+ | |- | ||
+ | |''SIRT1-AS'' | ||
+ | |[[SIRT1-AS]] | ||
+ | |N/A | ||
+ | |SIRT1 antisense RNA | ||
+ | |- | ||
+ | |''SMAD1-AS1'' | ||
+ | |[[SMAD1-AS1]] | ||
+ | |ENST00000513542 | ||
+ | |SMAD1 antisense RNA 1 | ||
+ | |- | ||
+ | |''SMAD5-AS1'' | ||
+ | |[[SMAD5-AS1]] | ||
+ | |DAMS | ||
+ | |SMAD5 antisense RNA 1 | ||
+ | |- | ||
+ | |''SMCR2'' | ||
+ | |[[SMCR2]] | ||
+ | |N/A | ||
+ | |Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding) | ||
+ | |- | ||
+ | |''SMCR5'' | ||
+ | |[[SMCR5]] | ||
+ | |NCRNA00034 | ||
+ | |Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding) | ||
+ | |- | ||
+ | |''SMCR6'' | ||
+ | |[[SMCR6]] | ||
+ | |N/A | ||
+ | |Smith-Magenis syndrome chromosome region, candidate 6 (non-protein coding) | ||
|- | |- | ||
− | |'' | + | |''SMG7-AS1'' |
− | |[[ | + | |[[SMG7-AS1]] |
− | | | + | |DKFZP564C196 |
− | | | + | |SMG7 antisense RNA 1 |
|- | |- | ||
− | |'' | + | |''SNAI3-AS1'' |
− | |[[ | + | |[[SNAI3-AS1]] |
− | | | + | |MGC23284 |
− | | | + | |SNAI3 antisense RNA 1 |
|- | |- | ||
− | |'' | + | |''snaR'' |
− | |[[ | + | |[[lnc-BSPH1-1:1,lnc-BSPH1-2:1]] |
− | | | + | |small NF90-associated RNAs |
− | | | + | |small NF90-associated RNAs |
|- | |- | ||
|''SNHG1'' | |''SNHG1'' | ||
Line 275: | Line 3,165: | ||
|UHG, ENSG00000255717 | |UHG, ENSG00000255717 | ||
|SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene. | |SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene. | ||
+ | |- | ||
+ | |''SNHG10'' | ||
+ | |[[SNHG10]] | ||
+ | |FLJ40557, NCRNA00063, LINC00063 | ||
+ | |small nucleolar RNA host gene 10 | ||
+ | |- | ||
+ | |''SNHG11'' | ||
+ | |[[SNHG11]] | ||
+ | |LINC00101 | ||
+ | |small nucleolar RNA host gene 11 | ||
+ | |- | ||
+ | |''SNHG12'' | ||
+ | |[[SNHG12]] | ||
+ | |PNAS-123, LINC00100, ASLNC04080 | ||
+ | |small nucleolar RNA host gene 12 | ||
+ | |- | ||
+ | |''SNHG14'' | ||
+ | |[[SNHG14]] | ||
+ | |NCRNA00214, UBE3A-AS | ||
+ | |small nucleolar RNA host gene 14 | ||
+ | |- | ||
+ | |''SNHG15'' | ||
+ | |[[SNHG15]] | ||
+ | |FLJ38860, MYO1GUT, Linc-Myo1g | ||
+ | |small nucleolar RNA host gene 15 | ||
+ | |- | ||
+ | |''SNHG16'' | ||
+ | |[[SNHG16]] | ||
+ | |ncRAN | ||
+ | |small nucleolar RNA host gene 16 | ||
+ | |- | ||
+ | |''SNHG20'' | ||
+ | |[[SNHG20]] | ||
+ | |PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG | ||
+ | |small nucleolar RNA host gene 20 | ||
|- | |- | ||
|''SNHG3'' | |''SNHG3'' | ||
Line 295: | Line 3,220: | ||
|U87HG, ENSG00000245910 | |U87HG, ENSG00000245910 | ||
|Small nucleolar RNA host gene 6 | |Small nucleolar RNA host gene 6 | ||
+ | |- | ||
+ | |''SNHG7'' | ||
+ | |[[SNHG7]] | ||
+ | |MGC16037, NCRNA00061 | ||
+ | |small nucleolar RNA host gene 7 | ||
+ | |- | ||
+ | |''SNHG8'' | ||
+ | |[[SNHG8]] | ||
+ | |NCRNA00060, LINC00060 | ||
+ | |small nucleolar RNA host gene 8 | ||
+ | |- | ||
+ | |''SOCS2-AS1'' | ||
+ | |[[SOCS2-AS1]] | ||
+ | |N/A | ||
+ | |SOCS2 antisense RNA 1 | ||
+ | |- | ||
+ | |''SOX21-AS1'' | ||
+ | |[[SOX21-AS1]] | ||
+ | |N/A | ||
+ | |SOX21 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''SOX2-OT'' | ||
+ | |[[SOX2-OT]] | ||
+ | |DKFZp761J1324, NCRNA00043 | ||
+ | |SOX2 overlapping transcript | ||
+ | |- | ||
+ | |''SPATA3-AS1'' | ||
+ | |[[SPATA3-AS1]] | ||
+ | |N/A | ||
+ | |SPATA3 antisense RNA 1 (head to head) | ||
|- | |- | ||
|''SPRY4-IT1'' | |''SPRY4-IT1'' | ||
Line 305: | Line 3,260: | ||
|SRA1, ENSG00000213523 | |SRA1, ENSG00000213523 | ||
|Steroid receptor RNA Activator | |Steroid receptor RNA Activator | ||
+ | |- | ||
+ | |''ST7-AS1'' | ||
+ | |[[ST7-AS1]] | ||
+ | |ST7AS1 | ||
+ | |ST7 antisense RNA 1 | ||
+ | |- | ||
+ | |''ST7-AS2'' | ||
+ | |[[ST7-AS2]] | ||
+ | |ST7AS2 | ||
+ | |ST7 antisense RNA 2 | ||
+ | |- | ||
+ | |''ST7OT'' | ||
+ | |[[NONHSAT122926,NONHSAT122918,NONHSAT122914,NONHSAT122932]] | ||
+ | |ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188 | ||
+ | |N/A | ||
+ | |- | ||
+ | |''ST7-OT3'' | ||
+ | |[[ST7-OT3]] | ||
+ | |NCRNA00026 | ||
+ | |ST7 overlapping transcript 3 | ||
+ | |- | ||
+ | |''STAM-AS1'' | ||
+ | |[[STAM-AS1]] | ||
+ | |locus3182 | ||
+ | |STAM antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''STX18-AS1'' | ||
+ | |[[STX18-AS1]] | ||
+ | |LOC100507266 | ||
+ | |STX18 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''TARID'' | ||
+ | |[[TARID]] | ||
+ | |N/A | ||
+ | |TCF21 antisense RNA inducing promoter demethylation | ||
+ | |- | ||
+ | |''TCL6'' | ||
+ | |[[TCL6]] | ||
+ | |TCL6e1, TNG2, TNG1 | ||
+ | |T-cell leukemia/lymphoma 6 (non-protein coding) | ||
+ | |- | ||
+ | |''TDRG1'' | ||
+ | |[[TDRG1]] | ||
+ | |LINC00532, lincRNA-NRN/A024015 | ||
+ | |testis development related 1 (non-protein coding) | ||
|- | |- | ||
|''TEA-ncRNAs'' | |''TEA-ncRNAs'' | ||
Line 311: | Line 3,311: | ||
|T early alpha | |T early alpha | ||
|- | |- | ||
− | |'' | + | |''TEX41'' |
− | |[[ | + | |[[TEX41]] |
− | | | + | |DKFZp686O1327, LINC00953 |
− | | | + | |testis expressed 41 (non-protein coding) |
+ | |- | ||
+ | |''TGFB2-OT1'' | ||
+ | |[[TGFB2-OT1]] | ||
+ | |FLJ11812 | ||
+ | |TGFB2 overlapping transcript 1 | ||
+ | |- | ||
+ | |''TH2LCRR'' | ||
+ | |[[TH2LCRR]] | ||
+ | |TH2-LCR | ||
+ | |T helper type 2 locus control region associated RNA | ||
+ | |- | ||
+ | |''THRIL'' | ||
+ | |[[THRIL]] | ||
+ | |Linc1992, TCONSN/A00020260, BRI3BP-AS1 | ||
+ | |TNF and HNRNPL related immunoregulatory long non-coding RNA | ||
+ | |- | ||
+ | |''TINCR'' | ||
+ | |[[TINCR]] | ||
+ | |FLJ90734, NCRNA00036, LINC00036, onco-lncRNA-16 | ||
+ | |tissue differentiation-inducing non-protein coding RNA | ||
+ | |- | ||
+ | |''TLX1NB'' | ||
+ | |[[TLX1NB]] | ||
+ | |TD1, TDI, APT-B7 | ||
+ | |TLX1 neighbor | ||
+ | |- | ||
+ | |''TMEM161B-AS1'' | ||
+ | |[[lnc-RASA1-3:23,lnc-RASA1-3:25]] | ||
+ | |AK082072,linc-POLR3G-8, ENSG00000247828 | ||
+ | |TMEM161B antisense RNA 1 | ||
+ | |- | ||
+ | |''TMEM92-AS1'' | ||
+ | |[[TMEM92-AS1]] | ||
+ | |RP11-893F2.9, lncRNA-508851, TCONSN/A00025237 | ||
+ | |TMEM92 antisense RNA 1 | ||
+ | |- | ||
+ | |''TMEM9B-AS1'' | ||
+ | |[[TMEM9B-AS1]] | ||
+ | |N/A | ||
+ | |TMEM9B antisense RNA 1 | ||
|- | |- | ||
|''TncRNA'' | |''TncRNA'' | ||
Line 320: | Line 3,360: | ||
|TSU | |TSU | ||
|TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA). | |TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA). | ||
+ | |- | ||
+ | |''TOLLIP-AS1'' | ||
+ | |[[TOLLIP-AS1]] | ||
+ | |N/A | ||
+ | |TOLLIP antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''TP53COR1'' | ||
+ | |[[TP53COR1]] | ||
+ | |linc-p21, lincRNA-p21, Trp53cor1 | ||
+ | |tumor protein p53 pathway corepressor 1 (non-protein coding) | ||
+ | |- | ||
+ | |''TP53TG1'' | ||
+ | |[[TP53TG1]] | ||
+ | |HN/ARG012D21.9, LINC00096 | ||
+ | |TP53 target 1 (non-protein coding) | ||
+ | |- | ||
+ | |''TP73-AS1'' | ||
+ | |[[TP73-AS1]] | ||
+ | |PDAM | ||
+ | |TP73 antisense RNA 1 | ||
+ | |- | ||
+ | |''TRERNA1'' | ||
+ | |[[TRERNA1]] | ||
+ | |ncRNA-a7, treRNA | ||
+ | |translation regulatory long non-coding RNA 1 | ||
+ | |- | ||
+ | |''TRPM2-AS'' | ||
+ | |[[TRPM2-AS]] | ||
+ | |TRPM2-AS1 | ||
+ | |TRPM2 antisense RNA | ||
+ | |- | ||
+ | |''TSIX'' | ||
+ | |[[TSIX]] | ||
+ | |NCRNA00013, XIST-AS1, LINC00013 | ||
+ | |TSIX transcript, XIST antisense RNA | ||
+ | |- | ||
+ | |''TSPEAR-AS2'' | ||
+ | |[[TSPEAR-AS2]] | ||
+ | |N/A | ||
+ | |TSPEAR antisense RNA 2 | ||
+ | |- | ||
+ | |''TTC28-AS1'' | ||
+ | |[[TTC28-AS1]] | ||
+ | |KIAA1648 | ||
+ | |TTC28 antisense RNA 1 | ||
+ | |- | ||
+ | |''TTTY15'' | ||
+ | |[[TTTY15]] | ||
+ | |DKFZP434I143, NCRNA00138 | ||
+ | |testis-specific transcript, Y-linked 15 (non-protein coding) | ||
+ | |- | ||
+ | |''TTTY17A'' | ||
+ | |[[TTTY17A]] | ||
+ | |NCRNA00140 | ||
+ | |testis-specific transcript, Y-linked 17A (non-protein coding) | ||
+ | |- | ||
+ | |''TTTY3'' | ||
+ | |[[TTTY3]] | ||
+ | |TTY3, TTTY3A, LINC00121 | ||
+ | |testis-specific transcript, Y-linked 3 (non-protein coding) | ||
+ | |- | ||
+ | |''TTTY4'' | ||
+ | |[[TTTY4]] | ||
+ | |TTY4, TTTY4A, LINC00123 | ||
+ | |testis-specific transcript, Y-linked 4 (non-protein coding) | ||
+ | |- | ||
+ | |''TTTY5'' | ||
+ | |[[TTTY5]] | ||
+ | |TTY5, LINC00126 | ||
+ | |testis-specific transcript, Y-linked 5 (non-protein coding) | ||
+ | |- | ||
+ | |''TTTY6'' | ||
+ | |[[TTTY6]] | ||
+ | |TTY6, TTTY6A, LINC00127 | ||
+ | |testis-specific transcript, Y-linked 6 (non-protein coding) | ||
+ | |- | ||
+ | |''TTTY9B'' | ||
+ | |[[TTTY9B]] | ||
+ | |NCRNA00132 | ||
+ | |testis-specific transcript, Y-linked 9B (non-protein coding) | ||
|- | |- | ||
|''TUG1'' | |''TUG1'' | ||
|[[NONHSAT084827]] | |[[NONHSAT084827]] | ||
|ENSG00000253352 | |ENSG00000253352 | ||
− | |taurine up-regulated gene 1 | + | |taurine up-regulated gene 1(Young (2005)). |
+ | |- | ||
+ | |''TUNAR'' | ||
+ | |[[TUNAR]] | ||
+ | |TUNA, HI-LNC78 | ||
+ | |TCL1 upstream neural differentiation-associated RNA | ||
+ | |- | ||
+ | |''TUSC7'' | ||
+ | |[[NONHSAT091315]] | ||
+ | |LINC00902, LOC285194, ENSG00000243197 | ||
+ | |tumor suppressor candidate 7 (non-protein coding) | ||
+ | |- | ||
+ | |''TUSC8'' | ||
+ | |[[TUSC8]] | ||
+ | |XLOCN/A010588 | ||
+ | |tumor suppressor candidate 8 (non-protein coding) | ||
|- | |- | ||
|''UCA1'' | |''UCA1'' | ||
Line 331: | Line 3,466: | ||
|urothelial cancer associated 1 (non-protein coding) | |urothelial cancer associated 1 (non-protein coding) | ||
|- | |- | ||
− | |'' | + | |''UMODL1-AS1'' |
− | |[[ | + | |[[UMODL1-AS1]] |
− | | | + | |FLJ33471 |
− | | | + | |UMODL1 antisense RNA 1 |
+ | |- | ||
+ | |''VLDLR-AS1'' | ||
+ | |[[VLDLR-AS1]] | ||
+ | |N/A | ||
+ | |VLDLR antisense RNA 1 | ||
+ | |- | ||
+ | |''WAC-AS1'' | ||
+ | |[[WAC-AS1]] | ||
+ | |N/A | ||
+ | |WAC antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''WASIR2'' | ||
+ | |[[WASIR2]] | ||
+ | |N/A | ||
+ | |WASH and IL9R antisense RNA 2 | ||
+ | |- | ||
+ | |''WDFY3-AS2'' | ||
+ | |[[WDFY3-AS2]] | ||
+ | |FBI4 | ||
+ | |WDFY3 antisense RNA 2 | ||
+ | |- | ||
+ | |''WFDC21P'' | ||
+ | |[[WFDC21P]] | ||
+ | |WAP four-disulfide core domain 21, pseudogene | ||
+ | |LOC645638, lnc-DC, LNCDC | ||
+ | |- | ||
+ | |''WSPAR'' | ||
+ | |[[WSPAR]] | ||
+ | |TCONSN/A00009511-XLOCN/A004555, lncTCF7 | ||
+ | |WNT signaling pathway activating non-coding RNA | ||
|- | |- | ||
|''WT1-AS'' | |''WT1-AS'' | ||
Line 340: | Line 3,505: | ||
|WIT1, ENSG00000183242 | |WIT1, ENSG00000183242 | ||
|WT1 (Wilms' tumor 1) antisense transcript | |WT1 (Wilms' tumor 1) antisense transcript | ||
+ | |- | ||
+ | |''XACT'' | ||
+ | |[[XACT]] | ||
+ | |N/A | ||
+ | |X active specific transcript (non-protein coding) | ||
|- | |- | ||
|''XIST'' | |''XIST'' | ||
Line 345: | Line 3,515: | ||
|ENSG00000229807 | |ENSG00000229807 | ||
|X inactive-specific transcript | |X inactive-specific transcript | ||
+ | |- | ||
+ | |''Y RNAs'' | ||
+ | |[[lnc-PDIA4-1:1]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |''YAM1'' | ||
+ | |[[YAM1]] | ||
+ | |Yam-1 | ||
+ | |YY1-associated myogenesis RNA 1 | ||
+ | |- | ||
+ | |''ZBED3-AS1'' | ||
+ | |[[ZBED3-AS1]] | ||
+ | |N/A | ||
+ | |ZBED3 antisense RNA 1 | ||
+ | |- | ||
+ | |''ZEB1-AS1'' | ||
+ | |[[ZEB1-AS1]] | ||
+ | |N/A | ||
+ | |ZEB1 antisense RNA 1 | ||
|- | |- | ||
|''ZEB2-AS1'' | |''ZEB2-AS1'' | ||
Line 355: | Line 3,545: | ||
|Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410 | |Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410 | ||
|ZNFX1 antisense RNA 1 | |ZNFX1 antisense RNA 1 | ||
+ | |- | ||
+ | |''ZFAT-AS1'' | ||
+ | |[[ZFAT-AS1]] | ||
+ | |SAS-ZFAT, NCRNA00070 | ||
+ | |ZFAT antisense RNA 1 | ||
|- | |- | ||
|''Zfhx2as'' | |''Zfhx2as'' | ||
Line 361: | Line 3,556: | ||
|zinc finger homeobox 2, antisense | |zinc finger homeobox 2, antisense | ||
|- | |- | ||
− | |'' | + | |''ZIM2-AS1'' |
− | |[[ | + | |[[ZIM2-AS1]] |
− | + | |ZIM2as | |
− | + | |ZIM2 antisense RNA 1 | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | | | ||
− | | | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
− | |'' | + | |''ZNF205-AS1'' |
− | |[[ | + | |[[ZNF205-AS1]] |
− | | | + | |MGC3771 |
− | | | + | |ZNF205 antisense RNA 1 |
|- | |- | ||
− | |'' | + | |''ZNF252P-AS1'' |
− | |[[ | + | |[[ZNF252P-AS1]] |
− | |||
|N/A | |N/A | ||
+ | |ZNF252P antisense RNA 1 | ||
|- | |- | ||
− | |'' | + | |''ZNF436-AS1'' |
− | |[[ | + | |[[ZNF436-AS1]] |
− | + | |FLJ90508 | |
− | + | |ZNF436 antisense RNA 1 | |
− | |||
− | |||
− | |||
− | | | ||
− | | | ||
|- | |- | ||
− | |'' | + | |''ZNF582-AS1'' |
− | |[[ | + | |[[ZNF582-AS1]] |
− | |||
|N/A | |N/A | ||
+ | |ZNF582 antisense RNA 1 (head to head) | ||
|- | |- | ||
− | |'' | + | |''ZNF667-AS1'' |
− | |[[ | + | |[[ZNF667-AS1]] |
− | | | + | |MORT |
− | | | + | |ZNF667 antisense RNA 1 (head to head) |
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
− | |'' | + | |''ZRANB2-AS2'' |
− | |[[ | + | |[[ZRANB2-AS2]] |
− | |||
|N/A | |N/A | ||
+ | |ZRANB2 antisense RNA 2 (head to head) | ||
|} | |} |
Revision as of 04:54, 24 June 2016
Name | Transcript ID | Alias | Description |
---|---|---|---|
FAM3D-AS1 | FAM3D-AS1 | lnc-KCTD6-3 | FAM3D antisense RNA 1 |
SHANK2-AS3 | SHANK2-AS3 | N/A | SHANK2 antisense RNA 3 |
21A | NONHSAT128494 | ncRNA 21A | N/A |
7SK | NONHSAT113149 | 7-3 RNA, K-RNA, 7SK-RNA, 7SK snRNA, RN7SK, ENSG00000202198 | RNA, 7SK small nuclear |
7SL | lnc-LRR1-1:1 | 7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486 | RNA, 7SL, cytoplasmic 1 |
AATBC | AATBC | N/A | apoptosis associated transcript in bladder cancer |
ABALON | ABALON | INXS | apoptotic BCL2L1-antisense long non-coding RNA |
ABHD11-AS1 | ABHD11-AS1 | NCRNA00035 | ABHD11 antisense RNA 1 (tail to tail) |
ABHD15-AS1 | ABHD15-AS1 | linc-TP53I13, lnc-TP53I13 | ABHD15 antisense RNA 1 |
ACTA2-AS1 | ACTA2-AS1 | uc001kfo.1, ZXF1 | ACTA2 antisense RNA 1 |
ADAMTS9-AS2 | ADAMTS9-AS2 | N/A | ADAMTS9 antisense RNA 2 |
ADORA2A-AS1 | ADORA2A-AS1 | FLJ34651 | ADORA2A antisense RNA 1 |
AFAP1-AS1 | AFAP1-AS1 | MGC10981 | AFAP1 antisense RNA 1 |
AGAP2-AS1 | AGAP2-AS1 | LOC100130776, PUNISHER | AGAP2 antisense RNA 1 |
AIRN | ENST00000609176.1 | AIRN, AIRN, IGF2RAS | Antisense of IGF2R non-protein coding RNA |
Alpha 250/Alpha 280 | NONHSAT104559,lnc-NDST1-1:2 | N/A | N/A |
ANP32A-IT1 | ANP32A-IT1 | FLJ11722, HsT18971 | ANP32A intronic transcript 1 |
APOA1-AS | APOA1-AS | APOA1 antisense RNA | N/A |
APTR | APTR | Alu-mediated CDKN1A/p21 | N/A |
ARRDC1-AS1 | ARRDC1-AS1 | N/A | ARRDC1 antisense RNA 1 |
ASAP1-IT1 | ASAP1-IT1 | HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT | ASAP1 intronic transcript 1 |
ASMTL-AS1 | ASMTL-AS1 | FLJ13330 | ASMTL antisense RNA 1 |
ATP1A1-AS1 | ATP1A1-AS1 | MGC16179 | ATP1A1 antisense RNA 1 |
ATXN8OS | NONHSAT034251 | NCRNA00003, non-protein coding RNA 3, ATXN8OS, KLHL1AS, SCA8, ENSG00000230223 | Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand |
B3GALT5-AS1 | B3GALT5-AS1 | N/A | B3GALT5 antisense RNA 1 |
B4GALT1-AS1 | B4GALT1-AS1 | N/A | B4GALT1 antisense RNA 1 |
BAALC-AS2 | BAALC-AS2 | MGC39526 | BAALC antisense RNA 2 |
BACE1-AS | NONHSAT024403,lnc-RNF214-1:2 | BACE1AS,NCRNA00177; FJ573250 | BACE1 antisense RNA |
BANCR | BANCR | LINC00586 | BRAF-activated non-protein coding RNA |
BCAR4 | BCAR4 | N/A | breast cancer anti-estrogen resistance 4 (non-protein coding) |
BCYRN1 | lnc-EPCAM-1:2 | BC200,BC200a, NCRNA00004, LINC00004 | BCYRN1, brain cytoplasmic RNA 1 |
BDNF-AS | BDNF-AS | BDNF antisense RNA | BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049 |
Beta-globin transcripts | NONHSAT017676,NONHSAT017675,NONHSAT017674 | N/A | N/A |
BFSP2-AS1 | BFSP2-AS1 | MGC2848 | BFSP2 antisense RNA 1 |
BGLT3 | BGLT3 | LINC01083, BGL3, lncRNA-BGL3 | beta globin locus transcript 3 (non-protein coding) |
BIN3-IT1 | BIN3-IT1 | FLJ14107 | BIN3 intronic transcript 1 |
BIRC6-AS1 | BIRC6-AS1 | N/A | BIRC6 antisense RNA 1 |
BIRC6-AS2 | BIRC6-AS2 | megamind | BIRC6 antisense RNA 2 |
BISPR | BISPR | N/A | BST2 interferon stimulated positive regulator (non-protein coding) |
BLACAT1 | BLACAT1 | linc-UBC1,LINC00912, onco-lncRNA-30 | bladder cancer associated transcript 1 (non-protein coding) |
BOK-AS1 | BOK-AS1 | NCRNA00151, NAToB | BOK antisense RNA 1 |
BPESC1 | BPESC1 | NCRNA00187 | blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding) |
BRWD1-AS2 | BRWD1-AS2 | N/A | BRWD1 antisense RNA 2 |
C1QTNF9B-AS1 | C1QTNF9B-AS1 | PCOTH | C1QTNF9B antisense RNA 1 |
C21orf91-OT1 | C21orf91-OT1 | D21S2089E | C21orf91 overlapping transcript 1 |
C5orf66-AS1 | C5orf66-AS1 | CTC-276P9.1, Epist | C5orf66 antisense RNA 1 |
C5orf66-AS2 | C5orf66-AS2 | N/A | C5orf66 antisense RNA 2 |
C8orf34-AS1 | C8orf34-AS1 | N/A | C8orf34 antisense RNA 1 |
CACNA1G-AS1 | CACNA1G-AS1 | N/A | CACNA1G antisense RNA 1 |
CAHM | CAHM | LINC00468 | colon adenocarcinoma hypermethylated (non-protein coding) |
CAPN10-AS1 | CAPN10-AS1 | locus959 | CAPN10 antisense RNA 1 (head to head) |
CAR Intergenic 10 | NONHSAT016928,lnc-FANK1-3:1 | Intergenic10, CR611911, AK055628 | Chromatin Associated RNA 10 |
CARD8-AS1 | CARD8-AS1 | LOC100505812 | CARD8 antisense RNA 1 |
CARMN | CARMN | CARMEN | cardiac mesoderm enhancer-associated non-coding RNA |
CASC11 | CASC11 | TCONSN/A00014535, LINC00990, CARLo-7 | cancer susceptibility candidate 11 (non-protein coding) |
CASC15 | CASC15 | N/A | cancer susceptibility candidate 15 (non-protein coding) |
CASC19 | CASC19 | CARLo-6 | cancer susceptibility candidate 19 (non-protein coding) |
CASC2 | CASC2 | N/A | cancer susceptibility candidate 2 (non-protein coding) |
CASC21 | CASC21 | CARLo-2 | cancer susceptibility candidate 21 (non-protein coding) |
CASC22 | CASC22 | TCONSN/A00024290, LincRNA-ENST00000515084 | cancer susceptibility candidate 22 (non-protein coding) |
CASC8 | CASC8 | LINC00860,CARLo-1 | cancer susceptibility candidate 8 (non-protein coding) |
CASC9 | CASC9 | LINC00981, ESCCAL-1 | cancer susceptibility candidate 9 (non-protein coding) |
CBR3-AS1 | CBR3-AS1 | PlncRNA-1 | CBR3 antisense RNA 1 |
CCAT1 | CCAT1 | CARLo-5, onco-lncRNA-40 | colon cancer associated transcript 1 (non-protein coding) |
CCAT2 | CCAT2 | NCCP1, LINC00873 | colon cancer associated transcript 2 (non-protein coding) |
CCDC18-AS1 | CCDC18-AS1 | ENST00000440778.1 | CCDC18 antisense RNA 1 |
CCDC26 | CCDC26 | MGC27434, RAM | CCDC26 long non-coding RNA |
CCEPR | CCEPR | CCHE1 | cervical carcinoma expressed PCNA regulatory lncRNA |
CDKN1A-AS1 | CDKN1A-AS1 | p21NAT | CDKN1A antisense RNA 1 |
CDKN2B-AS1 | NONHSAT130421,lnc-C9orf53-2:1 | ANRIL, p15AS, ENSG00000240498 | CDKN2B antisense RNA 1 |
CDR1-AS | CDR1-AS | CDR1NAT, ciRS-7, CDR1as | CDR1 antisense RNA |
CDRT7 | CDRT7 | NCRNA00025, LINC00025 | CMT1A duplicated region transcript 7 (non-protein coding) |
CDRT8 | CDRT8 | N/A | CMT1A duplicated region transcript 8 |
CECR3 | CECR3 | N/A | cat eye syndrome chromosome region, candidate 3 (non-protein coding) |
CECR5-AS1 | CECR5-AS1 | NCRNA00017 | CECR5 antisense RNA 1 |
CECR7 | CECR7 | SAHL1 | cat eye syndrome chromosome region, candidate 7 (non-protein coding) |
CECR9 | CECR9 | N/A | cat eye syndrome chromosome region, candidate 9 (non-protein coding) |
CEP83-AS1 | CEP83-AS1 | N/A | CEP83 antisense RNA 1 (head to head) |
CIRBP-AS1 | CIRBP-AS1 | MGC39338 | CIRBP antisense RNA 1 |
CISTR | CISTR | CISTR-ACT, CISTRACT, re52431 | chondrogenesis-associated transcript |
CLRN1-AS1 | CLRN1-AS1 | UCRP | CLRN1 antisense RNA 1 |
COPG2IT1 | COPG2IT1 | CIT1, NCRNA00170, COPG2AS | COPG2 imprinted transcript 1 (non-protein coding) |
CPS1-IT1 | CPS1-IT1 | PRO0132, CPS1-IT | CPS1 intronic transcript 1 |
CRNDE | CRNDE | LOC643911, LINC00180, CRNDEP | colorectal neoplasia differentially expressed (non-protein coding) |
CSNK1G2-AS1 | CSNK1G2-AS1 | MGC39696 | CSNK1G2 antisense RNA 1 |
CSTF3-AS1 | CSTF3-AS1 | N/A | CSTF3 antisense RNA 1 (head to head) |
CTBP1-AS | CTBP1-AS | PCAT10 | CTBP1 antisense RNA |
CTBP1-AS2 | CTBP1-AS2 | MGC21675 | CTBP1 antisense RNA 2 (head to head) |
CYP1B1-AS1 | CYP1B1-AS1 | MGC34824 | CYP1B1 antisense RNA 1 |
CYP4A22-AS1 | ENST00000444042.2 | Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506 | CYP4A22 antisense RNA 1 |
CYP51A1-AS1 | CYP51A1-AS1 | ENST00000453068, LRRD1-AS1 | CYP51A1 antisense RNA 1 |
CYYR1-AS1 | CYYR1-AS1 | cysteine and tyrosine rich 1 antisense RNA 1 | N/A |
DACOR1 | DACOR1 | TCONSN/A00023265 | DNMT1-associated colon cancer repressed lncRNA 1 |
DALIR | DALIR | DALI | DNMT1-associated long intergenic non-coding RNA |
DANCR | DANCR | differentiation antagonizing non-protein coding RNA | ANCR, AGU2, lncRNA-ANCR |
DANT1 | DANT1 | N/A | DXZ4 associated non-coding transcript 1, proximal |
DANT2 | DANT2 | N/A | DXZ4 associated non-coding transcript 2, distal |
DAOA-AS1 | DAOA-AS1 | G30 | DAOA antisense RNA 1 |
DAPK1-IT1 | DAPK1-IT1 | N/A | DAPK1 intronic transcript 1 |
DBET | DBET | DBE-T, DUX4L30 | D4Z4 binding element transcript (non-protein coding) |
DBH-AS1 | DBH-AS1 | BPR | DBH antisense RNA 1 |
DGCR10 | DGCR10 | DGS-B | DiGeorge syndrome critical region gene 10 (non-protein coding) |
DGCR11 | DGCR11 | DGS-D | DiGeorge syndrome critical region gene 11 (non-protein coding) |
DGCR12 | DGCR12 | DGS-E | DiGeorge syndrome critical region gene 12 (non-protein coding) |
DGCR5 | DGCR5 | NCRNA00037, LINC00037 | DiGeorge syndrome critical region gene 5 (non-protein coding) |
DGCR9 | DGCR9 | DGS-A, POM121L5P | DiGeorge syndrome critical region gene 9 (non-protein coding) |
DHFR upstream transcripts | NONHSAT102417 | DHFR minor transcript 5'-UTR, ENSG00000228716 | N/A |
DHRS4-AS1 | DHRS4-AS1 | DHRS4 antisense RNA 1 | PRO1488,AS1DHRS4 |
DIAPH2-AS1 | DIAPH2-AS1 | N/A | DIAPH2 antisense RNA 1 |
DIO3OS | NONHSAT040032,NONHSAT040039 | DIO3-AS1, NCRNA00041, non-protein coding RNA 41, ENSG00000258498 | DIO3 opposite strand/antisense RNA (head to head) |
DISC1FP1 | DISC1FP1 | N/A | DISC1 fusion partner 1 (non-protein coding) |
DISC2 | NONHSAT010191 | DISC1-AS1, DISC1OS, NCRNA00015 | disrupted in schizophrenia 2 (non-protein coding) |
DLEU1 | DLEU1 | deleted in lymphocytic leukemia 1 (non-protein coding) | LEU1, XTP6, NCRNA00021, LINC00021, BCMS1 |
DLEU2 | DLEU2 | deleted in lymphocytic leukemia 2 (non-protein coding) | LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG |
DLG2-AS1 | DLG2-AS1 | PSZA11q14, SZ-1 | DLG2 antisense RNA 1 |
DLGAP1-AS3 | DLGAP1-AS3 | N/A | DLGAP1 antisense RNA 3 |
DLX6-AS1 | DLX6-AS1 | FLJ34048, Evf-2 | DLX6 antisense RNA 1 |
DNM3OS | DNM3OS | MIR199A2HG, DNM3-AS1 | DNM3 opposite strand/antisense RNA |
DRAIC | DRAIC | N/A | downregulated RNA in cancer, inhibitor of cell invasion and migration |
DSCR10 | DSCR10 | N/A | Down syndrome critical region 10 (non-protein coding) |
DSCR9 | DSCR9 | NCRNA00038 | Down syndrome critical region 9 (non-protein coding) |
DUBR | DUBR | N/A | DPPA2 upstream binding RNA |
EGFR-AS1 | EGFR-AS1 | N/A | EGFR antisense RNA 1 |
EGOT | NONHSAT087635 | EGO, eosinophil granule ontogeny, NCRNA00190, non-protein coding RNA 190, ENSG00000235947 | Eosinophil granule ontogeny (EGO) RNA |
ELFN1-AS1 | ELFN1-AS1 | N/A | ELFN1 antisense RNA 1 |
EMX2OS | lnc-PDZD8-3:1 | EMX2-AS1, NCRNA00045, non-protein coding RNA 45,ENSG00000229847 | Emx2 opposite strand transcript. |
ENTPD3-AS1 | ENTPD3-AS1 | FLJ36665 | ENTPD3 antisense RNA 1 |
EPB41L4A-AS1 | EPB41L4A-AS1 | TIGA1 | EPB41L4A antisense RNA 1 |
EPB41L4A-AS2 | EPB41L4A-AS2 | FLJ11235 | EPB41L4A antisense RNA 2 (head to head) |
ERC2-IT1 | ERC2-IT1 | Po42 | ERC2 intronic transcript 1 |
ERICD | ERICD | TCONS_00014875, ERIC | E2F1-regulated inhibitor of cell death (non-protein coding) |
ERICH1-AS1 | ERICH1-AS1 | N/A | ERICH1 antisense RNA 1 |
ESRG | ESRG | HESRG | embryonic stem cell related (non-protein coding) |
Evf2 | lnc-DLX5-3:1 | Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764 | N/A |
EWSAT1 | EWSAT1 | FLJ33768 | Ewing sarcoma associated transcript 1 |
EXOC3-AS1 | EXOC3-AS1 | N/A | EXOC3 antisense RNA 1 |
EXTL3-AS1 | EXTL3-AS1 | N/A | EXTL3 antisense RNA 1 |
F11-AS1 | F11-AS1 | N/A | F11 antisense RNA 1 |
FALEC | ENST00000416894.1 | LINC00568, long intergenic non-protein coding RNA 568, ENSG00000228126.1 | focally amplified long non-coding RNA in epithelial cancer |
FAM138A | FAM138A | F379 | family with sequence similarity 138 member A |
FAM138B | FAM138B | F379 | family with sequence similarity 138 member B |
FAM138C | FAM138C | F379 | family with sequence similarity 138 member C |
FAM138D | FAM138D | F379 | family with sequence similarity 138 member D |
FAM138E | FAM138E | F379 | family with sequence similarity 138 member E |
FAM138F | FAM138F | F379 | family with sequence similarity 138 member F |
FAM13A-AS1 | FAM13A-AS1 | NCRNA00039 | FAM13A antisense RNA 1 |
FAM201A | FAM201A | N/A | family with sequence similarity 201 member A |
FAM215A | FAM215A | APR-2, LINC00530 | family with sequence similarity 215 member A (non-protein coding) |
FAM222A-AS1 | FAM222A-AS1 | N/A | FAM222A antisense RNA 1 |
FAM226A | FAM226A | MGC34827 | family with sequence similarity 226 member A (non-protein coding) |
FAM226B | FAM226B | N/A | family with sequence similarity 226 member B (non-protein coding) |
FAM27E3 | FAM27E3 | MGC42630 | family with sequence similarity 27 member E3 |
FAM41AY1 | FAM41AY1 | N/A | family with sequence similarity 41 member A, Y-linked 1 |
FAM41C | FAM41C | N/A | family with sequence similarity 41 member C |
FAM66C | FAM66C | N/A | family with sequence similarity 66 member C |
FAM74A3 | FAM74A3 | OTTHUMG00000067149 | family with sequence similarity 74 member A3 |
FAM83H-AS1 | FAM83H-AS1 | onco-lncRNA-3 | FAM83H antisense RNA 1 (head to head) |
FAM87A | FAM87A | N/A | family with sequence similarity 87 member A |
FAS-AS | NONHSAT015489 | SAF, ENSG00000026103 | FAS antisense RNA 1 |
FAS-AS1 | FAS-AS1 | SAF | FAS antisense RNA 1 |
FENDRR | FENDRR | FOXF1 adjacent non-coding developmental regulatory RNA | lincFOXF1, onco-lncRNA-21 |
FGF10-AS1 | FGF10-AS1 | RP11-473L15.2 | FGF10 antisense RNA 1 |
FIRRE | FIRRE | firre intergenic repeating RNA element | LINC01200 |
FLG-AS1 | FLG-AS1 | N/A | FLG antisense RNA 1 |
FLVCR1-AS1 | FLVCR1-AS1 | LQK1 | FLVCR1 antisense RNA 1 (head to head) |
FMR1-AS1 | FMR1-AS1 | ASFMR1, FMR4 | FMR1 antisense RNA 1 |
FOXC2-AS1 | FOXC2-AS1 | ODRUL | FOXC2 antisense RNA 1 |
FOXCUT | FOXCUT | TCONS_00011636 | FOXC1 upstream transcript (non-protein coding) |
FOXG1-AS1 | FOXG1-AS1 | FOXG1-AS | FOXG1 antisense RNA 1 (head to head) |
FRGCA | FRGCA | LncRNA-AP001631.9 | FOXM1-regulated, gastric cancer associated |
FTX | FTX | LINC00182,FLJ33139 | FTX transcript, XIST regulator (non-protein coding) |
GABPB1-AS1 | GABPB1-AS1 | N/A | GABPB1 antisense RNA 1 |
GACAT1 | GACAT1 | LINC00876, AC096655.1-002 | gastric cancer associated transcript 1 (non-protein coding) |
GACAT2 | GACAT2 | HMlincRNA717 | gastric cancer associated transcript 2 (non-protein coding) |
GACAT3 | GACAT3 | lncRNA-AC130710 | gastric cancer associated transcript 3 (non-protein coding) |
GAPLINC | GAPLINC | TCONSN/A00026238 | gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA |
GAS1RR | GAS1RR | LncRNA-Hh | GAS1 adjacent regulatory RNA |
GAS5 | NONHSAT007663 | SNHG2, ENSG00000234741 | N/A |
GAS6-AS1 | GAS6-AS1 | N/A | GAS6 antisense RNA 1 |
GAS8-AS1 | GAS8-AS1 | N/A | GAS8 antisense RNA 1 |
GATA3-AS1 | GATA3-AS1 | N/A | GATA3 antisense RNA 1 |
GATA6-AS1 | GATA6-AS1 | locus5689 | GATA6 antisense RNA 1 (head to head) |
GDNF-AS1 | GDNF-AS1 | GDNFOS | GDNF antisense RNA 1 (head to head) |
GHET1 | GHET1 | lncRNA-GHET1 | gastric carcinoma proliferation enhancing transcript 1 |
GHRLOS | GHRLOS | NCRNA00068,GHRL-AS1 | ghrelin opposite strand/antisense RNA |
GLIDR | GLIDR | MGC21881, TCONSN/A00015562 | glioblastoma down-regulated RNA |
GLIS3-AS1 | GLIS3-AS1 | MGC16153 | GLIS3 antisense RNA 1 |
GNAS-AS1 | lnc-CTSZ-5:1 | GNAS antisense, GNAS1AS, NCRNA00075, NESP-AS, NESPAS, non-protein coding RNA 75, SANG, ENSG00000235590 | neuroendocrine secretory protein (Nesp) antisense. |
GNG12-AS1 | GNG12-AS1 | N/A | GNG12 antisense RNA 1 |
GPR1-AS | GPR1-AS | GPR1AS | GPR1 antisense RNA |
GTSCR1 | GTSCR1 | N/A | Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding) |
H19 | NONHSAT017465 | Q96MK8,ENSG00000130600 | H19, imprinted maternally expressed transcript (non-protein coding) |
H1FX-AS1 | H1FX-AS1 | FLJ34151 | H1FX antisense RNA 1 |
HAGLR | HAGLR | Mdgt | HOXD antisense growth-associated long non-coding RNA |
HAND2-AS1 | HAND2-AS1 | DEIN, NBLA00301, FLJ11539 | HAND2 antisense RNA 1 (head to head) |
HAR1A | lnc-BIRC7-2:1 | HAR1F, ENSG00000238820 | highly accelerated region 1A |
HAR1B | ENST00000447910.2 | HAR1R, ENSG00000231133 | highly accelerated region 1B |
HAS2-AS1 | HAS2-AS1 | HASNT, NCRNA00077 | HAS2 antisense RNA 1 |
HCCAT5 | HCCAT5 | HTA, FJ222407 | hepatocellular carcinoma associated transcript 5 (non-protein coding) |
HCG27 | HCG27 | bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123 | HLA complex group 27 (non-protein coding) |
HCG4 | HCG4 | HCGIV-10, HCGIV.9 | HLA complex group 4 (non-protein coding) |
HCG4B | HCG4B | HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3 | HLA complex group 4B (non-protein coding) |
HCG9 | HCG9 | PERB11, HCGIX, HCGIX4, HCGIX-4 | HLA complex group 9 (non-protein coding) |
HCP5 | HCP5 | D6S2650E, P5-1 | HLA complex P5 (non-protein coding) |
HEIH | HEIH | LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2 | hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA |
HELLPAR | HELLPAR | LINC-HELLP | HELLP associated long non-coding RNA |
HEXA-AS1 | HEXA-AS1 | FLJ13315 | HEXA antisense RNA 1 |
HIF1A-AS1 | HIF1A-AS1 | 5'aHIF-1A | HIF1A antisense RNA 1 |
HIF1A-AS2 | HIF1A-AS2 | 3'aHIF-1A, aHIF | HIF1A antisense RNA 2 |
HNF1A-AS1 | HNF1A-AS1 | FLJ38690 | HNF1A antisense RNA 1 |
HNF4A-AS1 | HNF4A-AS1 | uc002xlx | HNF4A antisense RNA 1 |
HORMAD2-AS1 | HORMAD2-AS1 | MTMR3-AS1, NONHSAG033653 | HORMAD2 antisense RNA 1 |
HOTAIR | NONHSAT028508 | Gm16258, Hox antisense intergenic RNA, ENSG00000228630 | Hox antisense intergenic RNA |
HOTAIRM1 | lnc-EVX1-12:1 | HIT06113, HIT92376, linc1548, ENSG00000233429 | HOXA transcript antisense RNA, myeloid-specific 1 |
HOTTIP | NONHSAT119717 | HOXA13as, HIT18844, NCRNA00213, ENSG00000243766 | HOXA transcript at the distal tip |
HOXA11-AS | NONHSAT119704 | HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, HOXA11 antisense RNA 1 (non-protein coding), HOXA11-AS1, HOXA11S, NCRNA00076, non-protein coding RNA 76, ENSG00000240990 | HOXA11 antisense RNA |
HOXA-AS2 | NONHSAT119676 | HOXA3as, ENSG00000253552 | HOXA cluster antisense RNA 2 |
HOXA-AS3 | lnc-EVX1-9:1 | HOXA6as | HOXA cluster antisense RNA 3 |
HPVC1 | HPVC1 | PE5L, HPV18E5L | human papillomavirus (type 18) E5 central sequence-like 1 |
HTT-AS | HTT-AS | HTTAS | HTT antisense RNA (head to head) |
HULC | NONHSAT107640 | ENSG00000251164 | hepatocellular carcinoma up-regulated long non-coding RNA |
HYMAI | HYMAI | NCRNA00020 | hydatidiform mole associated and imprinted (non-protein coding) |
IDI2-AS1 | IDI2-AS1 | HT009, Em:AC022536.4 | IDI2 antisense RNA 1 |
IFNG-AS1 | ENST00000538665.1 | LincR-Ifng-3'AS, NEST, Theiler's murine encephalomyelitis virus persistence candidate gene 1, Tmevpg1, ENSG00000255733 | IFNG antisense RNA 1 |
IGF2-AS | IGF2-AS | PEG8, IGF2-AS1 | IGF2 antisense RNA |
ILF3-AS1 | ILF3-AS1 | N/A | ILF3 antisense RNA 1 (head to head) |
INE1 | INE1 | NCRNA00010 | inactivation escape 1 (non-protein coding) |
INE2 | INE2 | NCRNA00011 | inactivation escape 2 (non-protein coding) |
IPW | NONHSAT041063 | NCRNA00002 | imprinted in Prader-Willi syndrome |
IRAIN | IRAIN | IGF1R-AS | IGF1R antisense imprinted non-protein coding RNA |
JADRR | JADRR | lncRNA-JADE | JADE1 adjacent regulatory RNA |
JMJD1C-AS1 | JMJD1C-AS1 | N/A | JMJD1C antisense RNA 1 |
JPX | lnc-ZCCHC13-1:1 | DCBALD06, ENOX, expressed neighbor of XIST, just proximal to XIST, LINC00183 | JPX transcript, XIST activator (non-protein coding) |
KANTR | KANTR | KDM5C adjacent non-coding transcript | Spasm |
KCNIP4-IT1 | NONHSAT095745 | non coding transcript UM9(5), UM9-5 | KCNIP4 intronic transcript 1 (non-protein coding) |
KCNK15-AS1 | KCNK15-AS1 | RP11-445H22.4 | KCNK15 antisense RNA 1 (head to head) |
KCNMB2-AS1 | KCNMB2-AS1 | RP11-385J1.2 | KCNMB2 antisense RNA 1 |
KCNQ1DN | KCNQ1DN | BWRT, HSA404617 | KCNQ1 downstream neighbor (non-protein coding) |
KCNQ1OT1 | NONHSAT017524 | KCNQ1 antisense RNA 2 (non-protein coding), KCNQ1 overlapping transcript 1 (non-protein coding), KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, non-protein coding RNA 12 | KCNQ1 opposite strand/antisense transcript 1 (non-protein coding) |
KIAA1614-AS1 | KIAA1614-AS1 | RP11-46A10.4 | KIAA1614 antisense RNA 1 |
KIF25-AS1 | KIF25-AS1 | HGC6.1.1 | KIF25 antisense RNA 1 |
KRASP1 | NONHSAT113225 | ENSG00000220635 | KRAS Pseudogene 1 |
LAMP5-AS1 | LAMP5-AS1 | N/A | LAMP5 antisense RNA 1 |
LBX2-AS1 | LBX2-AS1 | N/A | LBX2 antisense RNA 1 |
LCAL1 | LCAL1 | onco-lncRNA-27 | lung cancer associated lncRNA 1 |
LHX5-AS1 | LHX5-AS1 | locus4010 | LHX5 antisense RNA 1 (head to head) |
LIFR-AS1 | LIFR-AS1 | N/A | LIFR antisense RNA 1 |
LINC00029 | LINC00029 | bA305P22.4 | long intergenic non-protein coding RNA 29 |
LINC00052 | LINC00052 | FLJ31461 | long intergenic non-protein coding RNA 52 |
LINC00094 | LINC00094 | FLJ35348, bA374P20.3 | long intergenic non-protein coding RNA 94 |
LINC00114 | LINC00114 | N/A | long intergenic non-protein coding RNA 114 |
LINC00115 | LINC00115 | FLJ22639 | long intergenic non-protein coding RNA 115 |
LINC00152 | LINC00152 | MGC4677 | long intergenic non-protein coding RNA 152 |
LINC00160 | LINC00160 | N/A | long intergenic non-protein coding RNA 160 |
LINC00161 | LINC00161 | N/A | long intergenic non-protein coding RNA 161 |
LINC00163 | LINC00163 | NLC1-A, NLC1A | long intergenic non-protein coding RNA 163 |
LINC00165 | LINC00165 | NLC1-B | long intergenic non-protein coding RNA 165 |
LINC00189 | LINC00189 | N/A | long intergenic non-protein coding RNA 189 |
LINC00205 | LINC00205 | N/A | long intergenic non-protein coding RNA 205 |
LINC00235 | LINC00235 | N/A | long intergenic non-protein coding RNA 235 |
LINC00237 | LINC00237 | N/A | long intergenic non-protein coding RNA 237 |
LINC00244 | LINC00244 | N/A | long intergenic non-protein coding RNA 244 |
LINC00261 | LINC00261 | bA216C10.1, HCCDR1, TCONSN/A00027846, ALIEN, DEANR1, onco-lncRNA-17 | long intergenic non-protein coding RNA 261 |
LINC00265 | LINC00265 | NCRNA00265-1 | long intergenic non-protein coding RNA 265 |
LINC00272 | LINC00272 | RP1-223H12.3 | long intergenic non-protein coding RNA 272 |
LINC00293 | LINC00293 | BEYLA | long intergenic non-protein coding RNA 293 |
LINC00294 | LINC00294 | N/A | long intergenic non-protein coding RNA 294 |
LINC00299 | LINC00299 | FLJ45673 | long intergenic non-protein coding RNA 299 |
LINC00301 | LINC00301 | MGC39681 | long intergenic non-protein coding RNA 301 |
LINC00302 | LINC00302 | XP33 | long intergenic non-protein coding RNA 302 |
LINC00305 | LINC00305 | MGC39571, HsT1235 | long intergenic non-protein coding RNA 305 |
LINC00307 | LINC00307 | D21S2091E | long intergenic non-protein coding RNA 307 |
LINC00308 | LINC00308 | PRED16 | long intergenic non-protein coding RNA 308 |
LINC00310 | LINC00310 | N/A | long intergenic non-protein coding RNA 310 |
LINC00311 | LINC00311 | MGC22001 | long intergenic non-protein coding RNA 311 |
LINC00312 | LINC00312 | NAG7, NAG-7, ERR10, LMCD1DN, ERR-10 | long intergenic non-protein coding RNA 312 |
LINC00313 | LINC00313 | N/A | long intergenic non-protein coding RNA 313 |
LINC00314 | LINC00314 | N/A | long intergenic non-protein coding RNA 314 |
LINC00315 | LINC00315 | N/A | long intergenic non-protein coding RNA 315 |
LINC00320 | LINC00320 | PRED14, FLJ37539 | long intergenic non-protein coding RNA 320 |
LINC00322 | LINC00322 | FLJ16545 | long intergenic non-protein coding RNA 322 |
LINC00323 | LINC00323 | PRED42, FLJ37173 | long intergenic non-protein coding RNA 323 |
LINC00324 | LINC00324 | FLJ34790, MGC104931 | long intergenic non-protein coding RNA 324 |
LINC00334 | LINC00334 | N/A | long intergenic non-protein coding RNA 334 |
LINC00337 | LINC00337 | MGC40168 | long intergenic non-protein coding RNA 337 |
LINC00339 | LINC00339 | HSPC157 | long intergenic non-protein coding RNA 339 |
LINC00342 | LINC00342 | N/A | long intergenic non-protein coding RNA 342 |
LINC00346 | LINC00346 | N/A | long intergenic non-protein coding RNA 346 |
LINC00347 | LINC00347 | N/A | long intergenic non-protein coding RNA 347 |
LINC00426 | LINC00426 | N/A | long intergenic non-protein coding RNA 426 |
LINC00441 | LINC00441 | ncRNA-RB1 | long intergenic non-protein coding RNA 441 |
LINC00461 | LINC00461 | EyeLinc1, Visc-1a, Visc-1b, Visc-2, LOC645323 | long intergenic non-protein coding RNA 461 |
LINC00466 | LINC00466 | N/A | long intergenic non-protein coding RNA 466 |
LINC00467 | LINC00467 | MGC14801 | long intergenic non-protein coding RNA 467 |
LINC00470 | LINC00470 | N/A | long intergenic non-protein coding RNA 470 |
LINC00471 | LINC00471 | MGC43122 | long intergenic non-protein coding RNA 471 |
LINC00472 | LINC00472 | dJ288M22.3, FLJ13189 | long intergenic non-protein coding RNA 472 |
LINC00473 | LINC00473 | bA142J11.1 | long intergenic non-protein coding RNA 473 |
LINC00477 | LINC00477 | FLJ32894, FAM191B | long intergenic non-protein coding RNA 477 |
LINC00491 | LINC00491 | BC008363 | long intergenic non-protein coding RNA 491 |
LINC00493 | LINC00493 | LOC388789 | long intergenic non-protein coding RNA 493 |
LINC00494 | LINC00494 | N/A | long intergenic non-protein coding RNA 494 |
LINC00507 | LINC00507 | N/A | long intergenic non-protein coding RNA 507 |
LINC00511 | LINC00511 | onco-lncRNA-12 | long intergenic non-protein coding RNA 511 |
LINC00518 | LINC00518 | MGC40222 | long intergenic non-protein coding RNA 518 |
LINC00526 | LINC00526 | MGC17515, HsT959 | long intergenic non-protein coding RNA 526 |
LINC00528 | LINC00528 | FLJ40542 | long intergenic non-protein coding RNA 528 |
LINC00529 | LINC00529 | N/A | long intergenic non-protein coding RNA 529 |
LINC00536 | LINC00536 | N/A | long intergenic non-protein coding RNA 536 |
LINC00538 | LINC00538 | Yiya, PROX1UT | long intergenic non-protein coding RNA 538 |
LINC00570 | ENST00000437795.1,ENST00000432665.1,ENST00000453100.1,ENST00000417473.2 | KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, prostate cancer-associated noncoding RNA 1,ENSG00000224177, | prostate cancer associated transcript 6 (non-protein coding) |
LINC00575 | LINC00575 | N/A | long intergenic non-protein coding RNA 575 |
LINC00581 | lnc-PRL-6:2,lnc-PRL-6:1 | BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678 | long intergenic non-protein coding RNA 581 |
LINC00588 | LINC00588 | DKFZP434F122 | long intergenic non-protein coding RNA 588 |
LINC00593 | LINC00593 | MGC42951 | long intergenic non-protein coding RNA 593 |
LINC00598 | LINC00598 | TTL | long intergenic non-protein coding RNA 598 |
LINC00599 | lnc-TNKS-1:1 | retinal non-coding RNA 3, Rncr3, ENSG00000253230 | Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599 |
LINC00608 | LINC00608 | N/A | long intergenic non-protein coding RNA 608 |
LINC00612 | LINC00612 | MGC40170, FLJ41814 | long intergenic non-protein coding RNA 612 |
LINC00620 | LINC00620 | N/A | long intergenic non-protein coding RNA 620 |
LINC00623 | LINC00623 | N/A | long intergenic non-protein coding RNA 623 |
LINC00628 | LINC00628 | N/A | long intergenic non-protein coding RNA 628 |
LINC00632 | LINC00632 | N/A | long intergenic non-protein coding RNA 632 |
LINC00634 | LINC00634 | N/A | long intergenic non-protein coding RNA 634 |
LINC00635 | LINC00635 | N/A | long intergenic non-protein coding RNA 635 |
LINC00636 | LINC00636 | N/A | long intergenic non-protein coding RNA 636 |
LINC00638 | LINC00638 | MGC23270 | long intergenic non-protein coding RNA 638 |
LINC00649 | LINC00649 | TCONSN/A00028768 | long intergenic non-protein coding RNA 649 |
LINC00652 | LINC00652 | HSPC072 | long intergenic non-protein coding RNA 652 |
LINC00661 | LINC00661 | N/A | long intergenic non-protein coding RNA 661 |
LINC00662 | LINC00662 | N/A | long intergenic non-protein coding RNA 662 |
LINC00663 | LINC00663 | MGC39821 | long intergenic non-protein coding RNA 663 |
LINC00667 | LINC00667 | N/A | long intergenic non-protein coding RNA 667 |
LINC00668 | LINC00668 | N/A | long intergenic non-protein coding RNA 668 |
LINC00673 | LINC00673 | HI-LNC75 | long intergenic non-protein coding RNA 673 |
LINC00675 | LINC00675 | N/A | long intergenic non-protein coding RNA 675 |
LINC00682 | LINC00682 | N/A | long intergenic non-protein coding RNA 682 |
LINC00685 | LINC00685 | OTTHUMT00000055574 | long intergenic non-protein coding RNA 685 |
LINC00689 | LINC00689 | N/A | long intergenic non-protein coding RNA 689 |
LINC00692 | LINC00692 | N/A | long intergenic non-protein coding RNA 692 |
LINC00704 | LINC00704 | N/A | long intergenic non-protein coding RNA 704 |
LINC00705 | LINC00705 | N/A | long intergenic non-protein coding RNA 705 |
LINC00839 | LINC00839 | N/A | long intergenic non-protein coding RNA 839 |
LINC00850 | LINC00850 | KUCG1 | long intergenic non-protein coding RNA 850 |
LINC00852 | LINC00852 | NAG73, GHRL-AS2 | long intergenic non-protein coding RNA 852 |
LINC00853 | ENST00000429328.2 | PDZK1IP1 antisense RNA 1 (non-protein coding), PDZK1IP1 antisense RNA 1 (tail to tail), PDZK1IP1-AS1 ,ENSG00000224805 | long intergenic non-protein coding RNA 853 |
LINC00854 | LINC00854 | N/A | long intergenic non-protein coding RNA 854 |
LINC00857 | LINC00857 | N/A | long intergenic non-protein coding RNA 857 |
LINC00868 | LINC00868 | N/A | long intergenic non-protein coding RNA 868 |
LINC00869 | LINC00869 | KIAA0493 | long intergenic non-protein coding RNA 869 |
LINC00880 | LINC00880 | N/A | long intergenic non-protein coding RNA 880 |
LINC00882 | LINC00882 | N/A | long intergenic non-protein coding RNA 882 |
LINC00887 | LINC00887 | linc-ATP13A4-8 | long intergenic non-protein coding RNA 887 |
LINC00893 | LINC00893 | N/A | long intergenic non-protein coding RNA 893 |
LINC00901 | LINC00901 | TCONSN/A00005428, BC040587 | long intergenic non-protein coding RNA 901 |
LINC00917 | LINC00917 | N/A | long intergenic non-protein coding RNA 917 |
LINC00936 | LINC00936 | N/A | long intergenic non-protein coding RNA 936 |
LINC00942 | LINC00942 | N/A | long intergenic non-protein coding RNA 942 |
LINC00950 | LINC00950 | FP588 | long intergenic non-protein coding RNA 950 |
LINC00951 | LINC00951 | lincRNA-uc003opf.1, FLJ41649 | long intergenic non-protein coding RNA 951 |
LINC00961 | LINC00961 | N/A | long intergenic non-protein coding RNA 961 |
LINC00963 | LINC00963 | N/A | long intergenic non-protein coding RNA 963 |
LINC00964 | LINC00964 | N/A | long intergenic non-protein coding RNA 964 |
LINC00970 | LINC00970 | N/A | long intergenic non-protein coding RNA 970 |
LINC00974 | LINC00974 | N/A | long intergenic non-protein coding RNA 974 |
LINC00977 | LINC00977 | N/A | long intergenic non-protein coding RNA 977 |
LINC00982 | LINC00982 | FLJ42875 | long intergenic non-protein coding RNA 982 |
LINC00993 | LINC00993 | N/A | long intergenic non-protein coding RNA 993 |
LINC00994 | LINC00994 | N/A | long intergenic non-protein coding RNA 994 |
LINC00996 | LINC00996 | N/A | long intergenic non-protein coding RNA 996 |
LINC01016 | LINC01016 | N/A | long intergenic non-protein coding RNA 1016 |
LINC01018 | LINC01018 | N/A | long intergenic non-protein coding RNA 1018 |
LINC01019 | LINC01019 | N/A | long intergenic non-protein coding RNA 1019 |
LINC01020 | LINC01020 | N/A | long intergenic non-protein coding RNA 1020 |
LINC01021 | LINC01021 | N/A | long intergenic non-protein coding RNA 1021 |
LINC01024 | LINC01024 | MA-linc1 | long intergenic non-protein coding RNA 1024 |
LINC01029 | LINC01029 | N/A | long intergenic non-protein coding RNA 1029 |
LINC01080 | LINC01080 | TCONSN/A00021856 | long intergenic non-protein coding RNA 1080 |
LINC01081 | LINC01081 | TCONSN/A00024764 | long intergenic non-protein coding RNA 1081 |
LINC01082 | LINC01082 | TCONSN/A00024492 | long intergenic non-protein coding RNA 1082 |
LINC01089 | LINC01089 | N/A | long intergenic non-protein coding RNA 1089 |
LINC01090 | LINC01090 | N/A | long intergenic non-protein coding RNA 1090 |
LINC01091 | LINC01091 | N/A | long intergenic non-protein coding RNA 1091 |
LINC01096 | LINC01096 | N/A | long intergenic non-protein coding RNA 1096 |
LINC01105 | LINC01105 | FLJ30594, LOC150622 | long intergenic non-protein coding RNA 1105 |
LINC01108 | LINC01108 | LncRNA-ES1 | long intergenic non-protein coding RNA 1108 |
LINC01122 | LINC01122 | FLJ30838 | long intergenic non-protein coding RNA 1122 |
LINC01133 | LINC01133 | N/A | long intergenic non-protein coding RNA 1133 |
LINC01139 | LINC01139 | N/A | long intergenic non-protein coding RNA 1139 |
LINC01140 | LINC01140 | FLJ41676 | long intergenic non-protein coding RNA 1140 |
LINC01150 | LINC01150 | 2G7, TCONSN/A00019134 | long intergenic non-protein coding RNA 1150 |
LINC01152 | LINC01152 | TCONSN/A00025128, CMPD | long intergenic non-protein coding RNA 1152 |
LINC01154 | LINC01154 | N/A | long intergenic non-protein coding RNA 1154 |
LINC01157 | LINC01157 | TCONSN/A00010378, linc-Enc1 | long intergenic non-protein coding RNA 1157 |
LINC01158 | LINC01158 | linc-Brn1a | long intergenic non-protein coding RNA 1158 |
LINC01159 | LINC01159 | linc-Brn1b | long intergenic non-protein coding RNA 1159 |
LINC01184 | LINC01184 | FLJ33630 | long intergenic non-protein coding RNA 1184 |
LINC01185 | LINC01185 | FLJ16341 | long intergenic non-protein coding RNA 1185 |
LINC01191 | LINC01191 | VIN, lnc-ACTR3 | long intergenic non-protein coding RNA 1191 |
LINC01192 | LINC01192 | N/A | long intergenic non-protein coding RNA 1192 |
LINC01193 | LINC01193 | LOC348120 | long intergenic non-protein coding RNA 1193 |
LINC01194 | LINC01194 | TAG | long intergenic non-protein coding RNA 1194 |
LINC01202 | LINC01202 | N/A | long intergenic non-protein coding RNA 1202 |
LINC01207 | LINC01207 | N/A | long intergenic non-protein coding RNA 1207 |
LINC01225 | LINC01225 | N/A | long intergenic non-protein coding RNA 1225 |
LINC01228 | LINC01228 | lincRNA-DYNLRB2-2 | long intergenic non-protein coding RNA 1228 |
LINC01230 | LINC01230 | linc-DMRT2, lnc-DRMT2, TCONSN/A00015639 | long intergenic non-protein coding RNA 1230 |
LINC01232 | LINC01232 | FLJ41590, TCONSN/A00021520 | long intergenic non-protein coding RNA 1232 |
LINC01233 | LINC01233 | XLOCN/A013014 | long intergenic non-protein coding RNA 1233 |
LINC01234 | LINC01234 | onco-lncRNA-32 | long intergenic non-protein coding RNA 1234 |
LINC01252 | LINC01252 | N/A | long intergenic non-protein coding RNA 1252 |
LINC01262 | LINC01262 | TCONSN/Al2N/A00021807, RP11-462G22.1 | long intergenic non-protein coding RNA 1262 |
LINC01264 | LINC01264 | RP11-124O11.2 | long intergenic non-protein coding RNA 1264 |
LINC01268 | LINC01268 | LOC285758 | long intergenic non-protein coding RNA 1268 |
LINC01296 | LINC01296 | FLJ39632 | long intergenic non-protein coding RNA 1296 |
LINC01312 | LINC01312 | MGC34034 | long intergenic non-protein coding RNA 1312 |
LINC01317 | LINC01317 | N/A | long intergenic non-protein coding RNA 1317 |
LINC01370 | LINC01370 | HI-LNC25 | long intergenic non-protein coding RNA 1370 |
LINC01374 | LINC01374 | TCONSN/A00018278 | long intergenic non-protein coding RNA 1374 |
LINC01405 | LINC01405 | N/A | long intergenic non-protein coding RNA 1405 |
LINC01411 | LINC01411 | RP11-267A15.1 | long intergenic non-protein coding RNA 1411 |
LINC01420 | LINC01420 | N/A | long intergenic non-protein coding RNA 1420 |
LINC01433 | LINC01433 | LOC728228 | long intergenic non-protein coding RNA 1433 |
LINC01435 | LINC01435 | RP11-215N21.1, TCONSN/A00018040 | long intergenic non-protein coding RNA 1435 |
LINC01436 | LINC01436 | AP000688.8 | long intergenic non-protein coding RNA 1436 |
LINC01468 | LINC01468 | lnc-MBL2-4 | long intergenic non-protein coding RNA 1468 |
LINC01478 | LINC01478 | N/A | long intergenic non-protein coding RNA 1478 |
LINC01501 | LINC01501 | N/A | long intergenic non-protein coding RNA 1501 |
LINC01503 | LINC01503 | lnc-PPP2R4-5 | long intergenic non-protein coding RNA 1503 |
LINC01507 | LINC01507 | XLOCN/A000303 | long intergenic non-protein coding RNA 1507 |
LINC01511 | LINC01511 | RP11-325I22.2 | long intergenic non-protein coding RNA 1511 |
LINC01512 | LINC01512 | LOC100132354, TCONSN/A00011120, HI-LNC77 | long intergenic non-protein coding RNA 1512 |
LINC01513 | LINC01513 | RP11-1C1.7, TCONSN/A00009352 | long intergenic non-protein coding RNA 1513 |
LINC01525 | LINC01525 | lnc-MAN1A2-1 | long intergenic non-protein coding RNA 1525 |
LINC01526 | LINC01526 | Lnc-FAM46A-1 | long intergenic non-protein coding RNA 1526 |
LINC01527 | LINC01527 | lnc-SPRR2D-1 | long intergenic non-protein coding RNA 1527 |
LINC01537 | LINC01537 | RP11-169D4.1-001 | long intergenic non-protein coding RNA 1537 |
LINC01547 | LINC01547 | N/A | long intergenic non-protein coding RNA 1547 |
LINC01553 | LINC01553 | AC023904.2 | long intergenic non-protein coding RNA 1553 |
LINC01558 | LINC01558 | HGC6.2, dJ431P23.4 | long intergenic non-protein coding RNA 1558 |
LINC01559 | LINC01559 | FLJ33810 | long intergenic non-protein coding RNA 1559 |
LINC01560 | LINC01560 | N/A | long intergenic non-protein coding RNA 1560 |
LINC01562 | LINC01562 | RP11-296A18.3 | long intergenic non-protein coding RNA 1562 |
LINC01564 | LINC01564 | TCONSN/A00011314 | long intergenic non-protein coding RNA 1564 |
LINC01565 | LINC01565 | GR6 | long intergenic non-protein coding RNA 1565 |
LINC01574 | LINC01574 | HI-LNC12, TCONSN/A00009551 | long intergenic non-protein coding RNA 1574 |
LINC01587 | LINC01587 | aC1 | long intergenic non-protein coding RNA 1587 |
LINC01589 | LINC01589 | CTA-941F9.9, TCONSN/A00029353 | long intergenic non-protein coding RNA 1589 |
LINC01591 | LINC01591 | N/A | long intergenic non-protein coding RNA 1591 |
LINC01602 | LINC01602 | T1560 | long intergenic non-protein coding RNA 1602 |
LINC01611 | LINC01611 | RP1-90L14.1, TCONSN/Al2N/A00025430 | long intergenic non-protein coding RNA 1611 |
LINC01612 | LINC01612 | RP11-789C1.1, TCONSN/A00008319 | long intergenic non-protein coding RNA 1612 |
LINC01613 | LINC01613 | n341773 | long intergenic non-protein coding RNA 1613 |
LINC01614 | LINC01614 | LCAL4, TCONSN/A00003105 | long intergenic non-protein coding RNA 1614 |
LINC01616 | LINC01616 | n341006 | long intergenic non-protein coding RNA 1616 |
LINC01617 | LINC01617 | XLOCN/A006844 | long intergenic non-protein coding RNA 1617 |
LINC01618 | LINC01618 | LOC152578 | long intergenic non-protein coding RNA 1618 |
LINC01622 | LINC01622 | TCONSN/A00011202 | long intergenic non-protein coding RNA 1622 |
LINC01627 | LINC01627 | RP11-397D12.4 | long intergenic non-protein coding RNA 1627 |
LINC01628 | LINC01628 | AC007403.1 | long intergenic non-protein coding RNA 1628 |
LINC01629 | LINC01629 | linc-KIAA1737-2 | long intergenic non-protein coding RNA 1629 |
LINCMD1 | LINCMD1 | N/A | long intergenic non-protein coding RNA, muscle differentiation 1 |
LINC-PINT | LINC-PINT | FLJ43663, PINT, LincRNA-Pint | long intergenic non-protein coding RNA, p53 induced transcript |
lincRNA-ROR | NONHSAT059436 | ROR, lincRNA-ST8SIA3, ENSG00000258609 | long intergenic non-protein coding RNA, regulator of reprogramming |
LINGO1-AS1 | LINGO1-AS1 | N/A | LINGO1 antisense RNA 1 |
LMCD1-AS1 | LMCD1-AS1 | N/A | LMCD1 antisense RNA 1 (head to head) |
LOC100887755 | lnc-SNAI1-1:1 | Noncoding RNA activating7: ncRNA-a7, ENST00000431460.1,ENSG00000231265,TRERNA1 | translation regulatory long non-coding RNA 1 |
LOH12CR2 | LOH12CR2 | LOH2CR12 | loss of heterozygosity, 12, chromosomal region 2 (non-protein coding) |
LOXL1-AS1 | LOXL1-AS1 | N/A | LOXL1 antisense RNA 1 |
LPP-AS2 | LPP-AS2 | N/A | LPP antisense RNA 2 |
LRP1-AS | LRP1-AS | N/A | LRP1 antisense RNA |
LRRC75A-AS1 | LRRC75A-AS1 | MGC40157 | LRRC75A antisense RNA 1 |
LSINCT5 | LSINCT5 | N/A | long stress-induced non-coding transcript 5 |
LUADT1 | LUADT1 | N/A | lung adenocarcinoma associated transcript 1 |
LUCAT1 | LUCAT1 | SCAL1 | lung cancer associated transcript 1 (non-protein coding) |
LUNAR1 | LUNAR1 | N/A | leukemia-associated non-coding IGF1R activator RNA 1 |
MAFA-AS1 | MAFA-AS1 | RP11-909N17.3, TCONSN/A00014882 | MAFA antisense RNA 1 |
MAFG-AS1 | MAFG-AS1 | N/A | MAFG antisense RNA 1 (head to head) |
MAFTRR | MAFTRR | linc-MAF-4 | MAF transcriptional regulator RNA |
MAGEA8-AS1 | MAGEA8-AS1 | RP5-869M20.2 | MAGEA8 antisense RNA 1 (head to head) |
MALAT1 | ENST00000534336.1 | HCN, hepcarcin, LINC00047, long intergenic non-protein coding RNA 47, MALAT-1, mascRNA, metastasis associated in lung adenocarcinoma transcript 1, NCRNA00047, NEAT2, non-protein coding RNA 47, nuclear enriched abundant transcript 2, nuclear paraspeckle assembly transcript 2 (non-protein coding), PRO1073, ENSG00000251562 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
MAPKAPK5-AS1 | MAPKAPK5-AS1 | FLJ39616 | MAPKAPK5 antisense RNA 1 |
mascRNA | lnc-SCYL1-1:5 | Malat1 | mascRNA (MALAT1-associated small cytoplasmic RNA) |
MCM3AP-AS1 | MCM3AP-AS1 | FLJ10508, NCRNA00031 | MCM3AP antisense RNA 1 |
MDC1-AS1 | MDC1-AS1 | MDC1-AS | MDC1 antisense RNA 1 |
MEF2C-AS1 | MEF2C-AS1 | N/A | MEF2C antisense RNA 1 |
MEG3 | NONHSAT039745 | Gtl2, ENSG00000214548 | maternally expressed 3 (non-protein coding) |
MEG8 | ENST00000553584.1 | Bsr, Imprinted RNA near Meg3/Gtl2, Irm, LINC00024, long intergenic non-protein coding RNA 24, NCRNA00024, non-protein coding RNA 24, Rian, RNA Imprinted and Accumulated in Nucleus, ENSG00000258399 | Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8 |
MEG9 | MEG9 | LINC00584 | maternally expressed 9 (non-protein coding) |
MESTIT1 | MESTIT1 | NCRNA00040, MEST-AS1 | MEST intronic transcript 1, antisense RNA |
MGAT3-AS1 | MGAT3-AS1 | TapSAKI | MGAT3 antisense RNA 1 |
MHRT | MHRT | Myheart | myosin heavy chain-associated RNA transcript |
MIAT | lnc-CRYBA4-2:1 | FLJ25967, gomafu, LINC00066, lncRNA-MIAT, long intergenic non-protein coding RNA 66, NCRNA00066, non-protein coding RNA 66, Rncr2 | myocardial infarction associated transcript (non-protein coding) |
MIF-AS1 | MIF-AS1 | LOC284889 | MIF antisense RNA 1 |
MIMT1 | MIMT1 | MIM1, NCRNA00067, LINC00067 | MER1 repeat containing imprinted transcript 1 (non-protein coding) |
MINCR | MINCR | TCONSN/A00015189 | MYC-induced long noncoding RNA |
MIR100HG | MIR100HG | AGD1, lncRNA-N2 | mir-100-let-7a-2 cluster host gene |
MIR137HG | MIR137HG | N/A | MIR137 host gene |
MIR155HG | MIR155HG | BIC, NCRNA00172 | MIR155 host gene |
MIR17HG | MIR17HG | FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048 | miR-17-92a-1 cluster host gene |
MIR181A2HG | MIR181A2HG | N/A | MIR181A2 host gene |
MIR210HG | MIR210HG | N/A | MIR210 host gene |
MIR222HG | MIR222HG | Lnc-Ang362 | MIR222 host gene |
MIR22HG | MIR22HG | MGC14376, DKFZp686O06159, LOC554202 | MIR22 host gene |
MIR34AHG | MIR34AHG | N/A | MIR34A host gene |
MIR4435-2HG | MIR4435-2HG | LINC00978, AGD2, AK001796 | MIR4435-2 host gene |
MIR503HG | MIR503HG | MGC16121, H19X | MIR503 host gene |
MIR600HG | MIR600HG | GL012, FLJ22161 | MIR600 host gene |
MIR663AHG | MIR663AHG | RP3-410C9.1 | MIR663A host gene |
MIR7-3HG | MIR7-3HG | PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2 | MIR7-3 host gene |
MIR99AHG | MIR99AHG | MONC | mir-99a-let-7c cluster host gene |
MIRLET7BHG | MIRLET7BHG | linc-Ppara | MIRLET7B host gene |
MIRLET7DHG | MIRLET7DHG | N/A | MIRLET7D host gene |
MKRN3-AS1 | MKRN3-AS1 | FNZ127, NCRNA00009, ZNF127-AS | MKRN3 antisense RNA 1 |
MLK7-AS1 | MLK7-AS1 | N/A | MLK7 antisense RNA 1 |
MLLT4-AS1 | MLLT4-AS1 | HGC6.4, dJ431P23.3 | MLLT4 antisense RNA 1 (head to head) |
MORF4L2-AS1 | MORF4L2-AS1 | N/A | MORF4L2 antisense RNA 1 |
MT-LIPCAR | MT-LIPCAR | uc022bqs.1, LIPCAR | mitochondrially encoded long non-coding cardiac associated RNA |
MYCNOS | MYCNOS | NCYM, N-CYM, MYCN-AS1 | MYCN opposite strand |
MYCNUT | MYCNUT | lncUSMycN | MYCN upstream transcript (non-protein coding) |
N4BP2L2-IT2 | N4BP2L2-IT2 | CG030 | N4BPL2 intronic transcript 2 |
NALT1 | NALT1 | TCONSN/Al2N/A00029132 | NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1 |
NAMA | NAMA | N/A | non-protein coding RNA, associated with MAP kinase pathway and growth arrest |
NBAT1 | NBAT1 | NBAT-1 | neuroblastoma associated transcript 1 |
NBR2 | NBR2 | NCRNA00192 | neighbor of BRCA1 gene 2 (non-protein coding) |
NCBP2-AS2 | NCBP2-AS2 | N/A | NCBP2 antisense RNA 2 (head to head) |
NCOA7-AS1 | NCOA7-AS1 | N/A | NCOA7 antisense RNA 1 |
ncR-PAR | NONHSAT102247 | NCRUPAR, ENSG00000225407 | non-protein coding RNA, upstream of F2R/PAR1 |
NCRUPAR | NCRUPAR | ncR-uPAR, ncRuPAR, NCRNA00193 | non-protein coding RNA, upstream of F2R/PAR1 |
NDM29 | lnc-C11orf16-1:1 | 29A | neuroblastoma differentiation marker 29 (Castelnuovo (2010),?Pagano (2007)). |
NEAT1 | ENST00000501122.2,NONHSAT022111 | MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532 | Nuclear enriched abundant transcript 1. |
NFIA-AS1 | NFIA-AS1 | RP5-833A20.1 | NFIA antisense RNA 1 |
NIPBL-AS1 | NIPBL-AS1 | NIPBL-AS | NIPBL antisense RNA 1 (head to head) |
NKILA | NKILA | N/A | NF-kappaB interacting long non-coding RNA |
NKX2-2-AS1 | NKX2-2-AS1 | NKX2-2AS | NKX2-2 antisense RNA 1 |
NOP14-AS1 | NOP14-AS1 | RES4-24 | NOP14 antisense RNA 1 |
NORAD | NORAD | N/A | non-coding RNA activated by DNA damage |
NPHP3-AS1 | NPHP3-AS1 | N/A | NPHP3 antisense RNA 1 |
NPPA-AS1 | NPPA-AS1 | N/A | NPPA antisense RNA 1 |
NPSR1-AS1 | NPSR1-AS1 | AAA1, IMAGE:4827585 | NPSR1 antisense RNA 1 |
NPTN-IT1 | NPTN-IT1 | lncRNA-LET | NPTN intronic transcript 1 |
NR2F1-AS1 | NR2F1-AS1 | FLJ42709 | NR2F1 antisense RNA 1 |
NRAV | NRAV | N/A | negative regulator of antiviral response (non-protein coding) |
NRIR | NRIR | lncRNA-CMPK2 | negative regulator of interferon response (non-protein coding) |
NRON | NONHSAT134764 | ENSG00000253079 | non-protein coding RNA, repressor of NFAT |
NTT | NONHSAT115106 | N/A | noncoding transcript in T cells. |
OIP5-AS1 | ENST00000500949.2 | cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1 | OIP5 antisense RNA 1 |
OLMALINC | OLMALINC | bA34D15.5, FLJ12974, HI-LNC80 | oligodendrocyte maturation-associated long intergenic non-coding RNA |
OTX2-AS1 | lnc-C14orf101-5:1 | OTX2OS1, ENSG00000248550 | OTX2 antisense RNA 1 (head to head) |
OVAAL | OVAAL | LINC01131,OVAL | ovarian adenocarcinoma amplified long non-coding RNA |
PACERR | PACERR | PACER, PTGS2-AS1 | PTGS2 antisense NFKB1 complex-mediated expression regulator RNA |
PANCR | PANCR | N/A | PITX2 adjacent non-coding RNA |
PANDAR | lnc-CDKN1A-1:1 | P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR | promoter of CDKN1A antisense DNA damage activated RNA |
PAPPA-AS1 | PAPPA-AS1 | PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156 | PAPPA antisense RNA 1 |
PAPPA-AS2 | PAPPA-AS2 | AGU1 | PAPPA antisense RNA 2 |
PART1 | PART1 | DKFZP586D0823, NCRNA00206 | prostate androgen-regulated transcript 1 (non-protein coding) |
PARTICL | PARTICL | PARTICLE | promoter of MAT2A antisense radiation-induced circulating long non-coding RNA |
PAUPAR | PAUPAR | N/A | PAX6 upstream antisense RNA |
PAXIP1-AS1 | PAXIP1-AS1 | N/A | PAXIP1 antisense RNA 1 (head to head) |
PCA3 | PCA3 | DD3, NCRNA00019, PCAT3 | prostate cancer associated 3 (non-protein coding) |
PCAT1 | PCAT1 | PCAT-1, PCA1 | prostate cancer associated transcript 1 (non-protein coding) |
PCAT14 | PCAT14 | N/A | prostate cancer associated transcript 14 (non-protein coding) |
PCAT18 | PCAT18 | LINC01092 | prostate cancer associated transcript 18 (non-protein coding) |
PCAT19 | PCAT19 | LINC01190 | prostate cancer associated transcript 19 (non-protein coding) |
PCAT29 | PCAT29 | N/A | prostate cancer associated transcript 29 (non-protein coding) |
PCAT4 | PCAT4 | GDEP, PCAN1, PCA4 | prostate cancer associated transcript 4 (non-protein coding) |
PCAT5 | PCAT5 | TPCAT-10-36067 | prostate cancer associated transcript 5 (non-protein coding) |
PCAT6 | ENST00000425295.1,ENST00000553157.1,ENST00000417262.1 | N/A | Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288 |
PCAT7 | PCAT7 | PCAN-R2 | prostate cancer associated transcript 7 (non-protein coding) |
PCBP2-OT1 | PCBP2-OT1 | TUC338 | PCBP2 overlapping transcript 1 |
PCBP3-OT1 | PCBP3-OT1 | FLJ44028 | PCBP3 overlapping transcript 1 |
PCF11-AS1 | PCF11-AS1 | ENST00000602322.1 | PCF11 anstisense RNA 1 |
PCGEM1 | NONHSAT076153 | ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA | Prostate-specific transcript 1 |
PCNA-AS1 | PCNA-AS1 | N/A | PCNA antisense RNA 1 |
PEG13 | PEG13 | N/A | paternally expressed 13 |
PEG3-AS1 | PEG3-AS1 | APEG3, NCRNA00155 | PEG3 antisense RNA 1 |
PICSAR | PICSAR | PRED74, NLC1-C | P38 inhibited cutaneous squamous cell carcinoma associated lincRNA |
PINK1-AS | PINK1-AS | FLJ00387, PINK1AS, naPINK1 | PINK1 antisense RNA |
PISRT1 | PISRT1 | NCRNA00195 | polled intersex syndrome regulated transcript 1 (non-protein coding RNA) |
PR antisense transcripts | NONHSAT023851 | N/A | N/A |
PRINS | NONHSAT011777 | ENSG00000238115 | Psoriasis susceptibility-related RNA Gene Induced by Stress |
PRKCQ-AS1 | PRKCQ-AS1 | ENST00000414894.1 | PRKCQ antisense RNA 1 |
PRNCR1 | PRNCR1 | N/A | prostate cancer associated non-coding RNA 1 |
PRR7-AS1 | PRR7-AS1 | N/A | PRR7 antisense RNA 1 |
PSMA3-AS1 | PSMA3-AS1 | FLJ31306 | PSMA3 antisense RNA 1 |
PSMD5-AS1 | PSMD5-AS1 | N/A | PSMD5 antisense RNA 1 (head to head) |
PTCSC1 | NONHSAT129210 | AK023948, NCRNA00197 | papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding) |
PTCSC2 | PTCSC2 | N/A | papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding) |
PTCSC3 | PTCSC3 | N/A | papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) |
PTENP1 | NONHSAT130775 | PTENpg1, PTEN2, ENSG00000237984 | PTEN Pseudogene 1 |
PTENP1-AS | PTENP1-AS | PTENpg1-asRNA | PTENP1 antisense RNA |
PTPRJ-AS1 | PTPRJ-AS1 | N/A | PTPRJ antisense RNA 1 |
PVT1 | PVT1 | NCRNA00079, LINC00079, onco-lncRNA-100 | Pvt1 oncogene (non-protein coding) |
PWAR1 | PWAR1 | PAR1, PAR-1 | Prader Willi/Angelman region RNA 1 |
PWAR4 | PWAR4 | PAR4, PAR-4 | Prader Willi/Angelman region RNA 4 |
PWAR5 | PWAR5 | PAR5, PAR-5 | Prader Willi/Angelman region RNA 5 |
PWARSN | PWARSN | PAR-SN, PARSN | Prader Willi/Angelman region RNA, SNRPN neighbor |
PWRN1 | PWRN1 | NCRNA00198 | Prader-Willi region non-protein coding RNA 1 |
PWRN2 | PWRN2 | NCRNA00199 | Prader-Willi region non-protein coding RNA 2 |
RAD51-AS1 | RAD51-AS1 | TODRA | RAD51 antisense RNA 1 (head to head) |
RASSF1-AS1 | RASSF1-AS1 | RASSF1 antisense RNA 1 | ANRASSF1 |
RBM5-AS1 | NONHSAT089783 | LUCA-15-specific transcript, LUST, ENSG00000003756 | RBM5 antisense RNA 1 |
RFPL1S | RFPL1S |